NO820046L - ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOXYLIC ACID DERIVATIVES - Google Patents
ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOXYLIC ACID DERIVATIVESInfo
- Publication number
- NO820046L NO820046L NO820046A NO820046A NO820046L NO 820046 L NO820046 L NO 820046L NO 820046 A NO820046 A NO 820046A NO 820046 A NO820046 A NO 820046A NO 820046 L NO820046 L NO 820046L
- Authority
- NO
- Norway
- Prior art keywords
- group
- benzoic acid
- general formula
- theoretical
- yield
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 28
- 238000000034 method Methods 0.000 title claims description 11
- 150000001732 carboxylic acid derivatives Chemical class 0.000 title description 11
- 230000001225 therapeutic effect Effects 0.000 title 1
- -1 cyano, hydroxy Chemical group 0.000 claims description 133
- 150000001875 compounds Chemical class 0.000 claims description 84
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 79
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 64
- 239000005711 Benzoic acid Substances 0.000 claims description 54
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 40
- 125000004432 carbon atom Chemical group C* 0.000 claims description 34
- 235000010233 benzoic acid Nutrition 0.000 claims description 33
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 27
- 229910052757 nitrogen Inorganic materials 0.000 claims description 27
- 239000000460 chlorine Substances 0.000 claims description 25
- 229910052739 hydrogen Inorganic materials 0.000 claims description 24
- 239000001257 hydrogen Substances 0.000 claims description 24
- 125000000217 alkyl group Chemical group 0.000 claims description 23
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 23
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 21
- 239000011541 reaction mixture Substances 0.000 claims description 21
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 20
- 229910052801 chlorine Inorganic materials 0.000 claims description 20
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 18
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 17
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 17
- 229910052731 fluorine Inorganic materials 0.000 claims description 17
- 239000011737 fluorine Substances 0.000 claims description 17
- 150000001412 amines Chemical class 0.000 claims description 16
- 239000002585 base Substances 0.000 claims description 16
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 15
- 229910052794 bromium Inorganic materials 0.000 claims description 15
- 229910052740 iodine Inorganic materials 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 12
- 230000007062 hydrolysis Effects 0.000 claims description 12
- 238000006460 hydrolysis reaction Methods 0.000 claims description 12
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 11
- 125000005843 halogen group Chemical group 0.000 claims description 11
- 125000003545 alkoxy group Chemical group 0.000 claims description 8
- 125000003277 amino group Chemical group 0.000 claims description 7
- 150000007522 mineralic acids Chemical class 0.000 claims description 7
- 150000007524 organic acids Chemical class 0.000 claims description 7
- 235000005985 organic acids Nutrition 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 4
- 150000001408 amides Chemical class 0.000 claims description 4
- 230000032050 esterification Effects 0.000 claims description 4
- 238000005886 esterification reaction Methods 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- 239000002841 Lewis acid Substances 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 125000004429 atom Chemical group 0.000 claims description 3
- 150000007517 lewis acids Chemical class 0.000 claims description 3
- 230000000269 nucleophilic effect Effects 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 claims description 2
- 150000001447 alkali salts Chemical class 0.000 claims description 2
- 125000005907 alkyl ester group Chemical group 0.000 claims 3
- 150000001735 carboxylic acids Chemical class 0.000 claims 3
- WXBLLCUINBKULX-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1 WXBLLCUINBKULX-UHFFFAOYSA-N 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 238000002844 melting Methods 0.000 description 184
- 230000008018 melting Effects 0.000 description 184
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 74
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 57
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 55
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 46
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 44
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 41
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 38
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 35
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 32
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 32
- 238000006243 chemical reaction Methods 0.000 description 29
- 238000000297 Sandmeyer reaction Methods 0.000 description 28
- RBLUWLZGAZETKS-UHFFFAOYSA-N ethyl 4-(2-aminoethyl)benzoate Chemical compound CCOC(=O)C1=CC=C(CCN)C=C1 RBLUWLZGAZETKS-UHFFFAOYSA-N 0.000 description 28
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 27
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 26
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 25
- 229960000583 acetic acid Drugs 0.000 description 22
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 22
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 21
- 239000002904 solvent Substances 0.000 description 21
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 16
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 16
- 238000007127 saponification reaction Methods 0.000 description 16
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 15
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 14
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 14
- 238000005695 dehalogenation reaction Methods 0.000 description 13
- 235000011121 sodium hydroxide Nutrition 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- 238000009835 boiling Methods 0.000 description 11
- 230000003197 catalytic effect Effects 0.000 description 11
- 235000019260 propionic acid Nutrition 0.000 description 11
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 11
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 10
- 239000004305 biphenyl Substances 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 9
- QUEKGYQTRJVEQC-UHFFFAOYSA-N 2516-96-3 Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1Cl QUEKGYQTRJVEQC-UHFFFAOYSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 239000012954 diazonium Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000003208 petroleum Substances 0.000 description 8
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 8
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 7
- 239000001569 carbon dioxide Substances 0.000 description 7
- 229910002092 carbon dioxide Inorganic materials 0.000 description 7
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 7
- 150000001989 diazonium salts Chemical class 0.000 description 7
- 239000003480 eluent Substances 0.000 description 7
- WCTQEHGXBKFLKG-UHFFFAOYSA-N ethyl 4-(aminomethyl)benzoate Chemical compound CCOC(=O)C1=CC=C(CN)C=C1 WCTQEHGXBKFLKG-UHFFFAOYSA-N 0.000 description 7
- 238000001704 evaporation Methods 0.000 description 7
- 230000008020 evaporation Effects 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- SXQSMLIMBNMUNB-UHFFFAOYSA-N 2,5-dichloropyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC(Cl)=CN=C1Cl SXQSMLIMBNMUNB-UHFFFAOYSA-N 0.000 description 6
- BUSXHOIFZKTAFN-UHFFFAOYSA-N 2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-5-aminobenzoic acid Chemical compound OC(=O)C1=CC(N)=CC=C1N1CC2CCCCC2C1 BUSXHOIFZKTAFN-UHFFFAOYSA-N 0.000 description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 125000004093 cyano group Chemical group *C#N 0.000 description 6
- YFLWCZIVJVCWNQ-UHFFFAOYSA-N ethyl 4-(2-aminoethyl)benzoate;hydrochloride Chemical compound Cl.CCOC(=O)C1=CC=C(CCN)C=C1 YFLWCZIVJVCWNQ-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- KNCGDIHMXCSJDC-UHFFFAOYSA-N 2-(2-chloro-5-nitrophenyl)acetic acid Chemical compound OC(=O)CC1=CC([N+]([O-])=O)=CC=C1Cl KNCGDIHMXCSJDC-UHFFFAOYSA-N 0.000 description 5
- DFRXZLUYJPVZIT-UHFFFAOYSA-N 5-amino-2-(4-pentan-3-ylpiperidin-1-yl)benzoic acid Chemical compound NC=1C=CC(=C(C(=O)O)C1)N1CCC(CC1)C(CC)CC DFRXZLUYJPVZIT-UHFFFAOYSA-N 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 239000002026 chloroform extract Substances 0.000 description 5
- 239000010949 copper Substances 0.000 description 5
- 229910052802 copper Inorganic materials 0.000 description 5
- 229960003512 nicotinic acid Drugs 0.000 description 5
- 239000011664 nicotinic acid Substances 0.000 description 5
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- ODSNARDHJFFSRH-UHFFFAOYSA-N 2,3,3a,4,5,6,7,7a-octahydro-1h-isoindole Chemical compound C1CCCC2CNCC21 ODSNARDHJFFSRH-UHFFFAOYSA-N 0.000 description 4
- AZUFZNBAWWYNHK-UHFFFAOYSA-N 2-(1,3,3a,4,7,7a-hexahydroisoindol-2-yl)-5-aminobenzoic acid Chemical compound OC(=O)C1=CC(N)=CC=C1N1CC2CC=CCC2C1 AZUFZNBAWWYNHK-UHFFFAOYSA-N 0.000 description 4
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 4
- SPHWOQIQMWGODY-UHFFFAOYSA-N 5-chloro-2-(4-pentan-3-ylpiperidin-1-yl)benzoic acid Chemical compound ClC=1C=CC(=C(C(=O)O)C1)N1CCC(CC1)C(CC)CC SPHWOQIQMWGODY-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 4
- 230000010933 acylation Effects 0.000 description 4
- 238000005917 acylation reaction Methods 0.000 description 4
- 230000029936 alkylation Effects 0.000 description 4
- 238000005804 alkylation reaction Methods 0.000 description 4
- 150000008064 anhydrides Chemical class 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 229940093915 gynecological organic acid Drugs 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 229960004592 isopropanol Drugs 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 150000002905 orthoesters Chemical class 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 235000010288 sodium nitrite Nutrition 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- IDWRJRPUIXRFRX-KNVOCYPGSA-N (3r,5s)-3,5-dimethylpiperidine Chemical compound C[C@H]1CNC[C@@H](C)C1 IDWRJRPUIXRFRX-KNVOCYPGSA-N 0.000 description 3
- FQUJJEOJWYYNPB-UHFFFAOYSA-N 2-(5-chloro-2,3,4,5,6,7,7a,8-octahydro-1H-1-benzazonin-8-yl)acetic acid Chemical compound ClC1CCC2C(=CC=CC2CC(=O)O)NCCC1 FQUJJEOJWYYNPB-UHFFFAOYSA-N 0.000 description 3
- GLEYNGXPIIFRKB-UHFFFAOYSA-N 2-(5-chloro-2-piperidin-1-ylphenyl)acetic acid Chemical compound OC(=O)CC1=CC(Cl)=CC=C1N1CCCCC1 GLEYNGXPIIFRKB-UHFFFAOYSA-N 0.000 description 3
- UESBCOJAAOSJQJ-UHFFFAOYSA-N 2-[2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-5-chlorophenyl]acetic acid Chemical compound OC(=O)CC1=CC(Cl)=CC=C1N1CC2CCCCC2C1 UESBCOJAAOSJQJ-UHFFFAOYSA-N 0.000 description 3
- SJEJXIIOMXNGRP-UHFFFAOYSA-N 5-amino-2-(1,3-dihydroisoindol-2-yl)benzoic acid Chemical compound OC(=O)C1=CC(N)=CC=C1N1CC2=CC=CC=C2C1 SJEJXIIOMXNGRP-UHFFFAOYSA-N 0.000 description 3
- FZSWRICZSDBBTA-UHFFFAOYSA-N 5-chloro-2-(1,3-dihydroisoindol-2-yl)benzoic acid Chemical compound OC(=O)C1=CC(Cl)=CC=C1N1CC2=CC=CC=C2C1 FZSWRICZSDBBTA-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 239000007868 Raney catalyst Substances 0.000 description 3
- 229910000564 Raney nickel Inorganic materials 0.000 description 3
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 230000021523 carboxylation Effects 0.000 description 3
- 238000006473 carboxylation reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003245 coal Substances 0.000 description 3
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- HYBVWCPWTPZFQE-UHFFFAOYSA-N methyl 4-(2-aminoethyl)benzoate;hydrochloride Chemical compound Cl.COC(=O)C1=CC=C(CCN)C=C1 HYBVWCPWTPZFQE-UHFFFAOYSA-N 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 150000007530 organic bases Chemical group 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 235000011007 phosphoric acid Nutrition 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 150000007970 thio esters Chemical class 0.000 description 3
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 2
- VGUJAYWJJRUFKB-UHFFFAOYSA-N 2,5-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=NC(Cl)=C(C(O)=O)C=C1Cl VGUJAYWJJRUFKB-UHFFFAOYSA-N 0.000 description 2
- SBPWUFIVIXDGFU-UHFFFAOYSA-N 2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-5-bromobenzoic acid Chemical compound OC(=O)C1=CC(Br)=CC=C1N1CC2CCCCC2C1 SBPWUFIVIXDGFU-UHFFFAOYSA-N 0.000 description 2
- FFVBKEZCCHHUCQ-UHFFFAOYSA-N 2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-5-chloropyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC(Cl)=CN=C1N1CC2CCCCC2C1 FFVBKEZCCHHUCQ-UHFFFAOYSA-N 0.000 description 2
- VBNAHMLWOHZIBX-UHFFFAOYSA-N 2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-5-hydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1N1CC2CCCCC2C1 VBNAHMLWOHZIBX-UHFFFAOYSA-N 0.000 description 2
- NXHPJMQPCZEENH-UHFFFAOYSA-N 2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-5-nitrobenzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1N1CC2CCCCC2C1 NXHPJMQPCZEENH-UHFFFAOYSA-N 0.000 description 2
- OLSSZGGDNCOEFQ-UHFFFAOYSA-N 2-(1,3,3a,4,7,7a-hexahydroisoindol-2-yl)-5-nitrobenzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1N1CC2CC=CCC2C1 OLSSZGGDNCOEFQ-UHFFFAOYSA-N 0.000 description 2
- IFAYGRNFIHCFGS-UHFFFAOYSA-N 2-(4-azabicyclo[3.3.1]nonan-4-yl)-5-nitrobenzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1N1C(C2)CCCC2CC1 IFAYGRNFIHCFGS-UHFFFAOYSA-N 0.000 description 2
- SYMWAOVIFBMFSJ-UHFFFAOYSA-N 2-(5-amino-2-piperidin-1-ylphenyl)acetic acid Chemical compound OC(=O)CC1=CC(N)=CC=C1N1CCCCC1 SYMWAOVIFBMFSJ-UHFFFAOYSA-N 0.000 description 2
- PBXGVPNRGREOLW-UHFFFAOYSA-N 2-(5-amino-2-pyrrolidin-1-ylphenyl)acetic acid Chemical compound OC(=O)CC1=CC(N)=CC=C1N1CCCC1 PBXGVPNRGREOLW-UHFFFAOYSA-N 0.000 description 2
- YBUYROVESQMRPG-UHFFFAOYSA-N 2-(5-chloro-1,3-dihydroisoindol-2-yl)-5-nitrobenzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1N1CC2=CC(Cl)=CC=C2C1 YBUYROVESQMRPG-UHFFFAOYSA-N 0.000 description 2
- WJGCQYZNVBZAAM-UHFFFAOYSA-N 2-(5-chloro-2-piperidin-1-ylphenyl)propanoic acid Chemical compound OC(=O)C(C)C1=CC(Cl)=CC=C1N1CCCCC1 WJGCQYZNVBZAAM-UHFFFAOYSA-N 0.000 description 2
- FAJFVXBCIWUEDT-UHFFFAOYSA-N 2-(5-chloro-2-pyrrolidin-1-ylphenyl)acetic acid Chemical compound OC(=O)CC1=CC(Cl)=CC=C1N1CCCC1 FAJFVXBCIWUEDT-UHFFFAOYSA-N 0.000 description 2
- MIHYNVSNTINQBT-UHFFFAOYSA-N 2-(5-methoxy-1,3-dihydroisoindol-2-yl)-5-nitrobenzoic acid Chemical compound C1C2=CC(OC)=CC=C2CN1C1=CC=C([N+]([O-])=O)C=C1C(O)=O MIHYNVSNTINQBT-UHFFFAOYSA-N 0.000 description 2
- OAMLZHSUJCIZAA-UHFFFAOYSA-N 2-(5-nitro-2-piperidin-1-ylphenyl)acetic acid Chemical compound OC(=O)CC1=CC([N+]([O-])=O)=CC=C1N1CCCCC1 OAMLZHSUJCIZAA-UHFFFAOYSA-N 0.000 description 2
- GYDBXBJOSQHFLV-UHFFFAOYSA-N 2-(5-nitro-2-pyrrolidin-1-ylphenyl)acetic acid Chemical compound OC(=O)CC1=CC([N+]([O-])=O)=CC=C1N1CCCC1 GYDBXBJOSQHFLV-UHFFFAOYSA-N 0.000 description 2
- FHMPXEKRPXJXLZ-UHFFFAOYSA-N 2-[2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-5-nitrophenyl]acetic acid Chemical compound OC(=O)CC1=CC([N+]([O-])=O)=CC=C1N1CC2CCCCC2C1 FHMPXEKRPXJXLZ-UHFFFAOYSA-N 0.000 description 2
- RUHIXWBDOWVFSH-UHFFFAOYSA-N 2-[2-(azepan-1-yl)-5-nitrophenyl]acetic acid Chemical compound N1(CCCCCC1)C1=C(C=C(C=C1)[N+](=O)[O-])CC(=O)O RUHIXWBDOWVFSH-UHFFFAOYSA-N 0.000 description 2
- AWHIMRNDSMXCFT-UHFFFAOYSA-N 2-[5-amino-2-(azepan-1-yl)phenyl]acetic acid Chemical compound NC=1C=CC(=C(C=1)CC(=O)O)N1CCCCCC1 AWHIMRNDSMXCFT-UHFFFAOYSA-N 0.000 description 2
- WQEMTHXDNQQKKF-UHFFFAOYSA-N 4-[2-(N-acetyl-5-chloro-2-piperidin-1-ylanilino)ethyl]benzoic acid Chemical compound ClC=1C=CC(=C(C1)N(CCC1=CC=C(C(=O)O)C=C1)C(C)=O)N1CCCCC1 WQEMTHXDNQQKKF-UHFFFAOYSA-N 0.000 description 2
- HGWNVFYCBSQIFM-UHFFFAOYSA-N 4-[2-[[2-(4-azabicyclo[3.3.1]nonan-4-yl)-5-chlorobenzoyl]amino]ethyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CCNC(=O)C1=CC(Cl)=CC=C1N1C(C2)CCCC2CC1 HGWNVFYCBSQIFM-UHFFFAOYSA-N 0.000 description 2
- HRLNRYSVYHEMCL-UHFFFAOYSA-N 5-amino-2-(4-azabicyclo[3.3.1]nonan-4-yl)benzoic acid Chemical compound OC(=O)C1=CC(N)=CC=C1N1C(C2)CCCC2CC1 HRLNRYSVYHEMCL-UHFFFAOYSA-N 0.000 description 2
- WKMCCYKUXARGTL-UHFFFAOYSA-N 5-amino-2-(4-nonan-5-ylpiperidin-1-yl)benzoic acid Chemical compound NC=1C=CC(=C(C(=O)O)C1)N1CCC(CC1)C(CCCC)CCCC WKMCCYKUXARGTL-UHFFFAOYSA-N 0.000 description 2
- SQLMFAWMIOCOOH-UHFFFAOYSA-N 5-amino-2-(5-methoxy-1,3-dihydroisoindol-2-yl)benzoic acid Chemical compound C1C2=CC(OC)=CC=C2CN1C1=CC=C(N)C=C1C(O)=O SQLMFAWMIOCOOH-UHFFFAOYSA-N 0.000 description 2
- TUWCNCQDLYUSFQ-DTORHVGOSA-N 5-bromo-2-[(3s,5r)-3,5-dimethylpiperidin-1-yl]-6-methylpyridine-3-carboxylic acid Chemical compound C1[C@@H](C)C[C@@H](C)CN1C1=NC(C)=C(Br)C=C1C(O)=O TUWCNCQDLYUSFQ-DTORHVGOSA-N 0.000 description 2
- GCRXOERAOBJTJI-UHFFFAOYSA-N 5-bromo-2-chloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=NC(Cl)=C(C(O)=O)C=C1Br GCRXOERAOBJTJI-UHFFFAOYSA-N 0.000 description 2
- FLTMCVUUIBGFEV-UHFFFAOYSA-N 5-bromo-2-piperidin-1-ylpyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC(Br)=CN=C1N1CCCCC1 FLTMCVUUIBGFEV-UHFFFAOYSA-N 0.000 description 2
- FFADZWLPRJOURM-UHFFFAOYSA-N 5-bromo-6-methyl-2-piperidin-1-ylpyridine-3-carboxylic acid Chemical compound C1=C(Br)C(C)=NC(N2CCCCC2)=C1C(O)=O FFADZWLPRJOURM-UHFFFAOYSA-N 0.000 description 2
- FDZZKUCGEMKPHL-UHFFFAOYSA-N 5-chloro-2-(4-nonan-5-ylpiperidin-1-yl)benzoic acid Chemical compound ClC=1C=CC(=C(C(=O)O)C1)N1CCC(CC1)C(CCCC)CCCC FDZZKUCGEMKPHL-UHFFFAOYSA-N 0.000 description 2
- QWSOLAGQOXOXTG-UHFFFAOYSA-N 5-chloro-2-(5-methoxy-1,3-dihydroisoindol-2-yl)benzoic acid Chemical compound C1C2=CC(OC)=CC=C2CN1C1=CC=C(Cl)C=C1C(O)=O QWSOLAGQOXOXTG-UHFFFAOYSA-N 0.000 description 2
- HYCZUWKNZWIZDV-DTORHVGOSA-N 5-chloro-2-[(3r,5s)-3,5-dimethylpiperidin-1-yl]pyridine-3-carboxylic acid Chemical compound C1[C@@H](C)C[C@@H](C)CN1C1=NC=C(Cl)C=C1C(O)=O HYCZUWKNZWIZDV-DTORHVGOSA-N 0.000 description 2
- KWXDDXIMTSHOKE-UHFFFAOYSA-N 5-cyano-2-(4-pentan-3-ylpiperidin-1-yl)benzoic acid Chemical compound C(#N)C=1C=CC(=C(C(=O)O)C1)N1CCC(CC1)C(CC)CC KWXDDXIMTSHOKE-UHFFFAOYSA-N 0.000 description 2
- CRVAVJLIMWKGBN-UHFFFAOYSA-N 5-nitro-2-(4-pentan-3-ylpiperidin-1-yl)benzoic acid Chemical compound [N+](=O)([O-])C=1C=CC(=C(C(=O)O)C1)N1CCC(CC1)C(CC)CC CRVAVJLIMWKGBN-UHFFFAOYSA-N 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- QRWIRWPOHKZFMZ-UHFFFAOYSA-N CCOC(=O)C1=CC=C(C=C1)CCN(C2=C(C=CC(=C2)Cl)N3CCCCCC3)C(=O)C Chemical compound CCOC(=O)C1=CC=C(C=C1)CCN(C2=C(C=CC(=C2)Cl)N3CCCCCC3)C(=O)C QRWIRWPOHKZFMZ-UHFFFAOYSA-N 0.000 description 2
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 2
- GUMPZTJEMZBEKG-UHFFFAOYSA-N Cl.N1(CCCCC1)C(C(=O)O)(C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound Cl.N1(CCCCC1)C(C(=O)O)(C1=CC=CC=C1)C1=CC=CC=C1 GUMPZTJEMZBEKG-UHFFFAOYSA-N 0.000 description 2
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 2
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical class [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
- 241000009298 Trigla lyra Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 150000001409 amidines Chemical class 0.000 description 2
- NRHDCQLCSOWVTF-UHFFFAOYSA-N azonane Chemical compound C1CCCCNCCC1 NRHDCQLCSOWVTF-UHFFFAOYSA-N 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 125000004799 bromophenyl group Chemical group 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 2
- 125000000068 chlorophenyl group Chemical group 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 238000006193 diazotization reaction Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- ZELSFRHMYFZPBA-UHFFFAOYSA-N ethyl 4-[2-[[5-(4-chlorophenyl)-2-piperidin-1-ylbenzoyl]amino]ethyl]benzoate Chemical compound C(C)OC(C1=CC=C(C=C1)CCNC(C1=C(C=CC(=C1)C1=CC=C(C=C1)Cl)N1CCCCC1)=O)=O ZELSFRHMYFZPBA-UHFFFAOYSA-N 0.000 description 2
- FKQOXWHBNWYHIU-UHFFFAOYSA-N ethyl 4-[2-[[5-chloro-2-(1,3-dihydroisoindol-2-yl)benzoyl]amino]ethyl]benzoate Chemical compound C(C)OC(C1=CC=C(C=C1)CCNC(C1=C(C=CC(=C1)Cl)N1CC2=CC=CC=C2C1)=O)=O FKQOXWHBNWYHIU-UHFFFAOYSA-N 0.000 description 2
- DLAVJDCMDQYWEB-UHFFFAOYSA-N ethyl 4-[2-[[5-chloro-2-(4-pentan-3-ylpiperidin-1-yl)benzoyl]amino]ethyl]benzoate Chemical compound C(C)OC(C1=CC=C(C=C1)CCNC(C1=C(C=CC(=C1)Cl)N1CCC(CC1)C(CC)CC)=O)=O DLAVJDCMDQYWEB-UHFFFAOYSA-N 0.000 description 2
- DBVWOSOPMSLNFH-UHFFFAOYSA-N ethyl 4-[[2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-5-chlorophenyl]-acetamidomethyl]benzoate Chemical compound C(C)OC(C1=CC=C(C=C1)C(NC(C)=O)C1=C(C=CC(=C1)Cl)N1CC2CCCCC2C1)=O DBVWOSOPMSLNFH-UHFFFAOYSA-N 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 150000004820 halides Chemical group 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 150000002463 imidates Chemical class 0.000 description 2
- JBFYUZGYRGXSFL-UHFFFAOYSA-N imidazolide Chemical compound C1=C[N-]C=N1 JBFYUZGYRGXSFL-UHFFFAOYSA-N 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000006263 metalation reaction Methods 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- PGRXBPZMKRVUTN-UHFFFAOYSA-N methyl 2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-5-methoxybenzoate Chemical compound COC(C1=C(C=CC(=C1)OC)N1CC2CCCCC2C1)=O PGRXBPZMKRVUTN-UHFFFAOYSA-N 0.000 description 2
- KPUCADFYPKEWAN-UHFFFAOYSA-N methyl 4-[2-[(6-methyl-2-piperidin-1-ylpyridine-3-carbonyl)amino]ethyl]benzoate Chemical compound COC(C1=CC=C(C=C1)CCNC(C1=C(N=C(C=C1)C)N1CCCCC1)=O)=O KPUCADFYPKEWAN-UHFFFAOYSA-N 0.000 description 2
- 238000006396 nitration reaction Methods 0.000 description 2
- 125000002560 nitrile group Chemical group 0.000 description 2
- 150000002828 nitro derivatives Chemical class 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 150000002902 organometallic compounds Chemical class 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000001119 stannous chloride Substances 0.000 description 2
- 235000011150 stannous chloride Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- HHCLNZBCCQDVOQ-UHFFFAOYSA-N 1-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]pyrazol-3-yl]methyl]piperazin-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(N1CC2=C(CC1)NN=N2)=O)CN1C(CNCC1)=O HHCLNZBCCQDVOQ-UHFFFAOYSA-N 0.000 description 1
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 1
- HAWRXGIOVNBFBT-UHFFFAOYSA-N 2,2-diphenyl-2-piperidin-1-ylacetic acid Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)O)N1CCCCC1 HAWRXGIOVNBFBT-UHFFFAOYSA-N 0.000 description 1
- ADGDHLKQWFIASU-UHFFFAOYSA-N 2,2-diphenyl-2-piperidin-1-ylacetonitrile Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C#N)N1CCCCC1 ADGDHLKQWFIASU-UHFFFAOYSA-N 0.000 description 1
- UZFWCTSOYIFGCD-UHFFFAOYSA-N 2,2-diphenyl-2-pyrrolidin-1-ylacetic acid Chemical compound N1(CCCC1)C(C(=O)O)(C1=CC=CC=C1)C1=CC=CC=C1 UZFWCTSOYIFGCD-UHFFFAOYSA-N 0.000 description 1
- VRJMAKCJTSZUQR-UHFFFAOYSA-N 2,5-dichloropyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC(Cl)=CN=C1Cl VRJMAKCJTSZUQR-UHFFFAOYSA-N 0.000 description 1
- LSJHSKCISXICRB-UHFFFAOYSA-N 2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-3-chlorobenzoic acid Chemical compound OC(=O)C1=CC=CC(Cl)=C1N1CC2CCCCC2C1 LSJHSKCISXICRB-UHFFFAOYSA-N 0.000 description 1
- GVWISINCZNDBAS-UHFFFAOYSA-N 2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-3-methylbenzoic acid Chemical compound CC1=CC=CC(C(O)=O)=C1N1CC2CCCCC2C1 GVWISINCZNDBAS-UHFFFAOYSA-N 0.000 description 1
- MPMKMFZJLGQVJJ-UHFFFAOYSA-N 2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-5-iodobenzoic acid Chemical compound C1CCC2CN(CC2C1)C3=C(C=C(C=C3)I)C(=O)O MPMKMFZJLGQVJJ-UHFFFAOYSA-N 0.000 description 1
- FZTNGFKBXFNEFB-UHFFFAOYSA-N 2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-5-methoxybenzoic acid Chemical compound OC(=O)C1=CC(OC)=CC=C1N1CC2CCCCC2C1 FZTNGFKBXFNEFB-UHFFFAOYSA-N 0.000 description 1
- YBBIMHFBDMYIQL-UHFFFAOYSA-N 2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-5-methylaniline Chemical compound NC1=CC(C)=CC=C1N1CC2CCCCC2C1 YBBIMHFBDMYIQL-UHFFFAOYSA-N 0.000 description 1
- KGLSAZYISXXETH-UHFFFAOYSA-N 2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-5-methylbenzoic acid Chemical compound OC(=O)C1=CC(C)=CC=C1N1CC2CCCCC2C1 KGLSAZYISXXETH-UHFFFAOYSA-N 0.000 description 1
- ZYRIJZCGLWWPFA-UHFFFAOYSA-N 2-(1,3,3a,4,7,7a-hexahydroisoindol-2-yl)-5-acetamidobenzoic acid Chemical compound OC(=O)C1=CC(NC(=O)C)=CC=C1N1CC2CC=CCC2C1 ZYRIJZCGLWWPFA-UHFFFAOYSA-N 0.000 description 1
- HVYCTACLZKDRLT-UHFFFAOYSA-N 2-(1,3,3a,4,7,7a-hexahydroisoindol-2-yl)-5-chlorobenzoic acid Chemical compound OC(=O)C1=CC(Cl)=CC=C1N1CC2CC=CCC2C1 HVYCTACLZKDRLT-UHFFFAOYSA-N 0.000 description 1
- ZVNOWUSQKIKHRL-UHFFFAOYSA-N 2-(1,3,3a,4,7,7a-hexahydroisoindol-2-yl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1N1CC2CC=CCC2C1 ZVNOWUSQKIKHRL-UHFFFAOYSA-N 0.000 description 1
- BHGWEKGOHKSYMO-UHFFFAOYSA-N 2-(1,3-dihydroisoindol-2-yl)-5-nitrobenzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1N1CC2=CC=CC=C2C1 BHGWEKGOHKSYMO-UHFFFAOYSA-N 0.000 description 1
- MATDSLAISDSGAW-UHFFFAOYSA-N 2-(1,3-dihydroisoindol-2-yl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1N1CC2=CC=CC=C2C1 MATDSLAISDSGAW-UHFFFAOYSA-N 0.000 description 1
- OGPFILFOKYMAKO-UHFFFAOYSA-N 2-(1-oxidopyridin-1-ium-3-yl)acetonitrile Chemical compound [O-][N+]1=CC=CC(CC#N)=C1 OGPFILFOKYMAKO-UHFFFAOYSA-N 0.000 description 1
- WSCGGSZNIWXJPG-UHFFFAOYSA-N 2-(2-bromo-4-methylphenyl)-1,3,3a,4,5,6,7,7a-octahydroisoindole Chemical compound BrC1=CC(C)=CC=C1N1CC2CCCCC2C1 WSCGGSZNIWXJPG-UHFFFAOYSA-N 0.000 description 1
- OUJDQIGJMAKCTI-UHFFFAOYSA-N 2-(2-bromo-6-methylphenyl)-1,3,3a,4,5,6,7,7a-octahydroisoindole Chemical compound CC1=CC=CC(Br)=C1N1CC2CCCCC2C1 OUJDQIGJMAKCTI-UHFFFAOYSA-N 0.000 description 1
- IUJAAIZKRJJZGQ-UHFFFAOYSA-N 2-(2-chlorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC=C1Cl IUJAAIZKRJJZGQ-UHFFFAOYSA-N 0.000 description 1
- UVAPCFGWZFTTEH-UHFFFAOYSA-N 2-(4-azabicyclo[3.3.1]nonan-4-yl)-5-chlorobenzoic acid Chemical compound OC(=O)C1=CC(Cl)=CC=C1N1C(C2)CCCC2CC1 UVAPCFGWZFTTEH-UHFFFAOYSA-N 0.000 description 1
- WXZILEZUMPNMKF-UHFFFAOYSA-N 2-(4-pentan-3-ylpiperidin-1-yl)benzoic acid Chemical compound CCC(CC)C1CCN(CC1)C1=C(C(=O)O)C=CC=C1 WXZILEZUMPNMKF-UHFFFAOYSA-N 0.000 description 1
- CHSDHIQFLRUBDD-UHFFFAOYSA-N 2-(5-amino-2,3,4,5,6,7,7a,8-octahydro-1H-1-benzazonin-8-yl)acetic acid Chemical compound NC1CCC2C(=CC=CC2CC(=O)O)NCCC1 CHSDHIQFLRUBDD-UHFFFAOYSA-N 0.000 description 1
- SQZGPNHVNPZABI-UHFFFAOYSA-N 2-(azepan-1-yl)-2,2-diphenylacetic acid Chemical compound N1(CCCCCC1)C(C(=O)O)(C1=CC=CC=C1)C1=CC=CC=C1 SQZGPNHVNPZABI-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- ZVOXKLLUHCNDLB-UHFFFAOYSA-N 2-[2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-5-aminophenyl]acetic acid Chemical compound OC(=O)CC1=CC(N)=CC=C1N1CC2CCCCC2C1 ZVOXKLLUHCNDLB-UHFFFAOYSA-N 0.000 description 1
- ILZVFRYQXBWOKE-UHFFFAOYSA-N 2-[2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)phenyl]acetic acid Chemical compound OC(=O)CC1=CC=CC=C1N1CC2CCCCC2C1 ILZVFRYQXBWOKE-UHFFFAOYSA-N 0.000 description 1
- SDXWYJYUXJUMKE-UHFFFAOYSA-N 2-[2-(azepan-1-yl)-5-chlorophenyl]acetic acid Chemical compound ClC=1C=CC(=C(C=1)CC(=O)O)N1CCCCCC1 SDXWYJYUXJUMKE-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- ULDIJKOFRJIINQ-UHFFFAOYSA-N 2-[5-amino-2-(4-pentan-3-ylpiperidin-1-yl)phenyl]acetic acid Chemical compound NC=1C=CC(=C(C1)CC(=O)O)N1CCC(CC1)C(CC)CC ULDIJKOFRJIINQ-UHFFFAOYSA-N 0.000 description 1
- PNEYAQCNSWUTML-UHFFFAOYSA-N 2-[5-chloro-2-(4-pentan-3-ylpiperidin-1-yl)phenyl]acetic acid Chemical compound ClC=1C=CC(=C(C=1)CC(=O)O)N1CCC(CC1)C(CC)CC PNEYAQCNSWUTML-UHFFFAOYSA-N 0.000 description 1
- NAMYKGVDVNBCFQ-UHFFFAOYSA-N 2-bromopropane Chemical compound CC(C)Br NAMYKGVDVNBCFQ-UHFFFAOYSA-N 0.000 description 1
- ACQXHCHKMFYDPM-UHFFFAOYSA-N 2-chloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC=C(C(O)=O)C(Cl)=N1 ACQXHCHKMFYDPM-UHFFFAOYSA-N 0.000 description 1
- IBRSSZOHCGUTHI-UHFFFAOYSA-N 2-chloropyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC=CN=C1Cl IBRSSZOHCGUTHI-UHFFFAOYSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- XBNYMFVVGJILAR-UHFFFAOYSA-N 3-amino-2-piperidin-1-ylbenzoic acid Chemical compound NC1=CC=CC(C(O)=O)=C1N1CCCCC1 XBNYMFVVGJILAR-UHFFFAOYSA-N 0.000 description 1
- LSPGLRSKFJOUMQ-UHFFFAOYSA-N 3-chloro-2-piperidin-1-ylbenzoic acid Chemical compound OC(=O)C1=CC=CC(Cl)=C1N1CCCCC1 LSPGLRSKFJOUMQ-UHFFFAOYSA-N 0.000 description 1
- KLCIFXBDPMBMOQ-UHFFFAOYSA-N 4-(4-pentan-3-ylpiperidin-1-yl)benzene-1,3-dicarboxylic acid Chemical compound C1CC(C(CC)CC)CCN1C1=CC=C(C(O)=O)C=C1C(O)=O KLCIFXBDPMBMOQ-UHFFFAOYSA-N 0.000 description 1
- WNVHRECKQRUMFT-UHFFFAOYSA-N 4-[2-[(5-bromo-2-piperidin-1-ylpyridine-3-carbonyl)amino]ethyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CCNC(=O)C1=CC(Br)=CN=C1N1CCCCC1 WNVHRECKQRUMFT-UHFFFAOYSA-N 0.000 description 1
- MMPCXEQTPGCZCB-UHFFFAOYSA-N 4-[2-[(5-chloro-2-piperidin-1-ylpyridine-3-carbonyl)amino]ethyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CCNC(=O)C1=CC(Cl)=CN=C1N1CCCCC1 MMPCXEQTPGCZCB-UHFFFAOYSA-N 0.000 description 1
- XVFWXIMGGAXBRP-UHFFFAOYSA-N 4-[2-[(5-chloro-6-methyl-2-piperidin-1-ylpyridine-3-carbonyl)amino]ethyl]benzoic acid Chemical compound C=1C=C(C(O)=O)C=CC=1CCNC(=O)C=1C=C(Cl)C(C)=NC=1N1CCCCC1 XVFWXIMGGAXBRP-UHFFFAOYSA-N 0.000 description 1
- DNBWDRZWUGFOCT-UHFFFAOYSA-N 4-[2-[(6-methyl-2-piperidin-1-ylpyridine-3-carbonyl)amino]ethyl]benzoic acid Chemical compound C1CCCCN1C1=NC(C)=CC=C1C(=O)NCCC1=CC=C(C(O)=O)C=C1 DNBWDRZWUGFOCT-UHFFFAOYSA-N 0.000 description 1
- ITDYLAKLEQQZFG-UHFFFAOYSA-N 4-[2-[[2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-5-bromobenzoyl]amino]ethyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CCNC(=O)C1=CC(Br)=CC=C1N1CC2CCCCC2C1 ITDYLAKLEQQZFG-UHFFFAOYSA-N 0.000 description 1
- QAOIQUUQBDTHGF-UHFFFAOYSA-N 4-[2-[[2-(2,3,4,5,6,7,7a,8-octahydro-1H-1-benzazonin-8-yl)acetyl]amino]ethyl]benzoic acid Chemical compound N1CCCCCCC2C1=CC=CC2CC(=O)NCCC2=CC=C(C(=O)O)C=C2 QAOIQUUQBDTHGF-UHFFFAOYSA-N 0.000 description 1
- FWCXYULAHQNBMC-UHFFFAOYSA-N 4-[2-[[5-(2-methylphenyl)-2-piperidin-1-ylbenzoyl]amino]ethyl]benzoic acid Chemical compound CC1=CC=CC=C1C(C=C1C(=O)NCCC=2C=CC(=CC=2)C(O)=O)=CC=C1N1CCCCC1 FWCXYULAHQNBMC-UHFFFAOYSA-N 0.000 description 1
- MTDDOAOIJSHVNB-GASCZTMLSA-N 4-[2-[[5-bromo-2-[(3S,5R)-3,5-dimethylpiperidin-1-yl]-6-methylpyridine-3-carbonyl]amino]ethyl]benzoic acid Chemical compound BrC=1C(=NC(=C(C(=O)NCCC2=CC=C(C(=O)O)C=C2)C1)N1C[C@H](C[C@H](C1)C)C)C MTDDOAOIJSHVNB-GASCZTMLSA-N 0.000 description 1
- JTCDIKHQMUIVAZ-UHFFFAOYSA-N 4-[2-[[5-chloro-2-(4-nonan-5-ylpiperidin-1-yl)benzoyl]amino]ethyl]benzoic acid Chemical compound ClC=1C=CC(=C(C(=O)NCCC2=CC=C(C(=O)O)C=C2)C1)N1CCC(CC1)C(CCCC)CCCC JTCDIKHQMUIVAZ-UHFFFAOYSA-N 0.000 description 1
- YUSNOTLRPBDPNH-UHFFFAOYSA-N 4-[2-[[5-chloro-2-(ethylamino)benzoyl]amino]ethyl]benzoic acid Chemical group CCNC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(C(O)=O)C=C1 YUSNOTLRPBDPNH-UHFFFAOYSA-N 0.000 description 1
- SXDRHQFMERTLHU-GASCZTMLSA-N 4-[2-[[5-chloro-2-[(3s,5r)-3,5-dimethylpiperidin-1-yl]pyridine-3-carbonyl]amino]ethyl]benzoic acid Chemical compound C1[C@@H](C)C[C@@H](C)CN1C1=NC=C(Cl)C=C1C(=O)NCCC1=CC=C(C(O)=O)C=C1 SXDRHQFMERTLHU-GASCZTMLSA-N 0.000 description 1
- IHNMVKOVXOJGKH-UHFFFAOYSA-N 4-[[2-(5-chloro-2-piperidin-1-ylphenyl)propanoylamino]methyl]benzoic acid Chemical compound C=1C(Cl)=CC=C(N2CCCCC2)C=1C(C)C(=O)NCC1=CC=C(C(O)=O)C=C1 IHNMVKOVXOJGKH-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- JXKWWRSXIDJLPY-UHFFFAOYSA-N 4-pentan-3-ylpiperidine Chemical compound CCC(CC)C1CCNCC1 JXKWWRSXIDJLPY-UHFFFAOYSA-N 0.000 description 1
- LVRHRMWYXLHIJX-UHFFFAOYSA-N 5-(4-chlorophenyl)-2-piperidin-1-ylbenzoic acid Chemical compound OC(=O)C1=CC(C=2C=CC(Cl)=CC=2)=CC=C1N1CCCCC1 LVRHRMWYXLHIJX-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- DBSADRDNKQVNPC-UHFFFAOYSA-N 5-amino-2-(5-chloro-1,3-dihydroisoindol-2-yl)benzoic acid Chemical compound OC(=O)C1=CC(N)=CC=C1N1CC2=CC(Cl)=CC=C2C1 DBSADRDNKQVNPC-UHFFFAOYSA-N 0.000 description 1
- SRZWKRNBUAZMLJ-UHFFFAOYSA-N 5-bromo-2-(1,3-dihydroisoindol-2-yl)benzoic acid Chemical compound OC(=O)C1=CC(Br)=CC=C1N1CC2=CC=CC=C2C1 SRZWKRNBUAZMLJ-UHFFFAOYSA-N 0.000 description 1
- FEJLLACXMWMSEW-UHFFFAOYSA-N 5-bromo-2-(4-pentan-3-ylpiperidin-1-yl)benzoic acid Chemical compound BrC=1C=CC(=C(C(=O)O)C=1)N1CCC(CC1)C(CC)CC FEJLLACXMWMSEW-UHFFFAOYSA-N 0.000 description 1
- KDKRSWXFLFTSII-UHFFFAOYSA-N 5-chloro-2,3-dihydro-1h-isoindole Chemical compound ClC1=CC=C2CNCC2=C1 KDKRSWXFLFTSII-UHFFFAOYSA-N 0.000 description 1
- CRJARZAEVZZPLK-UHFFFAOYSA-N 5-chloro-2-(5-chloro-1,3-dihydroisoindol-2-yl)benzoic acid Chemical compound OC(=O)C1=CC(Cl)=CC=C1N1CC2=CC(Cl)=CC=C2C1 CRJARZAEVZZPLK-UHFFFAOYSA-N 0.000 description 1
- YQXDKGBUKMDCKJ-DTORHVGOSA-N 5-chloro-2-[(3s,5r)-3,5-dimethylpiperidin-1-yl]-6-methylpyridine-3-carboxylic acid Chemical compound C1[C@@H](C)C[C@@H](C)CN1C1=NC(C)=C(Cl)C=C1C(O)=O YQXDKGBUKMDCKJ-DTORHVGOSA-N 0.000 description 1
- XBHXNMLFJZTSAS-UHFFFAOYSA-N 5-chloro-2-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC(Cl)=CNC1=O XBHXNMLFJZTSAS-UHFFFAOYSA-N 0.000 description 1
- QULYXJBCWPLRCC-UHFFFAOYSA-N 5-chloro-2-piperidin-1-ylpyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC(Cl)=CN=C1N1CCCCC1 QULYXJBCWPLRCC-UHFFFAOYSA-N 0.000 description 1
- AGZKJXUJTZTHBE-UHFFFAOYSA-N 5-chloro-6-methyl-2-piperidin-1-ylpyridine-3-carboxylic acid Chemical compound C1=C(Cl)C(C)=NC(N2CCCCC2)=C1C(O)=O AGZKJXUJTZTHBE-UHFFFAOYSA-N 0.000 description 1
- ILDSNANJDUAXRB-UHFFFAOYSA-N 5-nitro-2-(4-nonan-5-ylpiperidin-1-yl)benzoic acid Chemical compound [N+](=O)([O-])C=1C=CC(=C(C(=O)O)C1)N1CCC(CC1)C(CCCC)CCCC ILDSNANJDUAXRB-UHFFFAOYSA-N 0.000 description 1
- ACGLNDSVCHALDN-UHFFFAOYSA-N 6-methyl-2-piperidin-1-ylpyridine-3-carboxylic acid Chemical compound CC1=CC=C(C(O)=O)C(N2CCCCC2)=N1 ACGLNDSVCHALDN-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- BMTAFVWTTFSTOG-UHFFFAOYSA-N Butylate Chemical compound CCSC(=O)N(CC(C)C)CC(C)C BMTAFVWTTFSTOG-UHFFFAOYSA-N 0.000 description 1
- OBKRQNYYISHMOX-UHFFFAOYSA-N CC1=C(C=C(C(=N1)N2CCCCC2)C(=O)NCCC3=CC=C(C=C3)C(=O)O)Br Chemical compound CC1=C(C=C(C(=N1)N2CCCCC2)C(=O)NCCC3=CC=C(C=C3)C(=O)O)Br OBKRQNYYISHMOX-UHFFFAOYSA-N 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101100400378 Mus musculus Marveld2 gene Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- QXNDZONIWRINJR-UHFFFAOYSA-N azocane Chemical compound C1CCCNCCC1 QXNDZONIWRINJR-UHFFFAOYSA-N 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical class BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- GNVMUORYQLCPJZ-UHFFFAOYSA-N carbamothioic s-acid Chemical class NC(S)=O GNVMUORYQLCPJZ-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 229910001902 chlorine oxide Inorganic materials 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 229940117975 chromium trioxide Drugs 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- WLXALCKAKGDNAT-UHFFFAOYSA-N diazoethane Chemical compound CC=[N+]=[N-] WLXALCKAKGDNAT-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical compound [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- YRVJRHNIYGVTJD-UHFFFAOYSA-N ethyl 4-[2-(N-acetyl-5-chloro-2-piperidin-1-ylanilino)ethyl]benzoate Chemical compound C(C)OC(C1=CC=C(C=C1)CCN(C(C)=O)C1=C(C=CC(=C1)Cl)N1CCCCC1)=O YRVJRHNIYGVTJD-UHFFFAOYSA-N 0.000 description 1
- DFVYZOBXANIGNZ-UHFFFAOYSA-N ethyl 4-[2-[(5-bromo-2-piperidin-1-ylpyridine-3-carbonyl)amino]ethyl]benzoate Chemical compound C(C)OC(C1=CC=C(C=C1)CCNC(C1=C(N=CC(=C1)Br)N1CCCCC1)=O)=O DFVYZOBXANIGNZ-UHFFFAOYSA-N 0.000 description 1
- UUSXIOWDJCSLSI-UHFFFAOYSA-N ethyl 4-[2-[[2-(1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-5-bromobenzoyl]amino]ethyl]benzoate Chemical compound C(C)OC(C1=CC=C(C=C1)CCNC(C1=C(C=CC(=C1)Br)N1CC2CCCCC2C1)=O)=O UUSXIOWDJCSLSI-UHFFFAOYSA-N 0.000 description 1
- ONUJLCNYTZGTBY-CALCHBBNSA-N ethyl 4-[2-[[5-bromo-2-[(3S,5R)-3,5-dimethylpiperidin-1-yl]-6-methylpyridine-3-carbonyl]amino]ethyl]benzoate Chemical compound C(C)OC(C1=CC=C(C=C1)CCNC(C1=C(N=C(C(=C1)Br)C)N1C[C@H](C[C@H](C1)C)C)=O)=O ONUJLCNYTZGTBY-CALCHBBNSA-N 0.000 description 1
- CKBXMOSJDKKXIQ-UHFFFAOYSA-N ethyl 4-[2-[[5-chloro-2-(4-nonan-5-ylpiperidin-1-yl)benzoyl]amino]ethyl]benzoate Chemical compound C(C)OC(C1=CC=C(C=C1)CCNC(C1=C(C=CC(=C1)Cl)N1CCC(CC1)C(CCCC)CCCC)=O)=O CKBXMOSJDKKXIQ-UHFFFAOYSA-N 0.000 description 1
- MEBCKIIKTFEWBR-CALCHBBNSA-N ethyl 4-[2-[[5-chloro-2-[(3R,5S)-3,5-dimethylpiperidin-1-yl]pyridine-3-carbonyl]amino]ethyl]benzoate Chemical compound C(C)OC(C1=CC=C(C=C1)CCNC(C1=C(N=CC(=C1)Cl)N1C[C@H](C[C@H](C1)C)C)=O)=O MEBCKIIKTFEWBR-CALCHBBNSA-N 0.000 description 1
- VNDKDGSXODYCLQ-CALCHBBNSA-N ethyl 4-[2-[[5-chloro-2-[(3S,5R)-3,5-dimethylpiperidin-1-yl]-6-methylpyridine-3-carbonyl]amino]ethyl]benzoate Chemical compound C(C)OC(C1=CC=C(C=C1)CCNC(C1=C(N=C(C(=C1)Cl)C)N1C[C@H](C[C@H](C1)C)C)=O)=O VNDKDGSXODYCLQ-CALCHBBNSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 150000007928 imidazolide derivatives Chemical class 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical compound C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 150000002641 lithium Chemical group 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical group [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- BPJSBPKUWXGZRX-UHFFFAOYSA-N methyl 4-[2-[(5-chloro-2-piperidin-1-ylpyridine-3-carbonyl)amino]ethyl]benzoate Chemical compound COC(C1=CC=C(C=C1)CCNC(C1=C(N=CC(=C1)Cl)N1CCCCC1)=O)=O BPJSBPKUWXGZRX-UHFFFAOYSA-N 0.000 description 1
- VUQUOGPMUUJORT-UHFFFAOYSA-N methyl 4-methylbenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=C(C)C=C1 VUQUOGPMUUJORT-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- ZPAPCUKKKOSLPZ-UHFFFAOYSA-N morphan Chemical compound C1CNC2CCCC1C2 ZPAPCUKKKOSLPZ-UHFFFAOYSA-N 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 150000005181 nitrobenzenes Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003450 sulfenic acids Chemical class 0.000 description 1
- 150000003455 sulfinic acids Chemical class 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- GZNAASVAJNXPPW-UHFFFAOYSA-M tin(4+) chloride dihydrate Chemical compound O.O.[Cl-].[Sn+4] GZNAASVAJNXPPW-UHFFFAOYSA-M 0.000 description 1
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Substances O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Description
Denne oppfinnelse angår fremstilling av nye karboksylsyre-derivater:ved den generelle formel This invention relates to the preparation of new carboxylic acid derivatives: by the general formula
og deres addisjonssalter, særlig deres fysiologisk forlikelige salter med uorganiske eller organiske syrer og også baser når Z betyr en karboksygruppe. and their addition salts, in particular their physiologically compatible salts with inorganic or organic acids and also bases when Z represents a carboxy group.
•Her beskrives også nye 2-amino-karboksylsyre-derivater med• New 2-amino-carboxylic acid derivatives are also described here
den generelle formelthe general formula
deres addisjonssalter, særlig deres salter med uorganiske eller organiske syrer og også baser'når W betyr en karboksy- their addition salts, especially their salts with inorganic or organic acids and also bases'when W means a carboxy-
gruppe, og fremgangsmåte for fremstilling derav og anvendelse av de nye 2-amino-karboksylsyre-derivater blant annet som mellomprodukter for fremstilling av de nye forbindelser eller den generelle, formel I. group, and method for its preparation and use of the new 2-amino-carboxylic acid derivatives, among other things, as intermediates for the preparation of the new compounds or the general formula I.
De nye forbindelser med de generelle formler I og Ia ogThe new compounds with the general formulas I and Ia and
deres optisk aktive antipoder, visst de inneholder et asymme-their optically active antipodes, although they contain an asym-
trisk karbonatom, oppviser verdifulle farmakologiske egenskaper,tric carbon atom, exhibits valuable pharmacological properties,
nemlig en virkning på det intermediære stoffskifte. Således har forbindelsene med den generelle formel I særlig en blod-sukker-senkende og/eller lipid-senkende virkning og forbindelsene med den generelle formel Ia en lipid-senkende virkning. namely an effect on the intermediate metabolism. Thus, the compounds of the general formula I in particular have a blood-sugar-lowering and/or lipid-lowering effect and the compounds of the general formula Ia a lipid-lowering effect.
I de ovenstående generelle formler I og Ia betyrIn the above general formulas I and Ia mean
m tallet 0 eller 1,m the number 0 or 1,
n tallet 1 eller 2,n the number 1 or 2,
R et hydrogenatom eller en alkylgruppe med 1 til 3 karbon-R a hydrogen atom or an alkyl group with 1 to 3 carbon
atomer,atoms,
R^et^hydrogen-, fluor-, klor-, brom- eller jodatom, en alkyl-eller alkoksygruppe med hver 1 til 4 karbonatomer, ehcyano-, hydroksy- eller trifluormetylgruppe eller en eventuelt med en alkylgruppe med 1 til 3 karbonatomer,'et fluor-, klor-eller bromatom substituert fenylgruppe, R^et^hydrogen, fluorine, chlorine, bromine or iodine atom, an alkyl or alkoxy group with each 1 to 4 carbon atoms, cyano, hydroxy or trifluoromethyl group or one optionally with an alkyl group with 1 to 3 carbon atoms,' a fluorine, chlorine or bromine substituted phenyl group,
R2 og R^sammen med det mellomliggende nitrogenatom en piperidino-, 3,5-dimetyl-piperidino-, oktahydro-lH-azonino-, dekahydro-azecino-, 1,3-dihydro-isoindolo-, heksahydro-isoindolo- eller oktahydro-isoindologruppe, en med en'alkylgruppe .med 5 til 10 karbonatomer substituert piperidinogruppe, en azabicykloalkylgruppe med 7 til 12 karbonatomer i bicykloalkanringen, som kan være substituert med en eller flere alkylgrupper med hver 1 til 3 karbonatomer, eller en med et halogenatom, en alkoksygruppe med 1 til 3 karbonatomer eller en aminogruppe substituert 1,3-dihydro-isoindologruppe eller også når m betyr tallet'1, en pyrrolidino-, heksametylenimino- eller R 2 and R 3 together with the intervening nitrogen atom a piperidino-, 3,5-dimethyl-piperidino-, octahydro-1H-azonino-, decahydro-azecino-, 1,3-dihydro-isoindolo-, hexahydro-isoindolo- or octahydro- isoindolo group, a piperidino group substituted with an alkyl group of 5 to 10 carbon atoms, an azabicycloalkyl group of 7 to 12 carbon atoms in the bicycloalkane ring, which may be substituted with one or more alkyl groups of 1 to 3 carbon atoms each, or one with a halogen atom, an alkoxy group with 1 to 3 carbon atoms or an amino group substituted 1,3-dihydro-isoindolo group or also when m means the number'1, a pyrrolidino-, hexamethyleneimino- or
heptametyleniminogruppe,heptamethyleneimino group,
X en CH-gruppe eller et nitrogenatom,X a CH group or a nitrogen atom,
Z og W hver en eventuelt forestret karboksygruppe,Z and W each an optionally esterified carboxy group,
R^ et hydrogen- eller "halogenatom, en amino-, cyano-, hydroksy-, R^ a hydrogen or "halogen atom, an amino-, cyano-, hydroxy-,
karboksy- eller acetaminogruppe, en alkyl- eller alkoksygruppe med hver 1 til 4 karbonatomer, carboxy or acetamino group, an alkyl or alkoxy group each having 1 to 4 carbon atoms,
Rg og R^sammen med det mellomliggende nitrogenatom en med en alkylgruppe med 5 til 10 karbonatomer substituert piperidino-gruppe, en azabicykloalkylgruppe med 7 til 12 karbonatomer i bicykloalkanringen, som kan være substituert med en eller flere alkylgrupper med 1 til 3 karbonatomer, en oktahydro-lH-azonino-, 1,3-dihydro-isoindolo-, heksahydro-isoindolo- eller oktahydro-isoindologruppe eller en med et halogenatom, en alkoksygruppe med 1 til 3 karbonatomer eller en aminogruppe Rg and R^ together with the intervening nitrogen atom a piperidino group substituted with an alkyl group of 5 to 10 carbon atoms, an azabicycloalkyl group of 7 to 12 carbon atoms in the bicycloalkane ring, which may be substituted with one or more alkyl groups of 1 to 3 carbon atoms, an octahydro -1H-azonino-, 1,3-dihydro-isoindolo-, hexahydro-isoindolo- or octahydro-isoindolo group or one with a halogen atom, an alkoxy group of 1 to 3 carbon atoms or an amino group
substituert 1,3-dihydro-isoindologruppe, ogsubstituted 1,3-dihydro-isoindolo group, and
Rg et hydrogenatom, en alkylgruppe med 1 til 3 karbonatomer eller en arylgruppe. Rg is a hydrogen atom, an alkyl group of 1 to 3 carbon atoms or an aryl group.
Blant de innledningsvis angitte betydninger for restene R, R^ til Rg og Z resp. W kommer for eksempel i betraktning Among the initially stated meanings for the residues R, R^ to Rg and Z resp. For example, W comes into consideration
for R betydningen et hydrogenatom, en metyl-, etyl-, propyl-eller isopropylgruppe, for R the meaning of a hydrogen atom, a methyl, ethyl, propyl or isopropyl group,
for R^betydningen et hydrogen-, fluor-, klor-, brom- eller jodatom, en metyl-, etyl-, propyl-, isopropyl-, butyl-, iso- for R^meaning a hydrogen, fluorine, chlorine, bromine or iodine atom, a methyl, ethyl, propyl, isopropyl, butyl, iso-
butyl-, tert.butyl-, hydroksy-, metoksy-, etoksy-, propoksy-, isopropoksy-, butoksy-, isobutoksy-, cyan-, trifluor-metyl-, fenyl-, metylfenyl-, etylfenyl-, iso-propylfenyl-, fluorfenyl-, klorfenyl- eller bromfenylgruppe, butyl-, tert.butyl-, hydroxy-, methoxy-, ethoxy-, propoxy-, isopropoxy-, butoxy-, isobutoxy-, cyano-, trifluoro-methyl-, phenyl-, methylphenyl-, ethylphenyl-, iso-propylphenyl- , fluorophenyl, chlorophenyl or bromophenyl group,
for R^og sammen med det mellomliggende nitrogenatom betydningen en pyrrolidino-, piperidino-, 3,5-dimetyl-piperidino-, pentyl-(3)-piperidino-, nonyl-(5)-piperidino-, heksametylenimino-, oktahydro-lH-azonino-, 1,3-dihydro-isoindolo-, heksahydro-isoindolo-, oktahydro-isoindolo-, klor-1,3-dihydro-isoindolo-, brom-1,3-dihydro-isoindolo-, metoksy-1,3-dihydro-isoindolo-, etoksy-1,3-dihydro-iso-indolp-, isopropoksy-1,3-dihydro-isoindolo-, amino-1,3-dihydro-isoindolo- eller 2-azabicyklo-nonan-2-yl-gruppe, for Z og W hver betydningen en karboksy-, metoksykarbonyl-, for R^ and together with the intervening nitrogen atom the meaning a pyrrolidino-, piperidino-, 3,5-dimethyl-piperidino-, pentyl-(3)-piperidino-, nonyl-(5)-piperidino-, hexamethyleneimino-, octahydro-lH -azonino-, 1,3-dihydro-isoindolo-, hexahydro-isoindolo-, octahydro-isoindolo-, chloro-1,3-dihydro-isoindolo-, bromo-1,3-dihydro-isoindolo-, methoxy-1,3 -dihydro-isoindolo-, ethoxy-1,3-dihydro-iso-indolp-, isopropoxy-1,3-dihydro-isoindolo-, amino-1,3-dihydro-isoindolo- or 2-azabicyclo-nonan-2-yl -group, for Z and W each meaning a carboxy-, methoxycarbonyl-,
etoksykarbonyl-, propoksykarbonyl-, isopropoksykarbonyl-, butoksykarbonyl-, isobutoksykarbonyl-, tert.butoksykarbonyl-, pentoksykarbonyl-, hexoksykarbonyl-, heptoksykarbonyl-, allyloksykarbonyl-, fenoksykarbonyl-, benzyloksykarbonyl-, fenyletoksykarbpnyl-, cyklopropoksykarbonyl-, cyklopent-oksykarbonyl-, cykloheksyloksykarbonyl- eller cyklohept-oksykarbonylgruppe, ethoxycarbonyl-, propoxycarbonyl-, isopropoxycarbonyl-, butoxycarbonyl-, isobutoxycarbonyl-, tert.butoxycarbonyl-, pentoxycarbonyl-, hexoxycarbonyl-, heptoxycarbonyl-, allyloxycarbonyl-, phenoxycarbonyl-, benzyloxycarbonyl-, phenylethoxycarbonyl-, cyclopropoxycarbonyl-, cyclopentoxycarbonyl, cyclohexyloxycarbonyl - or cycloheptoxycarbonyl group,
for R^ betydningen et hydrogen-,.fluor-, klor-, brom- eller jodatom, en metyl-, etyl-, cyano-, hydroksy-, metoksy-, karboksy-, amino- eller acetaminogruppe, for R^ the meaning of a hydrogen, fluorine, chlorine, bromine or iodine atom, a methyl, ethyl, cyano, hydroxy, methoxy, carboxy, amino or acetamino group,
for Rg og R^sammen med det mellomliggende nitrogenatom betydningen en pentyl-(3)-piperidino-, nonyl-(5)-piperidino-, 2-azabicyklo-nonan-2-yl-, 1,3-dihydro-isoindolo-, klor-1,3-dihydro-isoindolo-, -brom-1,3-dihydro-isoindolo-, metoksy-1,3-dihydro-isoindolo-, etoksy-1,3-dibydro-isoindolo-, isopropoksy-1,3-dihydro-isoindolo-, amino-1,3-dihydro-isoindolo-, heksahydro-isoindolo- eller oktahydro-isoindologruppe, og for Rg and R^ together with the intervening nitrogen atom the meaning a pentyl-(3)-piperidino-, nonyl-(5)-piperidino-, 2-azabicyclo-nonan-2-yl-, 1,3-dihydro-isoindolo-, chloro-1,3-dihydro-isoindolo-, -bromo-1,3-dihydro-isoindolo-, methoxy-1,3-dihydro-isoindolo-, ethoxy-1,3-dibydro-isoindolo-, isopropoxy-1,3 -dihydro-isoindolo-, amino-1,3-dihydro-isoindolo-, hexahydro-isoindolo- or octahydro-isoindolo group, and
for Rg betydningen et hydrogenatom, en metyl-, etyl-, propyl-, for Rg meaning a hydrogen atom, a methyl-, ethyl-, propyl-,
isopropyl- eller fenylgruppe.isopropyl or phenyl group.
Foretrukne forbindelser med de ovenstående generelle formler I og Ia er de hvor Preferred compounds of the above general formulas I and Ia are those where
m er tallet 0 eller 1,m is the number 0 or 1,
n er tallet 1 eller 2,n is the number 1 or 2,
X er en CH-gruppe eller et nitrogenatom,X is a CH group or a nitrogen atom,
R er et hydrogenatom eller en metylgruppe,R is a hydrogen atom or a methyl group,
R1er et hydrogen-, fluor-, klor-, brom- eller jodatom, en cyano-, trifluormetyl-, hydroksy-, metoksy-, metyl-, metylfenyl-, klorfenyl- eller bromfenylgruppe, R1 is a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano, trifluoromethyl, hydroxy, methoxy, methyl, methylphenyl, chlorophenyl or bromophenyl group,
R2og R^sammen med det mellomliggende nitrogenatom er en i •bi-stilling med en alkylgruppe med 5 til 9 karbonatomer substituert piperidinogruppe, en eventuelt med en metoksy- eller aminogruppe, et klor- eller et bromatom substituert 1,3-dihydro-isoindologruppe, en heksahydro-isoindolo- eller 2-aza-bicyklo-nonan-2-ylgruppe eller R2 and R^ together with the intervening nitrogen atom is a piperidino group substituted in bi-position with an alkyl group with 5 to 9 carbon atoms, a optionally substituted 1,3-dihydro-isoindolo group with a methoxy or amino group, a chlorine or a bromine atom, a hexahydro-isoindolo- or 2-aza-bicyclo-nonan-2-yl group or
en oktahydro-lH-azoninogruppe nåran octahydro-lH-azonino group when
m er tallet 1 ellerm is the number 1 or
m er tallet 0,m is the number 0,
R^er et hydrogen-, fluor- eller jodatom eller en metylgruppe, og X er en CH-gruppe, eller ' R^ is a hydrogen, fluorine or iodine atom or a methyl group, and X is a CH group, or '
m er tallet 0,m is the number 0,
X er et nitrogenatom ogX is a nitrogen atom and
R^er ikke et hydrogenatom, ellerR^ is not a hydrogen atom, or
en decahydro-lH-azecinogruppe, nåra decahydro-1H-azecino group, when
m er tallet 1 ellerm is the number 1 or
m er tallet 0,m is the number 0,
R^er en metylgruppe, et hydrogen-, fluor-, brom- eller jodatom, R^ is a methyl group, a hydrogen, fluorine, bromine or iodine atom,
og and
X -.er en CH-gruppe, ellerX -.is a CH group, or
m er tallet 0,m is the number 0,
X . er et nitrogenatom, ogX . is a nitrogen atom, and
R^er ikke et hydrogenatom, ellerR^ is not a hydrogen atom, or
en piper idinogruppe, nåra piper idinogroup, when
m er tallet 1 ellerm is the number 1 or
m er tallet 0,m is the number 0,
X er et nitrogenatom, ogX is a nitrogen atom, and
R^er ikke et hydrogenatom, ellerR^ is not a hydrogen atom, or
m er tallet 0,m is the number 0,
X er en CH-gruppe, ogX is a CH group, and
R-^er ikke et hydrogenatom, ellerR-^ is not a hydrogen atom, or
en oktahydro-isoindologruppe, nåran octahydro-isoindolo group, when
m er tallet 1 ellerm is the number 1 or
m er tallet 0,m is the number 0,
er et hydrogen-, fluor-, brom- eller jodatom, en metyl-, is a hydrogen, fluorine, bromine or iodine atom, a methyl,
hydroksy-, metoksy- eller cyanogruppe, oghydroxy, methoxy or cyano group, and
X er en CH-gruppe, ellerX is a CH group, or
m er tallet 0 og X er et nitrogenatom, eller m is the number 0 and X is a nitrogen atom, or
en 3,5-dimetyl-piperidinogruppe, nåra 3,5-dimethyl-piperidino group, when
m er tallet 1 ellerm is the number 1 or
m er tallet 0,'m is the number 0,'
R er et hydrogen-, klor- eller bromatom,R is a hydrogen, chlorine or bromine atom,
R er en metylgruppe, ogR is a methyl group, and
X er et nitrogenatom, ellerX is a nitrogen atom, or
m er tallet 0,.m is the number 0,.
Rj er en metyl-, hydroksy- eller cyanogruppe, et fluor- eller Rj is a methyl, hydroxy or cyano group, a fluorine or
jodatom- ogiodine atom and
X er en CH-gruppe, ellerX is a CH group, or
også en pyrrolidono-, heksametylenimino- eller heptametyleniminogruppe, når also a pyrrolidone, hexamethyleneimino or heptamethyleneimino group, when
nr er tallet 1,nr is the number 1,
Rg er et hydrogenatom,"en metyl- eller fenylgruppe,Rg is a hydrogen atom, a methyl or phenyl group,
Z og W er hver en karboksy- eller , en alkoksykarbonylgruppe medZ and W are each a carboxy or , an alkoxycarbonyl group with
i alt 2 til 4 karbonatomer,a total of 2 to 4 carbon atoms,
R^er et hydrogen-, fluor-, klor-, brom- eller jodatom, en alkyl-_ gruppe med 1 til 4 karbonatomer,'en hydroksy-, metoksy-, amiho-, cyano-, karboksy- eller acetaminogruppe, R^ is a hydrogen, fluorine, chlorine, bromine or iodine atom, an alkyl group with 1 to 4 carbon atoms, a hydroxy, methoxy, amino, cyano, carboxy or acetamino group,
Rg og R^sammen med det mellomliggende nitrogenatom er en i 4 - Rg and R^ together with the intervening nitrogen atom are one in 4 -
stilling med en alkylgruppe med 5 til 9 karbonatomer substituert piperidinogruppe, en eventuelt med et klor- eller bromatom, position with an alkyl group with 5 to 9 carbon atoms substituted piperidino group, one optionally with a chlorine or bromine atom,
en metoksy- eller en aminogruppe substituert 1,3-dihydro-isoindologruppe, en heksahydro-isoindolo- eller 2-aza-bicyklo-nonan-2-yl-gruppe eller også en oktahydro-isoindologruppe, når m betyr tallet 1 eller a methoxy or an amino group substituted 1,3-dihydro-isoindolo group, a hexahydro-isoindolo- or 2-aza-bicyclo-nonan-2-yl group or also an octahydro-isoindolo group, when m means the number 1 or
X er et nitrogenatom ellerX is a nitrogen atom or
m tallet 0,m the number 0,
R^er et hydrogen-, fluor-, brom- eller jodatom, en alkylgruppe med 1 til 4 karbonatomer, en hydroksy-, metoksy-, cyano-, karboksy- eller acetaminogruppe, og R^ is a hydrogen, fluorine, bromine or iodine atom, an alkyl group of 1 to 4 carbon atoms, a hydroxy, methoxy, cyano, carboxy or acetamino group, and
X er en CH-gruppe., ogX is a CH group., and
hvis de inneholder et asymmetrisk karbonatom, deres optisk if they contain an asymmetric carbon atom, their opt
aktive antipoder og deres salter.active antipodes and their salts.
Særlig foretrukne forbindelser med de- ovenstående generelle formler I og Ia er imidlertid de hvor Particularly preferred compounds with the above general formulas I and Ia are, however, those where
m er tallet 0 eller 1,m is the number 0 or 1,
n er tallet 2,n is the number 2,
X er en CH-gruppe,X is a CH group,
Z er en karboksy- eller alkoksykarbonylgruppen med i alt 2 til Z is a carboxy or alkoxycarbonyl group with a total of 2 more
4 karbonatomer,4 carbon atoms,
W er en karboksygruppe,W is a carboxy group,
R er et hydrogenatom,R is a hydrogen atom,
R-^i 5-stilling er et fluor-, klor-, brom- eller jodatom eller en metylgruppe eller også et hydrogenatom, når R£og R^sammen med det mellomliggende nitrogenatom er en oktahydro-lH-azoninogruppe, R-^ in the 5-position is a fluorine, chlorine, bromine or iodine atom or a methyl group or also a hydrogen atom, when R£ and R^ together with the intervening nitrogen atom is an octahydro-1H-azonino group,
■'i 5-stilling er et hydrogen-, klor- eller bromatom,■'in the 5-position is a hydrogen, chlorine or bromine atom,
R2og R^resp. Rg og R^ sammen med det mellomliggende nitrogenatom er en i 4-stilling med en alkylgruppe med 5 til 9 karbonatomer substituert piperidino-gruppe, en eventuelt med et klor- eller bromatom substituert 1,3-dihydro-isoindologruppe, R2 and R^ respectively. Rg and R^ together with the intervening nitrogen atom is a piperidino group substituted in the 4-position with an alkyl group with 5 to 9 carbon atoms, a 1,3-dihydro-isoindolo group optionally substituted with a chlorine or bromine atom,
en 2-aza-bicyklo-nonan-3-yl- eller heksahydro-isoindologruppe, eller a 2-aza-bicyclo-nonan-3-yl or hexahydro-isoindolo group, or
R2og R^sammen med det mellomliggende nitrogenatom er en oktahydro-lH-azoninogruppe, når R 2 and R 4 together with the intervening nitrogen atom is an octahydro-1H-azonino group, when
m er tallet 1, ellerm is the number 1, or
m er: tallet 0 ogm is: the number 0 and
R-^ er en metylgruppe, et hydrogen-, fluor- eller jodatom, R-^ is a methyl group, a hydrogen, fluorine or iodine atom,
elleror
Rg og R_, sammen med det mellomliggende nitrogenatom er en oktahydro-isoindologruppe, når Rg and R_, together with the intervening nitrogen atom is an octahydro-isoindolo group, when
m er tallet 1, ellerm is the number 1, or
m er tallet 0 ogm is the number 0 and
Rg er et bromatom, eller-Rg is a bromine atom, or-
R2og R^sammen med det mellomliggende nitrogenatom er en pyrrolidino-, piperidino-, heksametylenimino- eller heptametyleniminogruppe, når R2 and R^ together with the intervening nitrogen atom is a pyrrolidino, piperidino, hexamethyleneimino or heptamethyleneimino group, when
m er tallet 1, ogm is the number 1, and
Rg er et hydrogenatom, en metyl- eller fenylgruppe, ogRg is a hydrogen atom, a methyl or phenyl group, and
hvis de inneholder et asymmetrisk karbonatom, deres optisk if they contain an asymmetric carbon atom, their opt
aktive antipoder og deres fysiologisk forlikelige addisjonssalter med uorganiske eller organiske syrer eller også baser når Z eller W er en karboksygruppe. active antipodes and their physiologically compatible addition salts with inorganic or organic acids or also bases when Z or W is a carboxy group.
De nye forbindelser fremstilles som følger:The new compounds are prepared as follows:
1. Fremstilling av 2-aminokarboksylsyrederivatene eller den generelle formel Ia: a) For fremstilling av forbindelser, eller den generelle formel Ia hvor W er en karboksygruppe: Hydrolyse av en forbindelse med den generelle formel 1. Preparation of the 2-aminocarboxylic acid derivatives or the general formula Ia: a) For the preparation of compounds, or the general formula Ia where W is a carboxy group: Hydrolysis of a compound of the general formula
hvor R, Rg til Rg, m og X er som innledningsvis angitt, og A er en gruppe som ved hydrolyse kan overføres til en karboksygruppe.' where R, Rg to Rg, m and X are as indicated at the outset, and A is a group which can be transferred to a carboxy group by hydrolysis.'
Som slike hydrolyserbare grupper kommer for eksempel i betraktning en nitrilgruppe, funksjonelle derivater av karboksygruppen såsom dens usubstituerte eller substituerte amider, estere, tioestere,, o.rtoestere, iminoetere, amidiner As such hydrolysable groups come into consideration, for example, a nitrile group, functional derivatives of the carboxy group such as its unsubstituted or substituted amides, esters, thioesters, orthoesters, iminoethers, amidines
eller anhydrider, en malonester-(1)-yl-gruppe, en tetra-zolylgruppe, en eventuelt substituert 1,3-oksazol-(2)-yl-ellér dihydro-1,3-oksazol-(2)-yl-gruppe. or anhydrides, a malonester-(1)-yl group, a tetrazolyl group, an optionally substituted 1,3-oxazol-(2)-yl or dihydro-1,3-oxazol-(2)-yl group .
Hydrolysen utføres hensiktsmessig enten i nærvær av en syre såsom saltsyre, svovelsyre, fosforsyre eller tri-kloreddiksyre, eller i nærvær av en base såsom natriumhydroksyd eller kaliumhydroksyd i et egnet oppløsnings-middel såsom vann, etanol, vann/etanol, vann/isopropanol eller vann/dioksan ved temperaturer mellom -10 og 12 0°C, for eksempel ved temperaturer mellom romtemperatur og The hydrolysis is conveniently carried out either in the presence of an acid such as hydrochloric acid, sulfuric acid, phosphoric acid or trichloroacetic acid, or in the presence of a base such as sodium hydroxide or potassium hydroxide in a suitable solvent such as water, ethanol, water/ethanol, water/isopropanol or water /dioxane at temperatures between -10 and 12 0°C, for example at temperatures between room temperature and
reaksjonsblandingens koketemperatur.the boiling temperature of the reaction mixture.
Hvis.B betyr en cyanogruppe i en forbindelse med den generelle formel II, utføres omsetningen hensiktsmessig i nærvær av etanol/hydrogenklorid. Herved dannes i reaksjonsblandingen den tilsvarende imino- og ortoester resp. efter vanntilsetning den tilsvarende ester, som hydrolyseres efter tilsetning av vann. b) For fremstilling av forbindelser med den generelle formel Ia hvor R5betyr en aminogruppe: Reduksjon av en nitroforbindelse med den generelle formel hvor R, Rg til Rg, m, W og X er som innledningsvis angitt. Reduksjonen utføres hensiktsmessig i et oppløsningsmiddel såsom metanol, etanol, vann, vann/etanol, dioksan, metanol/dioksan, etylacetat, dimetylformamid eller dioksan/dimetylformamid med katalytisk aktivert hydrogen, ■ for eksempel med hydrogen i nærvær av en hydrogenerings-katalysator såsom palladium/kull, platina eller Raney-nikkel ved et hydrogentrykk på 1 til 10 bar,; med hydrazin i nærvær av Raney-nikkel, med nascerende hydrogen, for eksempel med zink/eddiksyre, tinn/saltsyre eller jern/- saltsyre, eller med et metallsalt, for eksempel tinn-(II)-klorid/saltsyre eller jern-(II)-sulfat/svovelsyre, ved temperaturer mellom 0 og 50°C, fortrinnsvis ved romtemperatur . c) For fremstilling av forbindelser med den generelle formel Ia hvor R^er en hydroksygruppe, en cyangruppe, et hydrogen-, If.B means a cyano group in a compound of the general formula II, the reaction is conveniently carried out in the presence of ethanol/hydrogen chloride. In this way, the corresponding imino- and orthoester resp. are formed in the reaction mixture. after addition of water the corresponding ester, which is hydrolysed after addition of water. b) For the preparation of compounds of the general formula Ia where R5 denotes an amino group: Reduction of a nitro compound of the general formula where R, Rg to Rg, m, W and X are as indicated at the outset. The reduction is conveniently carried out in a solvent such as methanol, ethanol, water, water/ethanol, dioxane, methanol/dioxane, ethyl acetate, dimethylformamide or dioxane/dimethylformamide with catalytically activated hydrogen, ■ for example with hydrogen in the presence of a hydrogenation catalyst such as palladium/coal, platinum or Raney nickel at a hydrogen pressure of 1 to 10 bar; with hydrazine in the presence of Raney nickel, with nascent hydrogen, for example with zinc/acetic acid, stannous/hydrochloric acid or ferric/hydrochloric acid, or with a metal salt, for example stannous chloride/hydrochloric acid or ferric (II )-sulphate/sulphuric acid, at temperatures between 0 and 50°C, preferably at room temperature. c) For the preparation of compounds of the general formula Ia where R^ is a hydroxy group, a cyano group, a hydrogen,
fluor-, klor- eller bromatom:fluorine, chlorine or bromine atom:
Omsetning av en forbindelse med den generelle formel hvor R, Rg til Rg, m,- W og X er som innledningsvis angitt, med et nitritt og påfølgende oppvarmning av de således oppnådde diazoniumsalter,eventuelt i nærvær av kobber eller et passende kobber(I)salt. Omsetningen utføres, hensiktsmessig ved at en forbindelse med den generelle formel IV i et egnet oppløsningsmiddel, for eksempel i vann/saltsyre, metanol/saltsyre eller dioksan/saltsyre, overføres til et diazoniumsalt ved lavere temperaturer, for eksempel ved temperaturer mellom -10 og 5°C, med et nitritt, for eksempel natriumnitritt eller en ester av saltpetersyren. Reaction of a compound with the general formula where R, Rg to Rg, m, - W and X are as indicated at the outset, with a nitrite and subsequent heating of the thus obtained diazonium salts, possibly in the presence of copper or a suitable copper(I) salt. The reaction is carried out, conveniently by a compound of the general formula IV in a suitable solvent, for example in water/hydrochloric acid, methanol/hydrochloric acid or dioxane/hydrochloric acid, being transferred to a diazonium salt at lower temperatures, for example at temperatures between -10 and 5 °C, with a nitrite, for example sodium nitrite or an ester of nitric acid.
Det således oppnådde tilsvarende diazoniumsalt overføres derefter, for eksempel som fluorborat, som hydrosulfat i svovelsyre, som hydroklorid i nærvær av kobber eller i nærvær av et passende kobber(I)salt såsom kobber(I)klorid/- saltsyre, kobber(I)bromid/bromhydrogensyre eller tri-natrium-kobber(I)tetracyanid ved pH 7, ved oppvarmning, for eksempel ved temperaturer mellom 15 og 90°C, til den ønskede forbindelse. d) For fremstilling av forbindelser med den generelle formel Ia hvor Rg betyr et hydrogenatom: Dehalogenering av en forbindelse med den generelle formel The corresponding diazonium salt thus obtained is then transferred, for example as fluoroborate, as hydrosulphate in sulfuric acid, as hydrochloride in the presence of copper or in the presence of a suitable copper (I) salt such as copper (I) chloride/hydrochloric acid, copper (I) bromide /hydrobromic acid or tri-sodium copper(I) tetracyanide at pH 7, by heating, for example at temperatures between 15 and 90°C, to the desired compound. d) For the preparation of compounds of the general formula Ia where Rg means a hydrogen atom: Dehalogenation of a compound of the general formula
hvor R, Rg til Rg, m, X og W er som innledningsvis angitt, og Hal betyr et halogenatom, for eksempel et klor-,' brom-eller jodatom. where R, Rg to Rg, m, X and W are as indicated at the outset, and Hal means a halogen atom, for example a chlorine, bromine or iodine atom.
Dehalogeneringen foretas fortrinnsvis i et oppløsnings-middel såsom metanol, etanol, eddiksyreetylester eller iseddik, ved hjelp av katalytisk aktivert hydrogen, for eksempel med hydrogen i nærvær av platina, palladium/kull eller Raney-nikkel, ved temperaturer mellom 0 og 75°C, fortrinnsvis ved romtemperatur, og ved et hydrogentrykk på 1-5 bar. e) For fremstilling av forbindelser med den generelle formel Ia hvor W betyr en karboksygruppe: Omsetning av én metallorganisk forbindelse med den generelle formel The dehalogenation is preferably carried out in a solvent such as methanol, ethanol, ethyl acetate or glacial acetic acid, using catalytically activated hydrogen, for example with hydrogen in the presence of platinum, palladium/coal or Raney nickel, at temperatures between 0 and 75°C, preferably at room temperature, and at a hydrogen pressure of 1-5 bar. e) For the preparation of compounds with the general formula Ia where W means a carboxy group: Reaction of one organometallic compound with the general formula
hvor R, Rg til Rg, m og X er som innledningsvis angitt, og Me er et alkaliatom, fortrinnsvis et litiumatom, eller en jordalkalihalogenidrest, fortrinnsvis en magnesium-klorid- eller magnesiumbromidrest, med karbondioksyd. where R, Rg to Rg, m and X are as indicated at the outset, and Me is an alkali atom, preferably a lithium atom, or an alkaline earth halide residue, preferably a magnesium chloride or magnesium bromide residue, with carbon dioxide.
Omsetningen utføres fortrinnsvis ved at en forbindelse med den generelle formel VI, eventuelt oppløst i et inert oppløsningsmiddel såsom dietyleter eller tetrahydrofuran, settes til fast karbondioksyd. f) For fremstilling av'forbindelser med den generelle formel Ia hvor X betyr et nitrogenatom: Omsetning av en forbindelse med den generelle formel The reaction is preferably carried out by adding a compound of the general formula VI, optionally dissolved in an inert solvent such as diethyl ether or tetrahydrofuran, to solid carbon dioxide. f) For the preparation of compounds of the general formula Ia where X represents a nitrogen atom: Reaction of a compound of the general formula
hvor R, Rg, Rg, W og m er som innledningsvis angitt, og B betyr en utskiftbar rest såsom et halogenatom eller en alkylsulfonylgruppe, for eksempel et klor- eller bromatom, en metyl- eller etylsulfonylgruppe, med et amin.med den generelle formel where R, Rg, Rg, W and m are as indicated at the outset, and B means a replaceable residue such as a halogen atom or an alkylsulfonyl group, for example a chlorine or bromine atom, a methyl or ethylsulfonyl group, with an amine of the general formula
hvor R b og R l er som innledningsvis angitt. where R b and R l are as indicated at the outset.
Omsetningen utføres, hensiktsmessig i et oppløsnings-middel såsom vann, vann/metanol, vann/etanol, van.n/iso-propanol, dimetylformamid eller i et overskudd av det anvendte amin med den generelle formel VIII, eventuelt i nærvær av en uorganisk eller tertiær organisk base, eventuelt i nærvær av en reaksjonsakseleirator såsom kobber, og eventuelt i et trykk-kar ved temperaturer mellom 20 og 150°C, fortrinnsvis ved reaksjonsblandingens koketemperatur, for eksempel ved temperaturer mellom 80 og The reaction is carried out, suitably in a solvent such as water, water/methanol, water/ethanol, water, n/iso-propanol, dimethylformamide or in an excess of the amine used with the general formula VIII, possibly in the presence of an inorganic or tertiary organic base, optionally in the presence of a reaction accelerator such as copper, and optionally in a pressure vessel at temperatures between 20 and 150°C, preferably at the boiling temperature of the reaction mixture, for example at temperatures between 80 and
100°C. Omsetningen kan imidlertid også utføres uten opp-løsn ingsmidde1. 100°C. However, the turnover can also be carried out without a solvent1.
g) For fremstilling av forbindelse med den generelle formelg) For the preparation of compounds with the general formula
Ia hvor R^ betyr en alkoksygruppe med 1 til 4 karbonatomer: Alkylering av en hydroksyforbindelse med den generelle formel Ia where R^ means an alkoxy group with 1 to 4 carbon atoms: Alkylation of a hydroxy compound of the general formula
hvor. R, Rg til Rg, W, X og m er som innledningsvis angitt, where. R, Rg to Rg, W, X and m are, as indicated at the outset,
ved en forbindelse med den generelle formelby a compound with the general formula
hvor R5' betyr en alkylgruppe med 1 til 4 karbonatomer, where R5' means an alkyl group with 1 to 4 carbon atoms,
og D en nukleofil utgående gruppe eller sammen med det nabostilte H-atom i resten R^' en diazogruppe, og om nødvendig påfølgende hydrolyse. and D a nucleophilic leaving group or, together with the adjacent H atom in the residue R^' a diazo group, and if necessary subsequent hydrolysis.
Som utgående gruppe kommer for eksempel i betraktning et klor-, brom- eller jodatom eller en sulfonyloksygruppe såsom en metansulfonyloksy-, p-toluensulfonyloksy- eller metbksy-sulfonyloksygruppe. For example, a chlorine, bromine or iodine atom or a sulphonyloxy group such as a methanesulphonyloxy, p-toluenesulphonyloxy or metoxy-sulphonyloxy group comes into consideration as a leaving group.
Omsetningen utføres hensiktsmessig i et oppløsningsmiddel såsom eter, tetrahydrofuran, etanol, aceton, dimetylformamid eller dimetylsulfoksyd, eventuelt i nærvær av en base såsom natriumkarbonat, kaliumkarbonat, bariumhydroksyd, natriumetylat eller kalium-tert.butylat med, et alkylerings-middel såsom diazometan, diazoetan, metyljodid, etyljodid, isopropylbromid, butylbromid, dimetylsulfat, dietylsulfat eller p-toluensulfonsyremetylester ved temperaturer mellom 0 og 100°C, fortrinnsvis ved temperaturer mellom 15 og 70°C. The reaction is suitably carried out in a solvent such as ether, tetrahydrofuran, ethanol, acetone, dimethylformamide or dimethylsulfoxide, optionally in the presence of a base such as sodium carbonate, potassium carbonate, barium hydroxide, sodium ethylate or potassium tert-butylate with, an alkylating agent such as diazomethane, diazoethane, methyl iodide, ethyl iodide, isopropyl bromide, butyl bromide, dimethyl sulfate, diethyl sulfate or p-toluenesulfonic acid methyl ester at temperatures between 0 and 100°C, preferably at temperatures between 15 and 70°C.
Hvis W her betyr en karboksygruppe, forestres denne samtidig ved alkyleringen med et diazoalkan eller ved alk.yl-eringen i nærvær av en sterk base. Den således oppnådde ester overføres derefter eventuelt ved hydrolyse i nærvær av en syre eller base til den tilsvarende karboksylsyre. If W here means a carboxy group, this is simultaneously esterified by the alkylation with a diazoalkane or by the alkylation in the presence of a strong base. The ester thus obtained is then optionally transferred by hydrolysis in the presence of an acid or base to the corresponding carboxylic acid.
En fremstilt forbindelse med den generelle formel Ia hvor W betyr en alkoksykarbonylgruppe, kan derefter ved hydrolyse overføres til en tilsvarende forbindelse med den generelle formel Ia hvor W betyr en karboksygruppe. A prepared compound of the general formula Ia where W means an alkoxycarbonyl group can then be transferred by hydrolysis to a corresponding compound of the general formula Ia where W means a carboxy group.
Den påfølgende hydrolyse foretas fortrinnsvis i et vann-blandbart oppløsningsmiddel såsom metanol, etanol, dioksan, vann/etanol eller vann/t.etrahydrof uran i nærvær av en syre. såsom saltsyre eller svovelsyre, eller en base såsom natrium-eller kaliumhydroksyd ved forhøyede temperaturer, for The subsequent hydrolysis is preferably carried out in a water-miscible solvent such as methanol, ethanol, dioxane, water/ethanol or water/tetrahydrofuran in the presence of an acid. such as hydrochloric or sulfuric acid, or a base such as sodium or potassium hydroxide at elevated temperatures, for
eksempel ved reaksjonsblahdingens koketemperatur. for example at the boiling temperature of the reaction mixture.
2%. Fremstilling av karboksylsyrederivatene med den generelle formel I: 2%. Preparation of the carboxylic acid derivatives of the general formula I:
a) Omsetning av en karboksylsyre med den generelle formel a) Reaction of a carboxylic acid with the general formula
hvor R, R^, R2, R3, Rg, X og m er som innledningsvis angitt, eller dens eventuelt i reaksjonsblandingen fremstilte* reaktive derivat, med et amin med den generelle formel where R, R^, R2, R3, Rg, X and m are as indicated at the outset, or its optionally produced* reactive derivative in the reaction mixture, with an amine of the general formula
hvor Z og n er som innledningsvis angitt, eller med et eventuelt i reaksjonsblandingen dannet N-aktivert amin med den generelle formel XII, når en karboksylsyre med den generelle formel XI anvendes og når Z i et N-aktivert amin med den generelle formel XII ikke betyr en karboksygruppe . where Z and n are as indicated at the outset, or with an N-activated amine of the general formula XII formed in the reaction mixture, when a carboxylic acid of the general formula XI is used and when Z in an N-activated amine of the general formula XII is not means a carboxy group.
Fremgangsmåten angår således acylering av et amin med den generelle formel XII med en karboksylsyre med den generelle formel XI i nærvær av et syreaktiverende eller vanntiltrekkende middel, eller med dens funksjonelle derivater, eller The method thus relates to the acylation of an amine of the general formula XII with a carboxylic acid of the general formula XI in the presence of an acid-activating or water-attracting agent, or with its functional derivatives, or
omsetning av en karboksylsyre med den generelle formel XI med et amin med den generelle formel XII hvor Z ikke betyr en karboksygruppe, i nærvær av et aminogruppe-aktivérende middel, eller med reaktive derivater derav. reaction of a carboxylic acid of the general formula XI with an amine of the general formula XII where Z does not represent a carboxy group, in the presence of an amino group-activating agent, or with reactive derivatives thereof.
Som eventuelt i reaksjonsblandingen fremstilte funksjonelle derivater: av en karboksylsyre med den generelle formel XI, kommer for eksempel i betraktning dens alkyl-, As possibly functional derivatives produced in the reaction mixture: of a carboxylic acid of the general formula XI, for example its alkyl,
aryl- eller aralkylestere eller -tioestere såsom metyl-, etyl-, fenyl- eller benzylesteren, dens imidazolider, aryl or aralkyl esters or thioesters such as the methyl, ethyl, phenyl or benzyl ester, its imidazolides,
dens syrehalogenider såsom syrekloridet eller -bromidet, dens anhydrider, dens blandede anhydrider med alifatiske eller aromatiske karboksyl-, sulfen-, sulfin- eller sulfon-syrer eller karbonsyreestere, for eksempel med eddiksyre>propionsyre, p-toluensulfonsyre eller 0-etyl-karbonsyre, dens 0-trifenylfosfonium- eller kobber-komplekser, dens N-acyloksyimider, dens azider eller nitriler eller de tilsvarende amino-tiokarboksylsyrederivater, og som eventuelt i reaksjonsblandingen fremstilte reaktive derivater av et amin med' den generelle formel XII, hvor X ikke betyr en karboksygruppe, dens fosfazoderivater. its acid halides such as the acid chloride or bromide, its anhydrides, its mixed anhydrides with aliphatic or aromatic carboxylic, sulfenic, sulfinic or sulfonic acids or carboxylic acid esters, for example with acetic>propionic acid, p-toluenesulfonic acid or O-ethylcarboxylic acid, its O-triphenylphosphonium or copper complexes, its N-acyloxyimides, its azides or nitriles or the corresponding amino-thiocarboxylic acid derivatives, and which optionally produced in the reaction mixture reactive derivatives of an amine of the general formula XII, where X does not mean a carboxy group , its phosphazo derivatives.
Som syreaktiverende og/eller vanntiltrekkende midler kommer for eksempel i betraktning en klormaursyreester såsom klor-maursyreetylester, tionylklorid, fosfortriklorid, fosfor-pentoksyd, N,N1 -di cykloheksylkarbodiimid, .N,N'-karbonyl diimidazol, N,N'-tionyldiimidazol, bortrifluorideterat As acid-activating and/or water-attracting agents, for example, a chloroformic acid ester such as chloroformic acid ethyl ester, thionyl chloride, phosphorus trichloride, phosphorus pentoxide, N,N1 -dicyclohexylcarbodiimide, .N,N'-carbonyl diimidazole, N,N'-thionyldiimidazole, boron trifluoride etherate
eller trifenylfosf in/karbontetraklorid.or triphenylphosphine/carbon tetrachloride.
Omsetningen utføres hensiktsmessig i et oppløsniirgsmiddel såsom metylenklorid, kloroform, karbontetraklorid, eter, tetrahydrofuran, dioksan, benzen, toluen, acetonitril eller dimetylformamid, eventuelt i nærvær av en.uorganisk base såsom natriumkarbonat eller en tertiær organisk base The reaction is conveniently carried out in a solvent such as methylene chloride, chloroform, carbon tetrachloride, ether, tetrahydrofuran, dioxane, benzene, toluene, acetonitrile or dimethylformamide, optionally in the presence of an inorganic base such as sodium carbonate or a tertiary organic base
såsom trietylamin eller pyridin, som samtidig, kan tjene som oppløsningsmiddel, og eventuelt i nærvær av et syreaktiverende middel ved temperaturer mellom -25 og 250°C, fortrinnsvis ved temperaturer mellom -10°C og det anvendte oppløsningsmiddels koketemperatur. Det er ikke nødvendig å isolere et eventuelt i reaksjonsblandingen dannet, funk-sjonelt derivat av en forbindelse med den generelle formel XI eller XII, og videre kan omsetningen også utføres uten oppløsningsmiddel. Dessuten kan vann som dannes under omsetningen, fjernes ved azeotropisk destillasjon, for eksempel ved oppvarmning med toluen på en vannutskiller, eller ved tilsetning av et tørremiddel såsom magnesiumsulfat eller molekylsikt. b) For fremstilling av forbindelser med den generelle formel I hvor such as triethylamine or pyridine, which can simultaneously serve as a solvent, and optionally in the presence of an acid activating agent at temperatures between -25 and 250°C, preferably at temperatures between -10°C and the boiling temperature of the solvent used. It is not necessary to isolate any functional derivative of a compound of the general formula XI or XII formed in the reaction mixture, and furthermore the reaction can also be carried out without a solvent. In addition, water formed during the reaction can be removed by azeotropic distillation, for example by heating with toluene on a water separator, or by adding a drying agent such as magnesium sulfate or molecular sieve. b) For the preparation of compounds of the general formula I where
X betyr ehCH-gruppe, og m betyr tallet 0:X means ehCH group, and m means the number 0:
Omsetning av en forbindelse med den generelle formel Reaction of a compound with the general formula
hvor R, R^, Z og n er som innledningsvis angitt, og E betyr en utskiftbar rest såsom et halogenatom, med et amin med den generelle formel where R, R^, Z and n are as indicated at the outset, and E means a replaceable residue such as a halogen atom, with an amine of the general formula
hvor R2og R^er som innledningsvis angitt. where R 2 and R 3 are as indicated at the outset.
Ved betegnelsen "et halogenatom" som er benyttet ved defini- sjonen av den utskiftbare rest E, skal særlig forståes et klor- eller bromatom. The term "a halogen atom" which is used in the definition of the replaceable residue E, is to be understood in particular as a chlorine or bromine atom.
Omsetningen utføres hensiktsmessig i et oppløsningsmiddel såsom vann, vann/metanol, vann/etanol, vann/isopropanol, dimetylformamid eller i et overskudd av det anvendte amin med den generelle formel XIV, eventuelt i nærvær av en uorganisk eller tertiær organisk base, eventuelt i nærvær The reaction is suitably carried out in a solvent such as water, water/methanol, water/ethanol, water/isopropanol, dimethylformamide or in an excess of the amine used with the general formula XIV, optionally in the presence of an inorganic or tertiary organic base, optionally in the presence
av den.reaksjonsakselerator såsom kobber, og eventuelt i trykk-kar ved temperaturer mellom 20 og 150°C, fortrinnsvis ved reaksjonsblandingens koketemperatur, for eksempel ved 100°C. Omsetningen kan imidlertid også utføres uten oppløsningsmiddel. of the reaction accelerator such as copper, and optionally in a pressure vessel at temperatures between 20 and 150°C, preferably at the boiling temperature of the reaction mixture, for example at 100°C. However, the reaction can also be carried out without a solvent.
c) For fremstilling av forbindelser med den generelle formel I hvor Z betyr en karboksygruppe: Oksydasjon av en forbindelse med den generelle formel c) For the preparation of compounds of the general formula I where Z means a carboxy group: Oxidation of a compound of the general formula
hvor R, R-^ til R^, Rg, X^ nr og n er som innledningsvis angitt, og G betyr en gruppe som ved oksydasjon kan over-føres til en karboksygruppe. where R, R-^ to R^, Rg, X^ nr and n are as indicated at the outset, and G means a group which can be transferred to a carboxy group by oxidation.
Som en slik oksyderbar gruppe kommer for eksempel i betrakt-■ ning en formylgruppe og dens aeetaler, en hydroksymetyl-gruppe og dens etere, en usubstituert eller substituert acylgruppe såsom en acetyl-, kloracetyl-, propionyl- As such an oxidizable group comes into consideration, for example, a formyl group and its aetals, a hydroxymethyl group and its ethers, an unsubstituted or substituted acyl group such as an acetyl-, chloroacetyl-, propionyl-
eller malonsyre-(1)-yl-gruppe eller en malonester-(1)-yl-gruppe . or malonic acid-(1)-yl group or a malonester-(1)-yl group.
Omsetningen utføres med et oksydasjonsmiddel i egnet opp-løsningsmiddel såsom vann, iseddik, pyridin eiler karbontetraklorid, ved temperaturer mellom 0 og 100°C, hensiktsmessig ved temperaturer mellom 20 og 50°C. Omsetningen ut-føres imidlertid fortrinnsvis med sølvoksyd/natronlut, mangandioksyd/aceton eller metylenklorid, hydrogenperoksyd/- natronlut, brom eller klor/natron- eller kalilut eller kromtrioksyd/pyridin. ■ d) For fremstilling av forbindelser med den generelle formel I hvor Z betyr en karboksygruppe: The reaction is carried out with an oxidizing agent in a suitable solvent such as water, glacial acetic acid, pyridine or carbon tetrachloride, at temperatures between 0 and 100°C, suitably at temperatures between 20 and 50°C. However, the reaction is preferably carried out with silver oxide/sodium hydroxide solution, manganese dioxide/acetone or methylene chloride, hydrogen peroxide/sodium hydroxide solution, bromine or chlorine/sodium hydroxide solution or potassium hydroxide solution or chromium trioxide/pyridine. ■ d) For the preparation of compounds of the general formula I where Z means a carboxy group:
Hydrolyse av en forbindelse med den generelle formelHydrolysis of a compound with the general formula
hvor R, R^til R^ , Rg , X, m og n er som innledningsvis angitt, og Q betyr en gruppe som ved hydrolyse kan over-føres til en karboksygruppe. where R, R^ to R^ , Rg , X, m and n are as indicated at the beginning, and Q means a group which can be transferred to a carboxy group by hydrolysis.
Som slike hydrolyserbare grupper kommer for eksempel i betraktning en nitrilgruppe, funksjonelle derivater av karboksygruppen såsom dens usubstituerte eller substituerte amider, estere, tioestere, or.toestere, iminoetere, amidiner eller anhydrider, en malonester-(1)-yl-gruppe, en tetrazolyl-gruppe, en eventuelt substituert 1,3-oksazol-(2)-yl- ,eller dihydro-1,3-oksazol-(2)-yl-gruppe. As such hydrolyzable groups come into consideration, for example, a nitrile group, functional derivatives of the carboxy group such as its unsubstituted or substituted amides, esters, thioesters, orthoesters, iminoethers, amidines or anhydrides, a malonester-(1)-yl group, a tetrazolyl - group, an optionally substituted 1,3-oxazol-(2)-yl- or dihydro-1,3-oxazol-(2)-yl group.
Hydrolysen utføres hensiktsmessig enten i nærvær av en syre såsom saltsyre, svovelsyre, fosforsyre eller triklor-eddiksyre eller i nærvær av en base såsom natriumhydroksyd eller kaliumhydroksyd, i et egnet oppløsningsmiddel såsom vann, etanol, vann/etanol, vann/isopropanol eller vann/- dioksan ved temperaturer mellom -10 og 12 0°C, for eksempel ved temperaturer mellom romtemperatur og reaksjonsblandingens koketemperatur. The hydrolysis is suitably carried out either in the presence of an acid such as hydrochloric acid, sulfuric acid, phosphoric acid or trichloroacetic acid or in the presence of a base such as sodium hydroxide or potassium hydroxide, in a suitable solvent such as water, ethanol, water/ethanol, water/isopropanol or water/- dioxane at temperatures between -10 and 12 0°C, for example at temperatures between room temperature and the boiling temperature of the reaction mixture.
Hvis Q betyr en cyangruppe i en forbindelse med den generelle formel XVI, utføres omsetningen hensiktsmessig i nærvær av etanol/hydrogenklorid, og i reaksjonsblandingen dannes da den tilsvarende imino- og ortoester resp. efter vanntilsetning den tilsvarende ester, som hydrolysefes efter tilsetning av vann. e) For fremstilling av forbindelser med den generelle formel I hvor X betyr en CH-gruppe og m tallet 0: ... Omsetning av et amid med den generelle formel If Q means a cyano group in a compound of the general formula XVI, the reaction is suitably carried out in the presence of ethanol/hydrogen chloride, and in the reaction mixture the corresponding imino- and ortho-ester resp. after addition of water the corresponding ester, which is hydrolysed after addition of water. e) For the preparation of compounds with the general formula I where X means a CH group and m the number 0: ... Reaction of an amide with the general formula
hvor R og R^til R^er som innledningsvis angitt, eller dets alkalisalt, med en forbindelse med den generelle formel where R and R^ to R^ are as initially indicated, or its alkali salt, with a compound of the general formula
hvor Z og n er som inneldningsvis angitt, og Y betyr en nukleofil, utgående gruppe såsom et halogenatom eller en sulfonyloksygruppe. where Z and n are as initially indicated, and Y means a nucleophilic leaving group such as a halogen atom or a sulfonyloxy group.
Omsetningen utføres hensiktsmessig i et oppløsningsmiddel såsom tetrahydrofuran, dioksan, toluen, dimetylformamid, dimetylsulfoksyd eller heksametylfosforsyretriamid, eventuelt i nærvær av en base såsom natriumhydrid eller kalium-tert.butylat ved temperaturer mellom 2 0 og 18 0°C, fortrinnsvis ved temperaturer mellom 50 og 150°C. f) For fremstilling av forbindelser med den generelle formel I hvor X betyr en CH-gruppe og Z en karboksygruppe: Acylering av en forbindelse med den generelle formel The reaction is conveniently carried out in a solvent such as tetrahydrofuran, dioxane, toluene, dimethylformamide, dimethylsulfoxide or hexamethylphosphoric acid triamide, optionally in the presence of a base such as sodium hydride or potassium tert.butylate at temperatures between 20 and 180°C, preferably at temperatures between 50 and 150°C. f) For the preparation of compounds of the general formula I where X means a CH group and Z a carboxy group: Acylation of a compound of the general formula
hvor R> R^til R^, Rg, m og n er som innledningsvis angitt, med et oksalylhalogenid eller fosgen i nærvær av en Lewis-syre. where R> R^ to R^, Rg, m and n are as initially stated, with an oxalyl halide or phosgene in the presence of a Lewis acid.
Friedel-krafts-acylereringen foretas hensiktsmessig i et oppløsningsmiddel såsom nitrobenzen eller karbondisulfid i nærvær av Lewis-syre såsom aluminiumklorid, ved temperaturer mellom 0 og 80°C, fortrinnsvis ved temperaturer mellom 20 og 6 0°C. g) For fremstilling av forbindelser med den generelle formel I hvor X betyr en CH-gruppe og Z en karboksygruppe: The Friedel force acylation is conveniently carried out in a solvent such as nitrobenzene or carbon disulphide in the presence of a Lewis acid such as aluminum chloride, at temperatures between 0 and 80°C, preferably at temperatures between 20 and 60°C. g) For the preparation of compounds of the general formula I where X means a CH group and Z a carboxy group:
Omsetning av en forbindelse med den generelle formelReaction of a compound with the general formula
hvor R, R^til R^, Rg, m og n er som innledningsvis angitt, med et eventuelt i reaksjonsblandingen fremstilt hypo-halogenitt. where R, R^ to R^, Rg, m and n are as stated at the outset, with any hypohalogenite produced in the reaction mixture.
Omsetningen utføres hensiktsmessig i et oppløsningsmiddel såsom vann/tetrahydrofuran eller vann/dioksan ved temperaturer mellom 0 og 80°C, fortrinnsvis ved temperaturer mellom 25 og 50°C. The reaction is conveniently carried out in a solvent such as water/tetrahydrofuran or water/dioxane at temperatures between 0 and 80°C, preferably at temperatures between 25 and 50°C.
Hvis man ved fremgangsmåten får et karboksylsyreamid med den generelle formel I hvor Z betyr en karboksygruppe, kan dette eventuelt ved forestring overføres til en tilsvarende forbindelse med den generelle formel I hvor Z er en forestret karboksygruppe. If the method yields a carboxylic acid amide of the general formula I where Z means a carboxy group, this can optionally be transferred by esterification to a corresponding compound of the general formula I where Z is an esterified carboxy group.
Den påfølgende forestring foretas' hensiktsmessig i et egnet oppløsningsmiddel, for eksempel i en tilsvarende alkohol, pyridin, toluen eller dioksan, i nærvær av et syreaktiverende og/eller vanntiltrekkende middel såsom tionylklorid, klormaursyreetyl-ester, N,N'-dicykloheksylkarbodiimid eller karbonyldiimidazol, eller ved omforestring, for' eksempel med en tilsvarende karbon-syrediester, ved temperaturer mellom 0 og 50°C, fortrinnsvis ved romtemperatur. The subsequent esterification is conveniently carried out in a suitable solvent, for example in a corresponding alcohol, pyridine, toluene or dioxane, in the presence of an acid-activating and/or water-attracting agent such as thionyl chloride, chloroformic acid ethyl ester, N,N'-dicyclohexylcarbodiimide or carbonyldiimidazole, or by transesterification, for example with a corresponding carboxylic acid diester, at temperatures between 0 and 50°C, preferably at room temperature.
De oppnådde forbindelser med de generelle formler I og Ia kan videre overføres til sine fysiologisk forlikelige salter med uorganiske eller organiske syrer og også baser når W eller Z betyr en karboksygruppe. Som syrer kommer her for eksempel i betraktning saltsyre, bromhydrogensyre, svovelsyre, fosforsyre, melke-syre, sitronsyre, vinsyre, ravsyre, maleinsyre eller fumarsyre, og som baser natriumhydroksyd, kaliumhydroksyd eller cykloheksyl-amin. The obtained compounds of the general formulas I and Ia can further be transferred to their physiologically compatible salts with inorganic or organic acids and also bases when W or Z means a carboxy group. As acids, for example, hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, lactic acid, citric acid, tartaric acid, succinic acid, maleic acid or fumaric acid, and as bases sodium hydroxide, potassium hydroxide or cyclohexylamine come into consideration.
De som utgangsstoffer anvendte forbindelser eller de generelle formler II til XX er kjent fra litteraturen, eller de kan fremstilles ved i og for seg kjente metoder. Således får man for eksempel en. forbindelse med den generelle formel II ved reduksjon av en tilsvarende nitroforbindelse og eventuelt på-følgende Sandmeyer-reaksjon og eventuelt påfølgende alkylering. The compounds used as starting materials or the general formulas II to XX are known from the literature, or they can be prepared by methods known per se. Thus you get, for example, a compound with the general formula II by reduction of a corresponding nitro compound and optionally subsequent Sandmeyer reaction and optionally subsequent alkylation.
En forbindelse med den generelle formel III får man for eksempel ved nitrering av en tilsvarende forbindelse, ved omsetning av en tilsvarende metallorganisk forbindelse med karbondioksyd eller ved omsetning av et tilsvarende benzylhalogenid med kaliumcyanid og-eventuelt påfølgende hydrolyse og/eller forestring. A compound of the general formula III is obtained, for example, by nitration of a corresponding compound, by reaction of a corresponding organometallic compound with carbon dioxide or by reaction of a corresponding benzyl halide with potassium cyanide and - possibly subsequent hydrolysis and/or esterification.
En forbindelse med den generelle formel IV eller XI får man . for eksempel ved omsetning av en tilsvarende 2-klor- eller 2-brom-nitrokarboksylsyre eller dens derivater med et tilsvarende amin, påfølgende reduksjon av nitrogruppen i en således oppnådd 2-aminoforbindelse ved hjelp av katalytisk aktivert hydrogen, ved hjelp av nascerende hydrogen, ved hjelp av metaller eller metall-salter, og' overføring av den salede.s oppnådde aminogruppe over et tilsvarende diazoniumsalt til en tilsvarende forbindelse med den generelle formel IV eller XI. For fremstilling av en utgangs-forbindelse med den generelle formel XI, hvor R^betyr en alkoksygruppe, blir en således fremstilt hydroksy-karboksylsyre derefter alkylert og hvis nødvendig derefter hydrolysert. A compound with the general formula IV or XI is obtained. for example by reacting a corresponding 2-chloro- or 2-bromo-nitrocarboxylic acid or its derivatives with a corresponding amine, subsequent reduction of the nitro group in a thus obtained 2-amino compound by means of catalytically activated hydrogen, by means of nascent hydrogen, by by means of metals or metal salts, and' transfer of the salted.s obtained amino group over a corresponding diazonium salt to a corresponding compound of the general formula IV or XI. For the preparation of a starting compound of the general formula XI, where R 1 denotes an alkoxy group, a hydroxy carboxylic acid thus prepared is then alkylated and, if necessary, then hydrolysed.
For eksempel får man en forbindelse med den generelle formelFor example, you get a connection with the general formula
V ved Sandmeyer-reaksjon av en tilsvarende aminoforbindelse, en forbindelse med den generelle formel VI ved metallering av en tilsvarende halogenforbindelse, en forbindelse med den generelle formel VII ved halogenering av en tilsvarende pyridinforbindelse, og en forbindelse med den generelle formel. IX ved innkokning av et tilsvarende diazoniumsalt. V by Sandmeyer reaction of a corresponding amino compound, a compound of the general formula VI by metalation of a corresponding halogen compound, a compound of the general formula VII by halogenation of a corresponding pyridine compound, and a compound of the general formula. IX by boiling in a corresponding diazonium salt.
En forbindelse med den generelle formel XI hvor R.^betyr en alkyl- eller trifluormetylgruppe, får man for eksempel ved reduksjon av et tilsvarende nitrobenzenderivat, Sandmeyer-reaksjon ved den oppnådde aminoforbindelse med kobber(I)bromid, metallering av den oppnådde bromforbindelse ved butyl-litium og på-følgende omsetning med karbondioksyd. A compound of the general formula XI where R.^ denotes an alkyl or trifluoromethyl group is obtained, for example, by reduction of a corresponding nitrobenzene derivative, Sandmeyer reaction of the obtained amino compound with copper (I) bromide, metallation of the obtained bromine compound with butyl -lithium and subsequent reaction with carbon dioxide.
En forbindelse med den generelle formel XII får man for eksempel ved omsetning av et tilsvarende 4-brommetyl-benzen-derivat med natriumcyanid og påfølgende katalytisk hydrogenering av den således oppnådde cyanoforbindelse. A compound of the general formula XII is obtained, for example, by reacting a corresponding 4-bromomethylbenzene derivative with sodium cyanide and subsequent catalytic hydrogenation of the cyano compound thus obtained.
En som utgangsmateriale anvendt forbindelse med de generelle formler XIII, XV til XVII, XIX og XX får man ved omsetning av en tilsvarende karboksylsyre med et tilsvarende amin i nærvær av et syreaktiverende eller vanntiltrekkende middel. A compound with the general formulas XIII, XV to XVII, XIX and XX used as starting material is obtained by reacting a corresponding carboxylic acid with a corresponding amine in the presence of an acid-activating or water-attracting agent.
En som utgangsmateriale anvendt forbindelse med den generelle formel XVIII får man ved halogenering av en tilsvarende alkohol eller omsetning av et sulfonsyrehalogenid ved en tilsvarende alkohol i nærvær av en base. A compound of the general formula XVIII used as starting material is obtained by halogenating a corresponding alcohol or reacting a sulfonic acid halide with a corresponding alcohol in the presence of a base.
Som nevnt innledningsvis oppviser de nye forbindelser medAs mentioned at the beginning, they show new connections with
de generelle formler I og Ia verdifulle farmakologiske egenskaper, nemlig en virkning på det intermediære stoffskifte. Således har forbindelsene med den generelle formel I særlig en blodsukkersenkende og/eller lipidsenkende virkning og forbindelsene med den generelle formel Ia en lipidsenkende virkning. Dessuten representerer forbindelsene ved den generelle formel Ia verdifulle mellomprodukter for fremstilling av de nye forbindelser ved den generelle formel I.. the general formulas I and Ia have valuable pharmacological properties, namely an effect on intermediate metabolism. Thus, the compounds of the general formula I in particular have a blood sugar-lowering and/or lipid-lowering effect and the compounds of the general formula Ia a lipid-lowering effect. Moreover, the compounds of the general formula Ia represent valuable intermediates for the production of the new compounds of the general formula I..
"'Som eksempler ble forbindelsene"'As examples were the compounds
Å = 4-[2-[2-(2-azabicyklo[3.3.1]nonan-2-yl)-5-klor-benzoylamino]-etyl]benzoesyre, Å = 4-[2-[2-(2-azabicyclo[3.3.1]nonan-2-yl)-5-chloro-benzoylamino]-ethyl]benzoic acid,
B = 4-[2-[5-fluor-2-(oktahydro-lH-azonino)-benzoylamino]etyl]-benzoesyre, B = 4-[2-[5-fluoro-2-(octahydro-1H-azonino)-benzoylamino]ethyl]-benzoic acid,
C = 4-[2-[5-klor-2-(cis-3,5-dimetylp.iperidino)-nikotinoylaminoj-etyl] benzoesyre og C = 4-[2-[5-chloro-2-(cis-3,5-dimethylpiperidino)-nicotinoylaminoj-ethyl]benzoic acid and
D = 4-[2-[5-metyl-2-(oktahydro-lH-azonino)-benzoylamino]-etyl]-benzoesyre D = 4-[2-[5-methyl-2-(octahydro-1H-azonino)-benzoylamino]-ethyl]-benzoic acid
sammenlignet medcompared with
E = 4-[2-(2-etylamino-5-klor-benzoylamino)-etyl]benzoesyreE = 4-[2-(2-ethylamino-5-chloro-benzoylamino)-ethyl]benzoic acid
(se eksempel 5 i belgisk patent 837 311)(see example 5 in Belgian patent 837 311)
undersøkt med hensyn til sine blodsukkersenkende egenskaper,investigated for its blood sugar-lowering properties,
og forbindelseneand the connections
F 5-klor-2-[4-(3-pentyl)-piperidino]benzoesyre,F 5-chloro-2-[4-(3-pentyl)-piperidino]benzoic acid,
G = 5-brom-2-(oktahydro-isoindol-2ryl)-benzoesyre,G = 5-bromo-2-(octahydro-isoindol-2ryl)-benzoic acid,
H = 5-klor-2 - (2 , 3 , '3a , 4 , 7 , 7a-heksahydro-lH-isoindol-2-yl) -benzoesyre og H = 5-chloro-2-(2,3,'3a,4,7,7a-hexahydro-1H-isoindol-2-yl)-benzoic acid and
I = 5-klor-2-(oktahydro-isoindol-2-yl)-nikotinsyreI = 5-chloro-2-(octahydro-isoindol-2-yl)-nicotinic acid
og ble undersøkt med hensyn til sine lipidsenkende egenskaper som følger: and was investigated for its lipid-lowering properties as follows:
1. Blodsukkersenkende virkning:1. Blood sugar-lowering effect:
Den'blodsukkersenkende virkning av prøveforbindelsene ble undersøkt på hunn-rotter av egen avl med vekt på 180-220 g, som ble fastet 24 timer før forsøkets begynnelse. Prøve-forbindelsene ble umiddelbart før forsøkets.begynnelse sus-pendert i 1,5 %ig metylcellulose og administrert via svelgsonde. Blodprøver ble tatt umiddelbart før administrering av prøve-forbindelsen og likeledes 1, 2, 3 og 4 timer derefter/i hvert tilfelle fra den retroorbitale veneplexus. Fra 50^ul av. hver av disse prøver ble proteiner fjernet med 0,5 ml 0,33 N perklorsyre, og prøvene ble sentrifugert. I væsken på toppen ble glukose bestemt ved heksokinasemetoden ved hjelp av et analysefotometer. Den statistiske bedømmelse ble foretatt ved t-testen ifølge Student med p =0,05 som signifikans-grense. D.en følgende tabell inneholder de fundne verdier i prosent sammenlignet med kontrollen. The hypoglycaemic effect of the test compounds was investigated on female rats of own breeding with a weight of 180-220 g, which were fasted 24 hours before the start of the experiment. The test compounds were suspended in 1.5% methylcellulose immediately before the start of the experiment and administered via a throat tube. Blood samples were taken immediately before administration of the test compound and likewise 1, 2, 3 and 4 hours thereafter/in each case from the retroorbital venous plexus. From 50^ul of. in each of these samples, proteins were removed with 0.5 ml of 0.33 N perchloric acid, and the samples were centrifuged. In the liquid on top, glucose was determined by the hexokinase method using an analytical photometer. The statistical assessment was carried out using the t-test according to Student with p = 0.05 as the significance limit. D. the following table contains the values found in percentage compared to the control.
2. Lipidsenkende virkning: 2. Lipid-lowering effect:
Litteratur: P.E. Schurr et al. i Atherosclerosis Drug Discovery (1976) , utgiver: CE. Day; Literature: P.E. Schurr et al. in Atherosclerosis Drug Discovery (1976) , Publisher: CE. Day;
Plenum-, New York, side 215.Plenum-, New York, page 215.
Unge hannrotter med en gjennomsnittsvekt på 100 g ble ved fire dagers tilførsel av en diett (bestående av 10 % kokos-fett, 1,5 % kolesterol, 0,5 %cholsyre, 0,2 % cholinklorid.og 15 % sukrose) gjort hyperlipemiske. Under bibeholdelse av dietten tilførte man i to på hverandre følgende dager prøve-forbindelsen i metylcellulose ved suspensjon via svelgsonde. Derefter ble dyrene holdt fastende natten over, og 4 og 24 timer efter siste tilførsel av prøveforbindelse ble blod-prøver- tatt for å få serum. Young male rats with an average weight of 100 g were fed a diet (consisting of 10% coconut fat, 1.5% cholesterol, 0.5% cholic acid, 0.2% choline chloride and 15% sucrose) for four days to become hyperlipemic . While maintaining the diet, the test compound in methyl cellulose was added in suspension via a throat tube on two consecutive days. The animals were then kept fasting overnight, and 4 and 24 hours after the last administration of the test compound, blood samples were taken to obtain serum.
I serumet ble den samlede kolesterolmengde (Boehringer Mannheim Testkombination 187.313) og triglycerider (Boehringer Mannheim Testkombination 126.039) bestemt enzymatisk. S-lipoproteinene ble bestemt nefelometrisk efter felling med Ca og heparin i en Autoanalyzer. In the serum, the total amount of cholesterol (Boehringer Mannheim Testkombination 187.313) and triglycerides (Boehringer Mannheim Testkombination 126.039) was determined enzymatically. The S-lipoproteins were determined nephelometrically after precipitation with Ca and heparin in an Autoanalyzer.
Beregningen av den prosentvise senkning ble gjort sammenlignet med en kontrollgruppe. The calculation of the percentage lowering was done in comparison with a control group.
Den følgende tabell inneholder de fundne verdier: The following table contains the values found:
Forandringene er statistisk signifikante ved p = 0,05. The changes are statistically significant at p = 0.05.
3. Akutt toksisitet:3. Acute toxicity:
På hunn- og hannmus av egen avl.med vekt på 20-26 g ble den toksiske virkning av forbindelsene undersøkt efter. oral administrering (suspensjon i 1 %ig metylcellulose) av en engangs-dose ved en observasjonstid på minst 7 dager. Den følgende tabell inneholder de fundne verdier: The toxic effect of the compounds was investigated on female and male mice of own breeding with a weight of 20-26 g. oral administration (suspension in 1% methylcellulose) of a single dose with an observation period of at least 7 days. The following table contains the values found:
På grunn av sine farmakologiske egenskaper er forbindelsene med formel. I fremstilt ifølge oppfinnelsen og deres fysiologisk Due to their pharmacological properties, the compounds of formula In prepared according to the invention and their physiological
■forlikelige salter egnet til behandling av Diabetes mellitus. For dette formål kan de, eventuelt i kombinasjon med andre virkestoffer, innarbeides i de vanlige galeniske tilberedelsesformer såsom tabletter, dragéer, kapsler, pulvere eller suspensjoner. ■compatible salts suitable for the treatment of Diabetes mellitus. For this purpose, they can, possibly in combination with other active substances, be incorporated into the usual galenic preparation forms such as tablets, dragees, capsules, powders or suspensions.
Enkeltdosen for voksne er 1-50 mg, fortrinnsvis 2,5-20 mg,The single dose for adults is 1-50 mg, preferably 2.5-20 mg,
1 eller 2 ganger daglig.1 or 2 times daily.
Videre er forbindelsene med den generelle formel Ia på grunn av sine farmakologiske egenskaper egnet til behandling av hyper-lipidemier, særlig av type Ila, Ilb og IV, og derav betingede arteriosklerotiske forandringer i karsystemet, og kan, eventuelt i kombinasjon med andre virkestoffer, innarbeides i de vanlige farmasøytiske tilberedelsesformer såsom dragéer, tabletter, kapsler, stikkpiller, suspensjoner eller oppløsninger. Enkeltdosen er 5-200 mg, fortrinnsvis 5-50 mg, og den daglige dose 10-500 mg, fortrinnsvis 15-150 mg. Furthermore, due to their pharmacological properties, the compounds of the general formula Ia are suitable for the treatment of hyperlipidaemias, particularly of type Ila, Ilb and IV, and hence conditional arteriosclerotic changes in the vascular system, and can, possibly in combination with other active substances, be incorporated in the usual pharmaceutical preparation forms such as dragées, tablets, capsules, suppositories, suspensions or solutions. The single dose is 5-200 mg, preferably 5-50 mg, and the daily dose 10-500 mg, preferably 15-150 mg.
De følgende eksempler skal tjene til å illustrere oppfinnelsen ytterligere: Eksempel A The following examples shall serve to further illustrate the invention: Example A
2-( 2- azabicyklo[ 3. 3. 1] nonan- 2- yl)- 5- nitro- benzoesyre2-( 2- azabicyclo[ 3. 3. 1] nonan- 2- yl)- 5- nitro- benzoic acid
I 600 ml etanol oppvarmes 40 g (320 nuMol) 2-azabicyklo[3.3.1]-nonan, 64,5 g (320 mMol) 2-klor-5-nitro-benzoesyre og 74,3 g natriumkarbonat i 4 dager til tilbakeløpstemperatur. Efter avdestillering av etanolen oppløses inndampningsresiduet i 800 ml vann, innstilles på pPT 4 med 2 N saltsyre og utrystes derefter med kloroform. Kloroformfåsene tørres over natriumsulfat, og inndampningsresiduet renses kromatografisk over en silikagel-kolonne med toluen/eddiksyreetylester (6:4) som elueringsmiddel. In 600 ml of ethanol, 40 g (320 nuMol) of 2-azabicyclo[3.3.1]-nonane, 64.5 g (320 mmol) of 2-chloro-5-nitro-benzoic acid and 74.3 g of sodium carbonate are heated for 4 days to reflux temperature . After distilling off the ethanol, the evaporation residue is dissolved in 800 ml of water, adjusted to pPT 4 with 2 N hydrochloric acid and then shaken out with chloroform. The chloroform phases are dried over sodium sulfate, and the evaporation residue is purified chromatographically over a silica gel column with toluene/acetic acid ethyl ester (6:4) as eluent.
Utbytte: 11,6 g (12,5 % av det teoretiske)Yield: 11.6 g (12.5% of the theoretical)
Smeltepunkt: 167°CMelting point: 167°C
Eksempel B Example B
5- nitro- 2-[ 4-( 3- pentyl)- piperidino] benzoesyre5-nitro-2-[4-(3-pentyl)-piperidino]benzoic acid
Fremstilt analogt med eksempel A fra 2-klor-5-nitro-benzoesyre o.g 4-(3-pentyl) -piperidin. Prepared analogously to example A from 2-chloro-5-nitro-benzoic acid and 4-(3-pentyl)-piperidine.
Utbytte: 60 % av det teoretiskeYield: 60% of the theoretical
Smeltepunkt: 146°CMelting point: 146°C
Eksempel C Example C
5- nitr" o- 2- [ 4- ( 5- nonyl) - piperidino] benzoesyre5-nitro"o-2-[4-(5-nonyl)-piperidino]benzoic acid
Fremstilt analogt med eksempel A fra 2-klor-5-nitro-benzoesyre og 4-(5-nonyl)-piperidln. Prepared analogously to example A from 2-chloro-5-nitro-benzoic acid and 4-(5-nonyl)-piperidln.
Utbytte: 73 % av det teoretiskeYield: 73% of the theoretical
Smeltepunkt: 150-152°CMelting point: 150-152°C
Eksempel D Example D
5- nitro- 2-( oktahydro- isoindol- 2- yl)- benzoesyre5-nitro-2-(octahydro-isoindol-2-yl)-benzoic acid
Fremstilt analogt med eksempel A fra 2-klor-5-nitro-benzoesyre og oktahydro-isoindol. Prepared analogously to example A from 2-chloro-5-nitro-benzoic acid and octahydro-isoindole.
Utbytte: 77,5 % av det teoretiskeYield: 77.5% of the theoretical
Smeltepunkt: 188-190°CMelting point: 188-190°C
Eksempel E Example E
3- brom- 4- ( oktahydro- lH- azonino)- toluen3-bromo-4-(octahydro-1H-azonino)-toluene
12,0 g (52 mMol) 5-metyl-2-(oktahydro-lH-azonino)-anilin (fremstilt ved reduksjon av 3-nitro-4-(oktahydro-lH-azonino)-toluen) oppløses i 200 ml 48 %ig vandig bromhydrogensyre og diazotiseres ved 5°C ved dråpevis tilsetning av en oppløsning av 3,8 g (55 mMol) natriumnitritt i 10 ml vann. Den således oppnådde diazoniumsaltoppløsning'settes derefter raskt dråpevis til en suspensjon av 10,75 g (75 mMol) kobber(I)bromid og 4,0 g kobberpulver i 100 ml 48. %ig vandig bromhydrogensyre. Man efterrører i en time ved 40°C, gjør blandingen alkalisk, ekstraherer med metylenklorid, tørrer ekstraktene over natriumsulfat, filtrerer og inndamper. 12.0 g (52 mmol) of 5-methyl-2-(octahydro-1H-azonino)-aniline (prepared by reduction of 3-nitro-4-(octahydro-1H-azonino)-toluene) is dissolved in 200 ml 48% ig aqueous hydrobromic acid and diazotized at 5°C by dropwise addition of a solution of 3.8 g (55 mmol) sodium nitrite in 10 ml of water. The diazonium salt solution thus obtained is then rapidly added dropwise to a suspension of 10.75 g (75 mmol) copper (I) bromide and 4.0 g copper powder in 100 ml 48% aqueous hydrobromic acid. The mixture is stirred for one hour at 40°C, the mixture is made alkaline, extracted with methylene chloride, the extracts are dried over sodium sulphate, filtered and evaporated.
Utbytte: 10,1. g (66 % av det teoretiske),Yield: 10.1. g (66% of the theoretical),
Smeltepunkt: <20°C.Melting point: <20°C.
Eksempel FExample F
3- brom- 4-( oktahydro- isoindol- 2- yl)- toluen3-bromo-4-(octahydro-isoindol-2-yl)-toluene
Fremstilt ved Sandmeyer-reaksjon analogt med eksempel E ved å gå ut fra 3-amino-4-(oktahydro-isoindol-2-yl)-toluen. Prepared by Sandmeyer reaction analogously to example E starting from 3-amino-4-(octahydro-isoindol-2-yl)-toluene.
Utbytte: 20'% av det teoretiske,Yield: 20% of the theoretical,
Smeltepunkt: 116°CMelting point: 116°C
Eksempel G Example G
( 5- n1tro- 2- piperidino- fenyl) eddiksyre(5-nitro-2-piperidino-phenyl)acetic acid
55 g (260 mMol) (2-klor-5-nitrofenyl)eddiksyre [fremstilt yed nitrering av (2-klorfenyl)-eddiksyre med nitrersyre,. smeltepunkt: 127°C] oppvarmes med 230 ml piperidin i 48 timer til til-bakeløpstemperatur. Efter tilsetning av 400 ml vann innstilles pH-verdien på 5,5 med saltsyre. Derved utfelles reaksjonspro-duktet, som efter avsugning efter-vaskes med. aceton og eter. Utbytte: 64 g (93 % av det teoretiske), 55 g (260 mmol) (2-chloro-5-nitrophenyl)acetic acid [prepared by nitration of (2-chlorophenyl)-acetic acid with nitric acid,. melting point: 127°C] is heated with 230 ml of piperidine for 48 hours to reflux temperature. After adding 400 ml of water, adjust the pH value to 5.5 with hydrochloric acid. Thereby the reaction product is precipitated, which is then washed with after extraction. acetone and ether. Yield: 64 g (93% of theoretical),
Smeltepunkt: 119°CMelting point: 119°C
Eksempel H Example H
( 2- oktahydro- lH- azonino- 5- nitro- fenyl) eddiksyre( 2- octahydro- 1H- azonino- 5- nitro- phenyl) acetic acid
50 g (240 mMol) (2-klor-5-nitro-fenyl)eddiksyre oppvarmes med 260 ml oktahydro-lH-azonin i -24 timer til 110-120°C. Efter inndampning til tørrhet oppløses resten i 400 ml vann, oppløsningen innstilles på pH 2-3 med saltsyre og utrystes med kloroform. De samlede kloroformfaser utrystes med fortynnet natronlut, og der-efter ekstraheres den vandige fase med kloroform efter fornyet surgjøring. Efter tørring og avdestillering av kloroformen vaskes det dannede krystallisat med petroletér/eter =5:1. 50 g (240 mmol) of (2-chloro-5-nitro-phenyl)acetic acid are heated with 260 ml of octahydro-1H-azonine for -24 hours to 110-120°C. After evaporation to dryness, the residue is dissolved in 400 ml of water, the solution is adjusted to pH 2-3 with hydrochloric acid and shaken out with chloroform. The combined chloroform phases are shaken with diluted caustic soda, and then the aqueous phase is extracted with chloroform after renewed acidification. After drying and distilling off the chloroform, the crystallisate formed is washed with petroleum ether/ether = 5:1.
Utbytte: 31 g (42 % av det teoretiske),Yield: 31 g (42% of the theoretical),
Smeltepunkt: 100-103°CMelting point: 100-103°C
Eksempel I Example I
[ 2-( oktahydro- isoindol- 2- yl)- 5- nitro- fenyl]- eddiksyre [ 2-( octahydro- isoindol- 2- yl)- 5- nitro- phenyl]- acetic acid
Fremstilt analogt med eksempel H fra (2-klor-5-nitro-fenyl)-eddiksyre og oktahydro-isoindol. Prepared analogously to example H from (2-chloro-5-nitro-phenyl)-acetic acid and octahydro-isoindole.
Utbytte: 53 % av det teoretiske,Yield: 53% of the theoretical,
Smeltepunkt: 228°CMelting point: 228°C
Eksempel K• Example K•
2-( 2, 3, 3a, 4, 7, 7a- heksahydro- lH- isoindol- 2- yl)- 5- nitro- benzoesyre Fremstilt analogt med eksempel A fra 2-klor-5-nitro-benzoesyre. og 2,3,3a,4,7,7a-heksahydro-lH-isoindol. 2-(2,3,3a,4,7,7a-hexahydro-1H-isoindol-2-yl)-5-nitro-benzoic acid Prepared analogously to example A from 2-chloro-5-nitro-benzoic acid. and 2,3,3α,4,7,7α-hexahydro-1H-isoindole.
Utbytte: 85 % av det teoretiske,Yield: 85% of the theoretical,
Smeltepunkt: 231°C Melting point: 231°C
Eksempel L Example L
2- ( 1, 3- dihydro- isolndol- 2- yl)- 5- nitro- benzoesyre2-( 1, 3- dihydro-isolndol- 2- yl)- 5- nitro- benzoic acid
Fremstilt analogt med eksempel A fra 2-klor-5-nitro-benzoesyre og 1,3-dihydroisoindol. Prepared analogously to example A from 2-chloro-5-nitro-benzoic acid and 1,3-dihydroisoindole.
Utbytte: 52 % av det teoretiske,Yield: 52% of the theoretical,
Smeltepunkt: 185-186°CMelting point: 185-186°C
Eksempel M Example M
DL- 2- ( 2- klor- 5- nitro- fenyl) propionsyreDL-2-(2-chloro-5-nitro-phenyl) propionic acid
■Til 2,9 g (157 mMol) DL-2-(2-klorfenyl)propionsyre, oppløst i 70 ml konsentrert svovelsyre, settes ved "15°C 23,5 ml nitrersyre (7,5 ml rykende salpetersyre med spesifikk vekt 1,5 og 16 ml konsentrert svovelsyre) så langsomt at temperaturen ikke stiger over 0°C. Efter avsluttet tilsetning og videre omrøring i en time ved romtemperatur, helles reaksjonsblandingen i isvann. Den utfelte syre avsuges, oppløses i kloroform og vaskes med vann. Kloroformekstraktene tørres, og inndampningsresiduet bringes til krystallisasjon med petroleter/eter. ■To 2.9 g (157 mmol) of DL-2-(2-chlorophenyl)propionic acid, dissolved in 70 ml of concentrated sulfuric acid, add at "15°C 23.5 ml of nitric acid (7.5 ml of fuming nitric acid with specific gravity 1 .5 and 16 ml of concentrated sulfuric acid) so slowly that the temperature does not rise above 0°C. After the addition is finished and further stirring for one hour at room temperature, the reaction mixture is poured into ice water. The precipitated acid is filtered off with suction, dissolved in chloroform and washed with water. The chloroform extracts dried, and the evaporation residue is crystallized with petroleum ether/ether.
Utbytte: 95 % av det teoretiske,Yield: 95% of the theoretical,
Smeltepunkt: 129-131°CMelting point: 129-131°C
Analogt ble følgende forbindelser fremstilt: Analogously, the following compounds were prepared:
DL-2-[2-(oktahydro-isoindol-2-yl)-5-nitro-fenyl]propionsyre DL-2-(2-oktahydro-lH-azonino-5-nitro-fenyl)-propionsyre DL-2-[2-(octahydro-isoindol-2-yl)-5-nitro-phenyl]propionic acid DL-2-(2-octahydro-1H-azonino-5-nitro-phenyl)-propionic acid
DL-2-(5-nitro-2-piperidino-fenyl)-propionsyreDL-2-(5-nitro-2-piperidino-phenyl)-propionic acid
Eksempel N Example N
2-( 5- klor- l, 3- dihydro- isoindol- 2- yl)- 5- nitro- benzoesyre 2-(5-chloro-1,3-dihydro-isoindol-2-yl)-5- nitro-benzoic acid
Fremstilt analogt med eksempel A fra 2-klor-5-nitro-benzoesyre og 5-klor-l,3-dihydro-isoindol. Prepared analogously to example A from 2-chloro-5-nitro-benzoic acid and 5-chloro-1,3-dihydro-isoindole.
Utbytte: 27 % av det teoretiske,Yield: 27% of the theoretical,
Smeltepunkt:' 163°C Melting point:' 163°C
Eksempel 0 Example 0
2- ( 1, 3- dihydro- 5- metoksy- isoindol- 2- yl)- 5- nitro- benzoesyre Fremstilt analogt med eksempel A fra 2-klor-5-nitro-benzoesyre og 5-metoksy-l, 3-dihydro-isoiridol. 2-(1,3-dihydro-5-methoxy-isoindol-2-yl)-5-nitro-benzoic acid Prepared analogously to example A from 2-chloro-5-nitro-benzoic acid and 5-methoxy-1,3-dihydro -isoiridol.
Utbytte: 57 % av det teoretiske,Yield: 57% of the theoretical,
Smeltepunkt: 152°CMelting point: 152°C
Eksempel P Example P
( 5- nitro- 2- pyrrolidino- fenyl) eddiksyre(5-nitro-2-pyrrolidino-phenyl)acetic acid
Fremstilt analogt med eksempel G fra (2-klor-5-nitrc-fenyl)-eddiksyre og pyrrolidin. Prepared analogously to example G from (2-chloro-5-nitrc-phenyl)-acetic acid and pyrrolidine.
Utbytte: 90% av det teoretiske,Yield: 90% of the theoretical,
Smeltepunkt: 2 0 8°C .Melting point: 2 0 8°C.
Eksempel Q Example Q
( 2- heksametylenimino- 5- nitro- fenyl) eddiksyre(2-hexamethyleneimino-5-nitro-phenyl) acetic acid
Fremstilt analogt med, eksempel H fra (2-klor-5-nitro-fenyl)-eddiksyre og heksametylenimin. Prepared analogously to, example H from (2-chloro-5-nitro-phenyl)-acetic acid and hexamethylene imine.
Utbytte: 96 % av det teoretiske,Yield: 96% of the theoretical,
Smeltepunkt: 144°CMelting point: 144°C
Eksempel R Example R
( 2- heptametylenimino- 5- nitro- fenyl) eddiksyre(2-heptamethyleneimino-5-nitro-phenyl) acetic acid
Fremstilt analogt med eksempel H fra (2-klor-5-nitro-fenyl)-eddiksyre og heptametylenimin. Prepared analogously to example H from (2-chloro-5-nitro-phenyl)-acetic acid and heptamethyleneimine.
Utbytte: 9 5 % av det teoretiske, Yield: 9 5% of the theoretical,
Smeltepunkt: 136°CMelting point: 136°C
Eksempel S 2, 5- diklor- nikotinsyre Example S 2,5-dichloronicotinic acid
a) En.blanding av 52,1 g (0,3 mol) 5-klor-2-hydroksy-nikotinsyre og 68,7 g- (0,33 mol) fosforpentaklorid omrøres i 30 minutter ved a) A mixture of 52.1 g (0.3 mol) 5-chloro-2-hydroxy-nicotinic acid and 68.7 g (0.33 mol) phosphorus pentachloride is stirred for 30 minutes at
140°C. Derefter tilsettes 500 ml toluen, uoppløste bestanddeler avsuges, og filtratet inndampes i vakuum. Residuet destilleres 140°C. 500 ml of toluene are then added, undissolved components are suctioned off, and the filtrate is evaporated in vacuo. The residue is distilled
i høy-vakuum. Utbytte: 40,1 g (63,5 % av det teoretiske), in high-vacuum. Yield: 40.1 g (63.5% of the theoretical),
Kokepunkt: 72,74°C ved 0,05 mbar.Boiling point: 72.74°C at 0.05 mbar.
b) 2, 5- diklor- nikotinsyreb) 2, 5-dichloro-nicotinic acid
72,2 g (0,343 mol) 2,5-diklor-nikotinsyreklorid tilsetter 72.2 g (0.343 mol) of 2,5-dichloronicotinic acid chloride add
man dråpevis under avkjøling og kraftig omrøring til vandig natronlut (fra 13,7 g (0,343 mol) natriumhydroksyd og 200 ml vann). Efter 1,5 timer avsuges bunnfallet og vaskes med vann. De oppnådde krystaller utgnies med acetonitril og avsuges. Utbytte: 62,7 g (95,2 % av det teoretiske) , is added dropwise under cooling and vigorous stirring to aqueous caustic soda (from 13.7 g (0.343 mol) sodium hydroxide and 200 ml water). After 1.5 hours, the precipitate is suctioned off and washed with water. The crystals obtained are triturated with acetonitrile and suctioned off. Yield: 62.7 g (95.2% of the theoretical),
Smeltepunkt: 153-155°CMelting point: 153-155°C
Eksempel T Example T
[ 2- piperidino- pyridyl-( 3)] acetonitril[ 2-piperidinopyridyl-(3)] acetonitrile
a) [ 2- klor- pyridyl-( 3)] acetonitrila) [2-chloro-pyridyl-(3)] acetonitrile
En oppløsning av 35,8 g (0,267 mol) 3-cyanometyl-pyridin-N-oksyd i 360 ml fosforoksyklorid oppvarmes langsomt til tilbakeløps-temperatur under omrør-ing. Efter 2 timer inndampes reaks jonsblandingen i vakuum, resten settes til isvann og bringes til pH 3 med natronlut. Efter ekstraksjon med kloroform foretas rensning kolonnekromatografisk over silikagel i elueringsmiddel toluen/eddiksyreetylester = 10:1, A solution of 35.8 g (0.267 mol) of 3-cyanomethyl-pyridine-N-oxide in 360 ml of phosphorus oxychloride is slowly heated to reflux temperature with stirring. After 2 hours, the reaction mixture is evaporated in vacuo, the residue is added to ice water and brought to pH 3 with caustic soda. After extraction with chloroform, purification is carried out by column chromatography over silica gel in eluent toluene/ethyl acetate = 10:1,
Utbytte: 8,5 g (21 % av det teoretiske),Yield: 8.5 g (21% of the theoretical),
Smeltepunkt: 82-84°CMelting point: 82-84°C
b) [ 2- piperidino- pyridyl-( 3)] acetonitrilb) [2-piperidinopyridyl-(3)]acetonitrile
Fremstilt fra [2-klor-pyridyl-(3)]acetonitril og piperidin Prepared from [2-chloro-pyridyl-(3)]acetonitrile and piperidine
analogt med eksempel H.analogous to example H.
Utbytte: 57 % av det teoretiske,Yield: 57% of the theoretical,
Smeltepunkt: <20°CMelting point: <20°C
.Beregnet: Moltopp: m/e = 201 .Calculated: Mole peak: m/e = 201
Funnet: Moltopp: m/e = 201Found: Mole top: m/e = 201
Eksempel 1 Example 1
4-[ 2- f 2-( 2- azabicyklo[ 3. 3. 1] nonan- 2- yl)- 5- klor- benzoylamino] etyl]-benzoesyre- etylester 4-[ 2- f 2-( 2- azabicyclo[ 3. 3. 1] nonan- 2- yl)- 5- chloro- benzoylamino] ethyl]-benzoic acid ethyl ester
Til en oppløsning av 3,7 g (13 mMol) 2-(2-aza'bicyklo [3 . 3 .1 ] - nonan-2-yl)-5-klor-benzoesyre i 20 ml absolutt pyridin settes To a solution of 3.7 g (13 mmol) 2-(2-aza'bicyclo[3.3.1]-nonan-2-yl)-5-chloro-benzoic acid in 20 ml absolute pyridine is added
2,3 (13 mMol) N,N'-karbonyl-diimidazol. Efter 5 timers oppvarmning til 80°C er imidazolidet dannet kvantitativt. Derefter tilsettes 3,1 g (16 mMol) 4-(2-amino-etyl)-benzoesyre-etylester, oppløst i 50 ml pyridin, og det hele oppvarmes i 16 timer til 90°C under omrøring. Efter avdestillering av 2.3 (13 mmol) N,N'-carbonyldiimidazole. After 5 hours of heating to 80°C, the imidazolide has been formed quantitatively. 3.1 g (16 mmol) of 4-(2-amino-ethyl)-benzoic acid ethyl ester, dissolved in 50 ml of pyridine, are then added, and the whole is heated for 16 hours to 90°C with stirring. After distilling off
pyridinet på en rotasjonsinndamper renses esteren kromatogråfisk over en silikagel-kolonne med toluen/eddiksyreetylester (9:1) som elueringsmiddel. the pyridine on a rotary evaporator, the ester is purified chromatographically over a silica gel column with toluene/acetic acid ethyl ester (9:1) as eluent.
Utbytte: 1,8 g (30 % av det teoretiske),Yield: 1.8 g (30% of the theoretical),
Smeltepunkt: <20°CMelting point: <20°C
Eksempel 2 4-[ 2-[ 5- klor- 2-( 4-( 3- pentyl)- piperidino)- benzoylamino] etyl]-benzoesyre- etylester Example 2 4-[2-[5-chloro-2-(4-(3-pentyl)-piperidino)-benzoylamino] ethyl]-benzoic acid ethyl ester
Fremstilt analogt med eksempel 1 fra 5-klor-2-(4-(3-pentyl)-piperidino)-benzoesyre og 4-(2-amino-etyl)-benzoesyre-etylester. Utbytte: 62 % av det teoretiske, Prepared analogously to example 1 from 5-chloro-2-(4-(3-pentyl)-piperidino)-benzoic acid and 4-(2-amino-ethyl)-benzoic acid ethyl ester. Yield: 62% of the theoretical,
Smeltepunkt: 95-96°CMelting point: 95-96°C
Eksempel 3 Example 3
4"- [ 2- [ 5- klor- 2 - ( 4 - ( 5- nonyl) - piperidino ) - benzoylamino] etyl] - benzoesyre- etylester 4"- [ 2- [ 5- chloro- 2 - ( 4 - ( 5- nonyl) - piperidino ) - benzoylamino] ethyl] - benzoic acid ethyl ester
Fremstilt analogt med eksempel 1 fra 5-klor-2- (4-(5-nonyl)-piperidino)-benzoesyre og 4-(2-amino-etyl)-benzoesyre-etylester. Utbytte: 79 % av det teoretiske, Prepared analogously to example 1 from 5-chloro-2-(4-(5-nonyl)-piperidino)-benzoic acid and 4-(2-amino-ethyl)-benzoic acid ethyl ester. Yield: 79% of the theoretical,
Smeltepunkt: 49-50°CMelting point: 49-50°C
Eksempel 4 4-[ 2- [ 5- brom- 2-( oktahydro- isoindol- 2- yl)- benzoylamino] etyl]-benzoesyre- etylester Example 4 4-[2-[5-bromo-2-(octahydro-isoindol-2-yl)-benzoylamino] ethyl]-benzoic acid ethyl ester
Fremstilt analogt med eksempel 1 fra 5-brom-2-(oktahydro-isoindol-2-yl)-benzoesyre og 4-(2-amino-etyl)-benzoesyre-etylester. Prepared analogously to example 1 from 5-bromo-2-(octahydro-isoindol-2-yl)-benzoic acid and 4-(2-amino-ethyl)-benzoic acid ethyl ester.
Utbytte: 67,7 % av det teoretiske,Yield: 67.7% of the theoretical,
Smeltepunkt: 178-17 9°C Melting point: 178-179°C
Eksempel 5 Example 5
4 - [ 2- [ 2- ( 2- azabicyklo[ 3. 3. 1] nonan- 2- yl)- 5- klor- benzoylamino] - etyl] benzoesyre 4 - [ 2- [ 2- ( 2- azabicyclo[ 3. 3. 1] nonan- 2- yl)- 5- chloro- benzoylamino] - ethyl] benzoic acid
1,3 g (2,9 mMol) 4-[2-[2-(2-azabicyklo[3.3.1]nonan-2-yl)-5-klor-benzoylamino]etyl]benzoesyre-etylester oppløses i 40 ml av en blanding av metanol/dioksan (1:1). Efter tilsetning av 0,65 g (12 mMol) kaliumhydroksyd, oppløst i 5 ml vann, tilsettes 100 ml vann så langsomt ved romtemperatur at det ikke oppstår noen utfelling av esteren. Efter noen timer avdestilleres det organiske oppløsningsmiddel på en rotasjonsinndamper, den vandige fase utrystes med kloroform, og den vandige fase innstilles på pH 5,5 med 2 N saltsyre. Efter ekstraksjon med kloroform, tørring over natriumsulfat, avdestillering av kloroformen og oppslutning med petroleter, får man syren. 1.3 g (2.9 mmol) of 4-[2-[2-(2-azabicyclo[3.3.1]nonan-2-yl)-5-chloro-benzoylamino]ethyl]benzoic acid ethyl ester is dissolved in 40 ml of a mixture of methanol/dioxane (1:1). After adding 0.65 g (12 mmol) of potassium hydroxide, dissolved in 5 ml of water, 100 ml of water is added so slowly at room temperature that no precipitation of the ester occurs. After a few hours, the organic solvent is distilled off on a rotary evaporator, the aqueous phase is shaken out with chloroform, and the aqueous phase is adjusted to pH 5.5 with 2 N hydrochloric acid. After extraction with chloroform, drying over sodium sulphate, distillation of the chloroform and digestion with petroleum ether, the acid is obtained.
Utbytte: 1 g (80 % av det teoretiske),Yield: 1 g (80% of the theoretical),
Smeltepunkt: 217°CMelting point: 217°C
Eksempel 6 Example 6
4-[ 2-[ 5- klor- 2-( 4-( 3- pentyl)- piperidino)- benzoylamino] etyl]-benzoesyre 4-[ 2-[ 5- chloro- 2-( 4-( 3- pentyl)-piperidino)- benzoylamino] ethyl]-benzoic acid
Fremstilt analogt med eksempel 5 ved alkalisk hydrolysePrepared analogously to example 5 by alkaline hydrolysis
av 4-[2-[5-klor-2-(4-(3-pentyl)-piperidino)-benzoylamino]etyl]-benzoesyre-etylester. of 4-[2-[5-chloro-2-(4-(3-pentyl)-piperidino)-benzoylamino]ethyl]-benzoic acid ethyl ester.
Utbytte: 20 % av det teoretiske,Yield: 20% of the theoretical,
Smeltepunkt: 130-132°CMelting point: 130-132°C
Eksempel 7 Example 7
4-[ 2-[ 5- klor- 2-( 4-( 5- nonyl)- piperidino)- benzoylamino] etyl]-benzoesyre 4-[ 2-[ 5- chloro- 2-( 4-( 5- nonyl)-piperidino)- benzoylamino] ethyl]-benzoic acid
Fremstilt analogt med eksempel 5 ved alkalisk hydrolysePrepared analogously to example 5 by alkaline hydrolysis
av 4-[2-[5-klor-2-(4-(5-nonyl)-piperidino)-benzoylamino]etyl]-benzoesyre-etylester. of 4-[2-[5-chloro-2-(4-(5-nonyl)-piperidino)-benzoylamino]ethyl]-benzoic acid ethyl ester.
Utbytte: 68 % av det teoretiske,Yield: 68% of the theoretical,
Smeltepunkt: 12 9-130°CMelting point: 12 9-130°C
Eksempel 8 Example 8
4-[ 2-[ 5- brom- 2-( oktahydro- isoindol- 2- yl)- benzoylamino] etyl]-benzoesyre 4-[ 2-[ 5- bromo- 2-( octahydro- isoindol- 2- yl)- benzoylamino] ethyl] benzoic acid
Fremstilt analogt med eksempel 5 ved alkalisk hydrolysePrepared analogously to example 5 by alkaline hydrolysis
av 4 - [2 - [5-brom-^2- (oktahydro-isoindol-2-yl) -benzoylamino] etyl ] - benzoesyre-etylester. of 4-[2-[5-bromo-^2-(octahydro-isoindol-2-yl)-benzoylamino] ethyl ]-benzoic acid ethyl ester.
Utbytte: 86,3 % av det teoretiske,Yield: 86.3% of the theoretical,
Smeltepunkt: 23 5°CMelting point: 23 5°C
. Eksempel 9 4-[ 2- ( 5- jod- 2-( oktahydro- lH- azonino)- benzoylamino) etyl] benzoesyre- etylester . Example 9 4-[2-(5-iodo-2-(octahydro-1H-azonino)-benzoylamino)ethyl]benzoic acid ethyl ester
2,9 g (7,8 mMol) 5-jod-2-(oktahydro-lH-azonino)-benzoesyre oppløses i 20 ml absolutt pyridin og overføres kvantitativt til imidazolidet ved 50°C med 1,5 g (8,5 mMol) N,N<1->karbonyldiimidazol i løpet av. 3 timer. Efter tilsetning av 1,75 g (9 mMol) 4-(2-amino-etyl)-benzoesyre-etylester oppvarmes reaksjonsblandingen i 8 timer til 90°C, og pyridinet avdestilleres derefter i en rotasjonsinndamper. Esteren renses kromatografisk- over en silikagel-kolonne med toluen/eddiksyreetyl-éster (9:1) som elueringsmiddel. 2.9 g (7.8 mmol) of 5-iodo-2-(octahydro-1H-azonino)-benzoic acid are dissolved in 20 ml of absolute pyridine and quantitatively transferred to the imidazolide at 50°C with 1.5 g (8.5 mmol ) N,N<1->carbonyldiimidazole during. 3 hours. After adding 1.75 g (9 mmol) of 4-(2-amino-ethyl)-benzoic acid ethyl ester, the reaction mixture is heated for 8 hours to 90°C, and the pyridine is then distilled off in a rotary evaporator. The ester is purified chromatographically over a silica gel column with toluene/acetic acid ethyl ester (9:1) as eluent.
Utbytte: 1,3 g (30 % av det teoretiske),Yield: 1.3 g (30% of the theoretical),
Smeltepunkt: <20°CMelting point: <20°C
Eksempel 10 Example 10
4- [ 2- ( 5- f luor- 2-.( oktahydro- lH- azonino) - benzoylamino) etyl] benzoesyre- etylester 4- [ 2- ( 5- fluoro- 2-.( octahydro- 1H- azonino) - benzoylamino) ethyl] benzoic acid ethyl ester
Fremstilt analogt med eksempel 9 fra 5-fluor-2-(oktahydro-lH-azonino)-benzoesyre og 4-(2-amino-etyl)-benzoesyre-etylester. Utbytte: 60 % av det teoretiske, Prepared analogously to example 9 from 5-fluoro-2-(octahydro-1H-azonino)-benzoic acid and 4-(2-amino-ethyl)-benzoic acid ethyl ester. Yield: 60% of the theoretical,
Smeltepunkt: <20°CMelting point: <20°C
Eksempel 11 Example 11
4-[ 2-( 5- metyl- 2-( oktahydro- lH- azonino)- benzoylamino) etyl]-benzoesyre- etylester 4-[ 2-( 5- methyl- 2-( octahydro- 1H- azonino)- benzoylamino) ethyl]-benzoic acid ethyl ester
Fremstilt analogt med eksempel 9 fra 5-metyl-2-(oktahydro-lH-azonino)-benzoesyre og 4 -(2-amino-etyl)-benzoesyre-etylester. Utbytte: 90 % av det teoretiske, Prepared analogously to example 9 from 5-methyl-2-(octahydro-1H-azonino)-benzoic acid and 4-(2-amino-ethyl)-benzoic acid ethyl ester. Yield: 90% of the theoretical,
Smeltepunkt: <20°CMelting point: <20°C
Eksempel 12 Example 12
4-[ 2-[ 5-( 2- tolyl)- 2- ( oktahydro- lH- azonino)- benzoylamino] etyl]-benzoesyre- etylester 4-[ 2-[ 5-( 2-tolyl)- 2-( octahydro- 1H- azonino)- benzoylamino] ethyl]-benzoic acid ethyl ester
Fremstilt analogt med eksempel 9 fra 5-(2-tolyl)-2-(okta- . hydro-lH-azonino)-benzoesyre og 4-(2-amino-etyl)-benzoesyre-etylester. Prepared analogously to example 9 from 5-(2-tolyl)-2-(octa-.hydro-1H-azonino)-benzoic acid and 4-(2-amino-ethyl)-benzoic acid ethyl ester.
Utbytte: 11 % av det teoretiske,Yield: 11% of the theoretical,
Smeltepunkt: <2 0°C Melting point: <2 0°C
Eksempel 13 Example 13
4-[ 2-[ 5-( 4- klorfenyl)- 2- piperidino- benzoylamino] etyl] benzoesyre- etylester 4-[ 2-[ 5-( 4- chlorophenyl)- 2- piperidino- benzoylamino] ethyl] benzoic acid ethyl ester
Fremstilt analogt med eksempel.9 fra 5-(4-klorfenyl)-2-piperidino-benzoesyre og 4-(2-amino-etyl)benzoesyre-etylester. Prepared analogously to example 9 from 5-(4-chlorophenyl)-2-piperidino-benzoic acid and 4-(2-amino-ethyl)benzoic acid ethyl ester.
Utbytte: 24 % av det teoretiskeYield: 24% of the theoretical
Smeltepunkt: 129-130°CMelting point: 129-130°C
Eksempel 14 Example 14
4-[ 2-[ 5- trifluormetyl- 2-( oktahydro- lH- azonino)- benzoylamino]-etyl] benzoesyre- etylester 4-[ 2-[ 5- trifluoromethyl- 2-( octahydro- 1H- azonino)- benzoylamino]-ethyl] benzoic acid ethyl ester
Fremstilt analogt med eksempel 9 fra 5-trifluormetyl->2-(oktahydro-lH-azonino)benzoesyre og 4-(2-amino-etyl)-benzoesyre-etylester. Prepared analogously to example 9 from 5-trifluoromethyl->2-(octahydro-1H-azonino)benzoic acid and 4-(2-amino-ethyl)-benzoic acid ethyl ester.
Utbytte: 80 % av det teoretiske,Yield: 80% of the theoretical,
Smeltepunkt: <20°CMelting point: <20°C
Analogt med de ovenstående eksempler 9-14 ble følgende forbindelser fremstilt: 4-[2-(5-isopropyl-2-(oktahydro-lH-azonino)-benzoylamino)etyl]-benzoesyre-etylester Analogous to the above examples 9-14, the following compounds were prepared: 4-[2-(5-isopropyl-2-(octahydro-1H-azonino)-benzoylamino)ethyl]-benzoic acid ethyl ester
4-[2-[5-tert.butyl-2-(oktahydro-lH-azonino)-benzoylamino]etyl]-benzoesyre-etylester■ 4-[2-[5-tert.butyl-2-(octahydro-1H-azonino)-benzoylamino]ethyl]-benzoic acid ethyl ester■
4-[2-[5-buty1-2-(oktahydro-lH-azonino)-benzoylamino]etyl]-benzoesyre-etylester 4-[2-[5-Butyl-2-(octahydro-1H-azonino)-benzoylamino]ethyl]-benzoic acid ethyl ester
4 -[2-[5-fluor-2-(dekahydro-azecino)-benzoylamino]etyl]benzoesyre-etylester 4-[2-[5-fluoro-2-(decahydro-azecino)-benzoylamino]ethyl]benzoic acid ethyl ester
4-[2-[5-brom-2-(dekahydro-azecino)-benzoylamino]etyl]benzoesyre-etylester 4-[2-[5-Bromo-2-(decahydro-azecino)-benzoylamino]ethyl]benzoic acid ethyl ester
4-[2-[5-jod-2-(dekahydro-azecino)-benzoylamino]etyl]benzoesyre-etylester 4-[2-[5-iodo-2-(decahydro-azecino)-benzoylamino]ethyl]benzoic acid ethyl ester
4-[2-[5-cyano-2-(dekahydro-azecino)-benzoylamino]etyl]benzoesyre-etylester 4-[2-[5-cyano-2-(decahydro-azecino)-benzoylamino]ethyl]benzoic acid ethyl ester
4 -[2-[5-metyl-2-(dekahydro-azecino)-benzoylamino]etyl]benzoesyre-etylester 4-[2-[5-methyl-2-(decahydro-azecino)-benzoylamino]ethyl]benzoic acid ethyl ester
4-[2-[5-metoksy-2-(dekahydro-azecino)-benzoylamino]etyl]benzoesyre-etylester 4-[2-[5-Methoxy-2-(decahydro-azecino)-benzoylamino]ethyl]benzoic acid ethyl ester
Eksempel 15 .. Example 15 ..
4-[ 2-[ 5- jod- 2-( oktahydro- lH- azonino)- benzoylamino] etyl] benzoesyre 1 g (1,8 mMol) 4-[,2-[ 5-jod-2-(oktahydro-lH-azonino)-benzoylamino] etyl] benzoesyre-etylester for-sepes i 20 ml dioksan/metanol (1:1) ved romtemperatur med 0,4 g (7,2 mMol) kalilut, oppløst i 50 ml vann. Efter avdestillering av det organiske oppløsnings-middel foretas utrystning med kloroform, den vandige fase innstilles på pH 4,5 med 2 N saltsyre og utrystes med kloroform. Den tørre rest fra kloroformekstraktene utgnies med petroléter, hvorved produktet utkrystalliserer. 4-[ 2-[ 5-iodo- 2-( octahydro-1H- azonino)- benzoylamino] ethyl] benzoic acid 1 g (1.8 mmol) 4-[,2-[ 5-iodo-2-(octahydro-1H -azonino)-benzoylamino] ethyl] benzoic acid ethyl ester is pre-saponified in 20 ml dioxane/methanol (1:1) at room temperature with 0.4 g (7.2 mmol) potassium chloride, dissolved in 50 ml water. After distilling off the organic solvent, shaking is carried out with chloroform, the aqueous phase is adjusted to pH 4.5 with 2 N hydrochloric acid and shaken with chloroform. The dry residue from the chloroform extracts is rubbed with petroleum ether, whereby the product crystallizes out.
Utbytte: 0,45 g (48 % av det teoretiske),Yield: 0.45 g (48% of theoretical),
Smeltepunkt: 7 3°C (sintring)Melting point: 7 3°C (sintering)
Eksempel 16 Example 16
4-[ 2-[ 5- fluor- 2-( oktahydro- lH- azonino)- benzoylamino] etyl]-benzoesyre 4-[ 2-[ 5- fluoro- 2-( octahydro- 1H- azonino)- benzoylamino] ethyl] benzoic acid
Fremstilt analogt med eksempel 15 ved alkalisk hydrolyse av 4-[2-(5-fluor-2-(oktahydro-lH-azonino)-benzoylamino)etyl]-benzoesyre-etylester. Prepared analogously to example 15 by alkaline hydrolysis of 4-[2-(5-fluoro-2-(octahydro-1H-azonino)-benzoylamino)ethyl]-benzoic acid ethyl ester.
Utbytte: 85 % av det teoretiske,Yield: 85% of the theoretical,
Smeltepunkt: 166-168°CMelting point: 166-168°C
Eksempel 17 Example 17
4-[ 2-[ 5- metyl- 2-( oktahydro- lH- azonino)- benzoylamino] etyl]-benzoesyre 4-[ 2-[ 5- methyl- 2-( octahydro- 1H- azonino)- benzoylamino] ethyl] benzoic acid
■■' Fremstilt analogt med eksempel 15 ved alkalisk hydrolyse av 4-[2-(5-metyl-2-(oktahydro-lH-azonino)-benzoylamino)etyl]-benzoesyre-etylester. ■■' Prepared analogously to example 15 by alkaline hydrolysis of 4-[2-(5-methyl-2-(octahydro-1H-azonino)-benzoylamino)ethyl]-benzoic acid ethyl ester.
Utbytte: 81 % av det 'teoretiske,Yield: 81% of the 'theoretical,
Smeltepunkt: 145-147PCMelting point: 145-147PC
Eksempel 18 Example 18
4 - [ 2-[ 5-( 4- klorfenyl)- 2- piperidino- benzoylamino] etyl] benzoesyre 4 - [ 2-[ 5-( 4- chlorophenyl)- 2- piperidino- benzoylamino] ethyl] benzoic acid
Fremstilt analogt med eksempel 15 ved alkalisk hydrolyse av 4-[2-[5-(4-klorfenyl)-2-piperidino-benzoylamino]etyl]benzoesyre-etylester . Prepared analogously to example 15 by alkaline hydrolysis of 4-[2-[5-(4-chlorophenyl)-2-piperidino-benzoylamino]ethyl]benzoic acid ethyl ester.
Utbytte: 73 % av det.teoretiske,Yield: 73% of the.theoretical,
Smeltepunkt: 249-252°CMelting point: 249-252°C
Eksempel 19 4- [ 2-[ 5- trifluormetyl- 2-( oktahydro- lH- azonino)- benzoylamino]-etyl] benzoesyre Example 19 4-[2-[5-trifluoromethyl-2-(octahydro-1H-azonino)-benzoylamino]-ethyl]benzoic acid
Fremstilt analogt med eksempel 15 ved alkalisk hydrolysePrepared analogously to example 15 by alkaline hydrolysis
av 4-[2-[5-trifluormetyl-2-(oktahydro-lH-azonino)-benzoylamino]-etyl] benzoesyre-etylester .■ of 4-[2-[5-trifluoromethyl-2-(octahydro-1H-azonino)-benzoylamino]-ethyl] benzoic acid ethyl ester .■
Utbytte: 48 % av det teoretiske,Yield: 48% of the theoretical,
Smeltepunkt: 149-150°CMelting point: 149-150°C
Analogt med eksemplene 15-19 ble følgende forbindelser fremstilt: 4 - [ 2 - [5-isopropyl-2- (oktahydro-lH-azonino) -benzoylamino].ety 1] - benzoesyre Analogous to examples 15-19, the following compounds were prepared: 4-[2-[5-isopropyl-2-(octahydro-1H-azonino)-benzoylamino].ety 1]-benzoic acid
4-[2-[5-tert.butyl-2-(oktahydro-lH-azonino)-benzoylamino]etyl]-benzoesyre 4-[2-[5-butyl-2-(oktahydro-lH-azonino)-benzoylamino]etyl]-benzoesyre 4-[2-[5-tert.butyl-2-(octahydro-1H-azonino)-benzoylamino]ethyl]-benzoic acid 4-[2-[5-butyl-2-(octahydro-1H-azonino)-benzoylamino] ethyl]-benzoic acid
4-[2-[5-(2-tolyl)-2-piperidino-benzoylamino]etyl]benzoesyre 4-[2-[5-fluor-2-(dekahydro-azecino)-benzoylamino]etyl]benzoesyre 4-[2-[5-(2-tolyl)-2-piperidino-benzoylamino]ethyl]benzoic acid 4-[2-[5-fluoro-2-(decahydro-azecino)-benzoylamino]ethyl]benzoic acid
4 - [2-[5-brom-2-(dekahydro-azecino)-benzoylamino]etyl]benzoesyre 4 - [2-[5-bromo-2-(decahydro-azecino)-benzoylamino]ethyl]benzoic acid
4-[2-[5-jod-2-(dekahydro-azecino)-benzoylamino]etyl]benzoe-4-[2-[5-iodo-2-(decahydro-azecino)-benzoylamino]ethyl]benzoe-
syre acid
4-[2-[5-cyano-2-(dekahydro-azecino)-benzoylamino]etyl]benzoesyre 4-[2-[5-cyano-2-(decahydro-azecino)-benzoylamino]ethyl]benzoic acid
4-[2-[5-metyl-2-(dekahydro-azecino)-benzoylamino]etyl]benzoesyre 4-[2-[5-methyl-2-(decahydro-azecino)-benzoylamino]ethyl]benzoic acid
4-[2-[5-metoksy-2-(dekahydro-azecino)-benzoylamino]etyl]benzoesyre 4-[2-[5-Methoxy-2-(decahydro-azecino)-benzoylamino]ethyl]benzoic acid
Eksempel 20 Example 20
4 -[ 2-( 5- klor- 6- metyl- 2- piperidino- nikotinoylamino)- etyl]-benzoesyre- metylester 4-[ 2-( 5- chloro- 6- methyl- 2- piperidino- nicotinoylamino)- ethyl]-benzoic acid methyl ester
2,5 g (13,7 mMol) 5-klor-6-metyl-2-piperidino-nikotinsyre, 3,0 g (13,7 mMol) 4-(2-amino-etyl)-benzoesyre-metylester-hydroklorid og 5,0 g (19,25 mMol) trifenylfosfin utrøres i 150 ml absolutt acetonitril og tilsettes derefter 1,4 ml (1.4 mMol) karbontetraklorid og 8,3 ml (60 mMol) trietylamin. Den således oppnådde suspensjon omrøres i 2 dager ved romtemperatur, inndampes derefter, tilsettes vann og ekstraheres flere ganger med kloroform. Kloroformekstraktene tørres over natriumsulfat og inndampes og renses kolonnekromatografisk over silikagel med toluen/eddiksyreetylester (2:1) som eluerings- 2.5 g (13.7 mmol) 5-chloro-6-methyl-2-piperidino-nicotinic acid, 3.0 g (13.7 mmol) 4-(2-amino-ethyl)-benzoic acid methyl ester hydrochloride and 5.0 g (19.25 mmol) of triphenylphosphine are stirred in 150 ml of absolute acetonitrile and then 1.4 ml (1.4 mmol) of carbon tetrachloride and 8.3 ml (60 mmol) of triethylamine are added. The suspension thus obtained is stirred for 2 days at room temperature, then evaporated, water is added and extracted several times with chloroform. The chloroform extracts are dried over sodium sulfate and evaporated and purified by column chromatography over silica gel with toluene/ethyl acetate (2:1) as eluent
middel..mean..
Utbytte: 3,35 g (58,8 % av det teoretiske), Yield: 3.35 g (58.8% of the theoretical),
Smeltepunkt: 88-90°C Melting point: 88-90°C
Eksempel 21 Example 21
4-[ 2-( 6- metyl- 2- piperidino- nikotinoylamino) etyl] benzoesyre-metylester 4-[ 2-( 6- methyl- 2- piperidino-nicotinoylamino) ethyl] benzoic acid methyl ester
Fremstilt analogt med eksempel 20 fra 6-metyl-2-piperidirio-nikotinsyre og 4-(2-amino-etyl)-benzoesyre-metylester-hydroklorid. Utbytte: 72,4 % av det teoretiske, Prepared analogously to example 20 from 6-methyl-2-piperidi-nicotinic acid and 4-(2-amino-ethyl)-benzoic acid methyl ester hydrochloride. Yield: 72.4% of the theoretical,
Smeltepunkt: 92-94°CMelting point: 92-94°C
Eksempel 2 2 Example 2 2
4-[ 2-( 5- klor- 2-( oktahydro- lH- azonino)- nikotinoylamino) etyl]-■ benzoesyre- etylester 4-[ 2-( 5- chloro- 2-( octahydro- 1H- azonino)- nicotinoylamino) ethyl]-■ benzoic acid ethyl ester
Fremstilt analogt»med eksempel 20 fra 5-klor-2-(oktahydro-lH-azonino)-nikotinsyre og 4-(2-amino-etyl)-benzoesyre-etylester-hydroklorid. Prepared analogously to Example 20 from 5-chloro-2-(octahydro-1H-azonino)-nicotinic acid and 4-(2-amino-ethyl)-benzoic acid ethyl ester hydrochloride.
Utbytte: 31 % av det teoretiske,Yield: 31% of the theoretical,
Smeltepunkt: <2 0°C Melting point: <2 0°C
Eksempel 23 Example 23
4-[ 2-( 5- brom- 2- piperidino- nikotinoylamino) etyl] benzoesyre-e tylester 4-[ 2-( 5- bromo- 2- piperidino-nicotinoylamino) ethyl] benzoic acid ethyl ester
Fremstilt analogt med eksempel 20 fra 5-brom-2-piperidinonikotinsyre og 4-(2-amino-etyl)-benzoesyre-etylester-hydroklorid. Utbytte: 41,8 % av det teoretiske, Prepared analogously to example 20 from 5-bromo-2-piperidinonicotinic acid and 4-(2-amino-ethyl)-benzoic acid ethyl ester hydrochloride. Yield: 41.8% of the theoretical,
Smeltepunkt: 93r95°CMelting point: 93r95°C
Eksempel 24-4-[ 2-[ 5- klor- 2-( cis- 3, 5- dimetyl- piperidino)- nikotinoylamino]-etyl] benzoesyre- etylester Example 24-4-[2-[5-chloro-2-(cis-3,5-dimethyl-piperidino)-nicotinoylamino]-ethyl]benzoic acid ethyl ester
Fremstilt analogt, med eksempel 20 fra 5-klor-2-(cis-3,5- dimetyl-piperidino)-nikotinsyre og 4-(2-amino-etyl)-benzoesyre-etylester-hydroklorid. Utbytte: 4 2,4 % av det teoretiske, Prepared analogously to Example 20 from 5-chloro-2-(cis-3,5-dimethyl-piperidino)-nicotinic acid and 4-(2-amino-ethyl)-benzoic acid ethyl ester hydrochloride. Yield: 4 2.4% of the theoretical,
Smeltepunkt: 94-9 6°CMelting point: 94-96°C
Eksempel 25 Example 25
4-[ 2- ( 5- klor- 2- piperidino- nikotinoylamino) etyl] benzoesyre-. metylester 4-[2-(5-chloro-2-piperidino-nicotinoylamino)ethyl]benzoic acid-. methyl ester
Fremstilt analogt med eksempel 20 fra 5-klor-2-piperidinonikotinsyre og 4-(2-amino-etyl)-benzoesyre-metylestef-hydroklorid. Prepared analogously to example 20 from 5-chloro-2-piperidinenicotinic acid and 4-(2-amino-ethyl)-benzoic acid methyl ester hydrochloride.
Utbytte: 49 % av det teoretiske,Yield: 49% of the theoretical,
Smeltepunkt:'113-115°CMelting point: '113-115°C
Eksempel 26 Example 26
4 -[ 2-( 5- brom- 6- metyl- 2- piperidino- nikotinoylamino) etyl] benzoesyre- etylester 4 -[ 2-( 5- bromo- 6- methyl- 2- piperidino- nicotinoylamino) ethyl] benzoic acid ethyl ester
Fremstilt analogt med eksempel 20 fra 4-(2-amino-etyl)-benzoesyre-etylester-hydroklorid og 5-brom-6-metyl-2-piperidino-nikotinsyre. Prepared analogously to example 20 from 4-(2-amino-ethyl)-benzoic acid ethyl ester hydrochloride and 5-bromo-6-methyl-2-piperidino-nicotinic acid.
Utbytte: 54,6 % av det teoretiske,.Yield: 54.6% of the theoretical.
Smeltepunkt: <20°CMelting point: <20°C
Eksempel 27 4 - [ 2 - [' 5- klor- 2 - ( 3 , 5- cis- dimetyl- piperidino) - 6- metyl- nikotinoylamino] etyl] benzoesyre- etylester Example 27 4-[2-['5-chloro-2-(3,5-cis-dimethyl-piperidino)-6-methyl-nicotinoylamino]ethyl]benzoic acid ethyl ester
Fremstilt analogt med eksempel 20 fra 5-klor-2-(3,5-cis-dimetyl-piperidino)-6-metyl-nikotinsyre og 4-(2-amino-etyl)-benzoesyre-etylester-hydroklorid . Prepared analogously to example 20 from 5-chloro-2-(3,5-cis-dimethyl-piperidino)-6-methyl-nicotinic acid and 4-(2-amino-ethyl)-benzoic acid ethyl ester hydrochloride.
Utbytte: 51 % av det teoretiske,Yield: 51% of the theoretical,
Smeltepunkt: <2 0°CMelting point: <2 0°C
Eksempel 28 Example 28
4-[ 2-[ 5- brom- 2-( 3, 5- cis- dimetyl- piperidino)- 6- metyl- nikotinoyl-3m"i nn 1 of ul 1 Vicin 7nacurc»- cif iri opf ov 4-[ 2-[ 5- bromo- 2-( 3, 5- cis- dimethyl-piperidino)- 6- methyl- nicotinoyl-3m"i nn 1 of ul 1 Vicin 7nacurc»- cifiri opf ov
Fremstilt analogt med eksempel 20 fra 5-brom-2-(3,5-cis-dimetyl-piperidino)-6-métyl-nikotinsyre og 4-(2-amino-etyl)-benzoesyre-etylester-hydroklorid. Prepared analogously to example 20 from 5-bromo-2-(3,5-cis-dimethyl-piperidino)-6-methyl-nicotinic acid and 4-(2-amino-ethyl)-benzoic acid ethyl ester hydrochloride.
Utbytte: 43 % av det teoretiske,Yield: 43% of the theoretical,
Smeltepunkt: <2 0°CMelting point: <2 0°C
Eksempel 2 9 Example 2 9
4-[ 2-( 5- klor- 6- metyl- 2- piperidino- nikotinoylamino) etyl]-benzoesyre 4-[2-(5-Chloro-6-methyl-2-piperidino-nicotinoylamino)ethyl]-benzoic acid
1,65 g (3,97 mMol) 4-[2-(5-klor-6-metyl-2-piperidino-nikotinoylamino)etyl]benzoesyre-metylester oppløses i 100 ml metanol og omrøres i 12 timer ved 40°C efter tilsetning av 25 ml 1 N natronlut. Derefter inndampes i vakuum. Inndampningsresiduet oppløses i vann, filtreres, bg filtratet tilsettes 25 ml IN saltsyre. Det dannede bunnfall avsuges og omkrystalliseres fra acetonitril. 1.65 g (3.97 mmol) of 4-[2-(5-chloro-6-methyl-2-piperidino-nicotinoylamino)ethyl]benzoic acid methyl ester is dissolved in 100 ml of methanol and stirred for 12 hours at 40°C after addition of 25 ml of 1 N caustic soda. It is then evaporated in a vacuum. The evaporation residue is dissolved in water, filtered, and 25 ml of IN hydrochloric acid is added to the filtrate. The formed precipitate is suctioned off and recrystallized from acetonitrile.
Utbytte: 1,1 g (58,75 % av det teoretiske),Yield: 1.1 g (58.75% of theoretical),
Smeltepunkt: 18.5-187°CMelting point: 18.5-187°C
Eksempel 3 0 Example 3 0
4-[ 2-( 6- metyl- 2- piperidino- nikotinoylamino) etyl] benzoesyre Fremstilt analogt med eksempel 29 ved alkalisk forsepning av 4-[2-(6-metyl-2-piperidino-nikotinoylamino)etyl]benzoesyre-metylester. 4-[2-(6-methyl-2-piperidino-nicotinoylamino)ethyl]benzoic acid Prepared analogously to example 29 by alkaline saponification of 4-[2-(6-methyl-2-piperidino-nicotinoylamino)ethyl]benzoic acid methyl ester.
Utbytte: 92 % av det teoretiske,Yield: 92% of the theoretical,
Smeltépunkt: . 152-154°CMelting point: . 152-154°C
Eksempel 31 Example 31
4-[ 2-( 5- klor- 2-( oktahydro- lH- azonino)- nikotinoylamino) etyl]-benzoesyre 4-[ 2-( 5- chloro- 2-( octahydro- 1H- azonino)- nicotinoylamino) ethyl]-benzoic acid
Fremstilt analogt med eksempel 29 fra 4-[2-(5-klor-2-(oktahydro-lH-azonino)-nikotinoylamino)etyl]benzoesyre-etylester ved alkalisk forsepning. Prepared analogously to example 29 from 4-[2-(5-chloro-2-(octahydro-1H-azonino)-nicotinoylamino)ethyl]benzoic acid ethyl ester by alkaline saponification.
Utbytte: 83,3 % av det teoretiske,Yield: 83.3% of the theoretical,
Smeltepunkt: 169-170°CMelting point: 169-170°C
Eksempel 32 Example 32
4-[ 2-( 5- brom- 2- piperidino- nikotinoylamino) etyl] benzoesyre 4-[ 2-( 5- bromo- 2- piperidino-nicotinoylamino) ethyl] benzoic acid
Fremstilt analogt med eksempel 29 fra 4-[2-(5-brom-2-piperidino-nikotinoylaminb)etyl]benzoesyre-etylester ved alkalisk forsepning. Prepared analogously to example 29 from 4-[2-(5-bromo-2-piperidino-nicotinoylamineb)ethyl]benzoic acid ethyl ester by alkaline saponification.
Utbytte: 93,5 % av det teoretiske,Yield: 93.5% of the theoretical,
Smeltepunkt: 175-177°CMelting point: 175-177°C
Eksempel 33 Example 33
4-[ 2-[ 5- klor- 2-( cis- 3, 5- dimetyl- piperidino)- nikotinoylamino]-etyl] benzoesyre 4-[ 2-[ 5- chloro- 2-( cis- 3, 5- dimethyl-piperidino)- nicotinoylamino]-ethyl] benzoic acid
Fremstilt analogt med eksempel 29 ved alkalisk forsepning av 4-[2-[5-klor-2-(cis-3,5-dimetyl-piperidino)-nikotinoylamino] etyl ] benzoesyre-etylester . Prepared analogously to example 29 by alkaline saponification of 4-[2-[5-chloro-2-(cis-3,5-dimethyl-piperidino)-nicotinoylamino] ethyl ] benzoic acid ethyl ester.
Utbytte: 76 % av det teoretiske,Yield: 76% of the theoretical,
Smeltepunkt: 191-193°CMelting point: 191-193°C
Eksempel 34 4.-. L2 - ( 5- klor- 2- piper idino- nikotinoylamino) etyl ] benzoesyre Example 34 4.-. L2 - ( 5- chloro- 2- piper idino-nicotinoylamino) ethyl ] benzoic acid
Fremstilt analogt med eksempel 29 ved alkalisk forsepning av 4-[2-(5-klor-2-piperidino-nikotinoylamino)etyl]benzoesyre-metylester. Prepared analogously to example 29 by alkaline saponification of 4-[2-(5-chloro-2-piperidino-nicotinoylamino)ethyl]benzoic acid methyl ester.
Utbytte: 82 % av det teoretiske,Yield: 82% of the theoretical,
Smeltepunkt: 164-166°CMelting point: 164-166°C
Eksempel 35 4 -[ 2-( 5- brom- 6- mety1- 2- piperidino- nikotinoylamino) etyl] benzoesyre. Example 35 4-[2-(5-bromo-6-methyl-2-piperidino-nicotinoylamino)ethyl]benzoic acid.
Fremstilt analogt med eksempel 29 fra 4-[2-(5-brom-6-metyl-2-piperidirio-nikotinoylamino)etyl]benzoesyre-etylester ved alkalisk forsepning. Prepared analogously to example 29 from 4-[2-(5-bromo-6-methyl-2-piperidirio-nicotinoylamino)ethyl]benzoic acid ethyl ester by alkaline saponification.
Utbytte: 85,5 % av det teoretiske,Yield: 85.5% of the theoretical,
Smeltepunkt: 199-201°CMelting point: 199-201°C
Eksempel 36 Example 36
4-[ 2-[ 5- klor- 2-( 3, 5- cis- dimetyl- piperidino)- 6- metyl- nikotinoylamino] etyl] benzoesyre 4-[ 2-[ 5- chloro- 2-( 3, 5- cis- dimethyl- piperidino)- 6- methyl- nicotinoylamino] ethyl] benzoic acid
Fremstilt analogt med eksempel 29 fra 4-[2-[5-klor-2-(3,5-cis-dimetyl-piperidino)-6-metyl-nikotinoylamino]etyl]benzoesyre-etylester ved alkalisk forsepning. Prepared analogously to example 29 from 4-[2-[5-chloro-2-(3,5-cis-dimethyl-piperidino)-6-methyl-nicotinoylamino]ethyl]benzoic acid ethyl ester by alkaline saponification.
Utbytte: 71 % av det teoretiske,Yield: 71% of the theoretical,
Smeltepunkt: 192-193°CMelting point: 192-193°C
Eksempel 37 Example 37
4 -[ 2-[ 5- brom- 2-( 3, 5- cis- dimetyl- piperidino)- 6- metyl- nikotinoylamino] etyl] benzoesyre 4-[ 2-[ 5- bromo- 2-( 3, 5- cis- dimethyl- piperidino)- 6- methyl- nicotinoylamino] ethyl] benzoic acid
Fremstilt analogt med eksempel 29 fra 4-[2-[5-brom-2-(3,5-cis-di-metyl-piperidino)-6-metyl-nikotinoylamino]etyl]benzoesyre-etylester ved alkalisk forsepning. Prepared analogously to example 29 from 4-[2-[5-bromo-2-(3,5-cis-dimethyl-piperidino)-6-methyl-nicotinoylamino]ethyl]benzoic acid ethyl ester by alkaline saponification.
Utbytte: 99 % av det"teoretiske,Yield: 99% of the "theoretical,
Smeltepunkt: 203-204°CMelting point: 203-204°C
Eksempel 38 Example 38
4-[ 2-[( 2- piperidino- pyridyl- 3) acetylamino] etyl] benzoesyre-etylester 4-[ 2-[( 2- piperidino- pyridyl- 3) acetylamino] ethyl] benzoic acid ethyl ester
Fremstilt fra [2-pipéridino-pyridyl-(3)]eddiksyre og 4-(2-amino-etyl)benzoesyre-etylester analogt med eksempel 20. Utbytte: 84 % avdet teoretiske, Prepared from [2-piperidino-pyridyl-(3)]acetic acid and 4-(2-amino-ethyl)benzoic acid ethyl ester analogously to example 20. Yield: 84% of the theoretical,
Smeltepunkt: 103-104°CMelting point: 103-104°C
Eksempel 3 9 Example 3 9
4-[( 2- piperidino- pyridyl- 3) acetylamino- metyl] benzoesyre-etylester. 4-[(2-piperidino-pyridyl-3)acetylamino-methyl]benzoic acid ethyl ester.
Fremstilt fra [2-piperidino-pyridyl-(3)]eddiksyre og 4-amino-mety1-benzoesyre-etylester analogt med eksempel 20. Utbytte: 86 % av det teoretiske, Prepared from [2-piperidino-pyridyl-(3)]acetic acid and 4-amino-methyl-benzoic acid ethyl ester analogously to example 20. Yield: 86% of the theoretical,
Smeltepunkt: 68-71°CMelting point: 68-71°C
Eksempel 4 0 Example 4 0
4-[ 2-[( 5- klor- 2- piperidino- pyridyl- 3) acetylamino] etyl] benzoesyre- etylester 4-[ 2-[( 5- chloro- 2- piperidino- pyridyl- 3) acetylamino] ethyl] benzoic acid ethyl ester
Fremstilt fra [5-klor-2-piperidino-pyridyl-(3)]eddiksyrePrepared from [5-chloro-2-piperidino-pyridyl-(3)]acetic acid
og 4-(2-aminoetyl)-benzoesyre-etylester analogt med eksempel 20. Utbytte: 86 % av det teoretiske, and 4-(2-aminoethyl)-benzoic acid ethyl ester analogously to example 20. Yield: 86% of the theoretical,
Smeltepunkt: 115-117°CMelting point: 115-117°C
Eksempel 41 Example 41
4-[ 2-[( 2- piperidino- pyridyl- 3) acetylamino] etyl] benzoesyre 4-[ 2-[( 2- piperidino- pyridyl- 3) acetylamino] ethyl] benzoic acid
Fremstilt fra 4-[2-[(2-piperidino-pyridyl-3)acetylamino]-etyl]benzoesyre-etylester ved alkalisk forsepning analogt med eksempel 29. Prepared from 4-[2-[(2-piperidino-pyridyl-3)acetylamino]-ethyl]benzoic acid ethyl ester by alkaline saponification analogously to example 29.
Utbytte: 60 % av det teoretiske,Yield: 60% of the theoretical,
Smeltepunkt: 153-155°CMelting point: 153-155°C
Eksempel 4 2 Example 4 2
4-[( 2- piperidino- pyridyl- 3) acetylaminometyl] benzoesyre Fremstilt ved alkalisk forsepning av 4-[(2-piperidino-pyridyl-3 ) acetylaminometyl] benzoesyre-etylester analogt med eksempel 29. 4-[(2-piperidino-pyridyl-3)acetylaminomethyl]benzoic acid Prepared by alkaline saponification of 4-[(2-piperidino-pyridyl-3)acetylaminomethyl]benzoic acid ethyl ester analogously to example 29.
Utbytte: 74 % av det teoretiske,Yield: 74% of the theoretical,
Smeltepunkt: 180-182°CMelting point: 180-182°C
Eksempel 4 3 4— [ 2-[( 5- klor- 2- piperidino- pyridyl- 3) acetylamino] etyl] benzoesyre Example 4 3 4— [2-[(5-chloro-2-piperidino-pyridyl-3)acetylamino]ethyl]benzoic acid
Fremstilt ved alkalisk forsepning av 4-[2-[(5-klor-2-piperidino-pyridyl-3)acetylamino]etyl]benzoesyre-etylester analogt med eksempel 29. Prepared by alkaline saponification of 4-[2-[(5-chloro-2-piperidino-pyridyl-3)acetylamino]ethyl]benzoic acid ethyl ester analogously to example 29.
Utbytte: 85 % av det teoretiske,Yield: 85% of the theoretical,
Smeltepunkt: 182-184°CMelting point: 182-184°C
Eksempel 4 4 4- [ ( 5- klor-^ 2- piperidino- f enyl) - acetyiamino- metyl] benzoesyre-etylester Example 4 4 4-[(5-chloro-^2-piperidino-phenyl)-acetylamino-methyl]benzoic acid ethyl ester
Fremstilt analogt med eksempel 1 fra (5-klor-2-piperidino-fenyl)eddiksyre og 4-aminometyl-benzoesyre-etylester. Prepared analogously to example 1 from (5-chloro-2-piperidino-phenyl)acetic acid and 4-aminomethyl-benzoic acid ethyl ester.
Utbytte:' 64. % av det teoretiske,Yield:' 64. % of the theoretical,
Smeltepunkt: 112°CMelting point: 112°C
Eksempel 45 Example 45
4-[ 2-[( 5- klor- 2- piperidino- fenyl)- acetylamino] etyl] benzoesyre- etylester 4-[ 2-[( 5- chloro- 2- piperidino- phenyl)- acetylamino] ethyl] benzoic acid ethyl ester
Fremstilt analogt med eksempel 1 fra (5-klor-2-piperidino-fenyl)eddiksyre og 4-(2-amino-etyl)-benzoesyre-etylester. Utbytte: 74 % av det teoretiske, Prepared analogously to example 1 from (5-chloro-2-piperidino-phenyl)acetic acid and 4-(2-amino-ethyl)-benzoic acid ethyl ester. Yield: 74% of the theoretical,
Smeltepunkt: 187-18 9°CMelting point: 187-18 9°C
Eksempel 4 6 Example 4 6
4-[( 5- klor- 2- oktahydro- lH- azonino- fenyl)- acetylaminometyl]-benzoesyre- etylester 4-[(5-chloro-2- octahydro-1H-azonino-phenyl)-acetylaminomethyl]-benzoic acid ethyl ester
Fremstilt analogt med eksempel 1 fra (5-klor.-2-oktahydro-lH-azonino-fenyl)eddiksyre og 4-amino-metyl-benzoesyre-etylester. Utbytte: 85 % av det teoretiske, Prepared analogously to example 1 from (5-chloro-2-octahydro-1H-azonino-phenyl)acetic acid and 4-amino-methyl-benzoic acid ethyl ester. Yield: 85% of the theoretical,
Smeltepunkt: <2 0°CMelting point: <2 0°C
Eksempel 47 Example 47
4-[ 2-[( 5- klor- 2- oktahydro- lH- azonino- fenyl)- acetylamino] etyl]-benzoesyre- etylester 4-[ 2-[( 5- chloro- 2- octahydro- 1H- azonino- phenyl)- acetylamino] ethyl]-benzoic acid ethyl ester
Fremstilt analogt med eksempel 1 fra (5-klor-2-oktahydro-lH-azonino-fenyl)eddiksyre og 4-(2-amino-etyl)-benzoesyre-etylester. Utbytte: 59 % av det teoretiske, Prepared analogously to example 1 from (5-chloro-2-octahydro-1H-azonino-phenyl)acetic acid and 4-(2-amino-ethyl)-benzoic acid ethyl ester. Yield: 59% of the theoretical,
Smeltepunkt: <2 0°CMelting point: <2 0°C
Beregnet: -Moltopp: m/e = 47 0/2Calculated: -Moltop: m/e = 47 0/2
Funnet: Moltopp: m/e = 470/2Found: Mole top: m/e = 470/2
Beregnet: C 68,84 H 7,49 N 5,95Calculated: C 68.84 H 7.49 N 5.95
Funnet: 68,17 7,14 5,75 Found: 68.17 7.14 5.75
Eksempel 48 Example 48
4- [ ( 5- klor- 2-( oktahydro- isoindol- 2- yl)- fenyl)- acetylaminometyl] benzoesyre- etylester 4- [ ( 5- chloro- 2-( octahydro- isoindol- 2- yl)- phenyl)- acetylaminomethyl] benzoic acid ethyl ester
Fremstilt analogt med eksempel 1 fra [5-klor-2-(oktahydro-isoindol-2-yl)-fenyl]eddiksyre og 4-amino-metyl-bénzoesyre-etylester. Utbytte: 45 % av det teoretiske, Prepared analogously to example 1 from [5-chloro-2-(octahydro-isoindol-2-yl)-phenyl]acetic acid and 4-amino-methyl-benzoic acid ethyl ester. Yield: 45% of the theoretical,
Smeltepunkt: 17 2°CMelting point: 17 2°C
Eksempel 49 4-[ 2-[( 5- klor- 2-( oktahydro- isoindol- 2- y1)- fenyl)- acetylamino]-etyl] benzoesyre- etylester .-Fremstilt analogt med eksempel 1 fra [5-klor-2-(oktahydro-isoindol-2-yl)-fenyl]eddiksyre og 4-(2-aminoetyl)benzoesyre-etylester . Example 49 4-[ 2-[(5-chloro-2-(octahydro-isoindol-2-y1)-phenyl)-acetylamino]-ethyl] benzoic acid ethyl ester.-Prepared analogously to example 1 from [5-chloro-2 -(octahydro-isoindol-2-yl)-phenyl]acetic acid and 4-(2-aminoethyl)benzoic acid ethyl ester.
Utbytte: 12,5 % av det teoretiske,Yield: 12.5% of the theoretical,
Smeltepunkt: 102°CMelting point: 102°C
Beregnet: Moltopp: m/e - 468/2 .Calculated: Mole top: m/e - 468/2 .
Funnet: Moltopp: m/e = 4 68/2Found: Mole top: m/e = 4 68/2
Eksempel 5 0 Example 5 0
DL- 4- [ ( 2-( 5^- klor- 2- piperidino- f enyl) propionylamino) metyl] - benzoesyre- etylester DL- 4- [ ( 2-( 5^- chloro- 2- piperidino- phenyl) propionylamino) methyl] - benzoic acid ethyl ester
Fremstilt analogt med eksempel 20 fra 2-(5-klor-2-piperidino-fenyl)propionsyre og 4-aminometyl-benzoesyre-etylester. Utbytte: 46 % av det teoretiske, Prepared analogously to example 20 from 2-(5-chloro-2-piperidino-phenyl)propionic acid and 4-aminomethyl-benzoic acid ethyl ester. Yield: 46% of the theoretical,
Smeltepunkt: <20°CMelting point: <20°C
Beregnet: Moltopp: m/e = 428/3 0Calculated: Mole top: m/e = 428/3 0
Funnet: Moltopp: m/e = 428/30Found: Mole top: m/e = 428/30
Eksempel 51 DL- 4-[ 2- [ 2- ( 5- klor- 2- piperidino^- fenyl) propionylamino] etyl] - benzoesyre- etylester Example 51 DL- 4-[ 2- [ 2-( 5- chloro- 2- piperidino^- phenyl) propionylamino] ethyl] - benzoic acid ethyl ester
Fremstilt analogt med eksempel 20 fra 2-(5-klor-2-piperidino-fenyl)propionsyre og 4-(2-amino-etyl)-benzoesyre-etylester. Utbytte: 52 % av det teoretiske, Prepared analogously to example 20 from 2-(5-chloro-2-piperidino-phenyl)propionic acid and 4-(2-amino-ethyl)-benzoic acid ethyl ester. Yield: 52% of the theoretical,
Smeltepunkt: <20°CMelting point: <20°C
Beregnet: Moltopp: m/e = 442/44Calculated: Mole top: m/e = 442/44
Funnet: Moltopp: m/e = 4 4 2/4 4 Found: Mole top: m/e = 4 4 2/4 4
Eksempel 52 Example 52
DL- 4-[ 2-[ 2-( 5- klor- 2- oktahydro- lH- azonino- fenyl)- propionyl-■ amino] etyl] benzoesyre- etylester DL- 4-[ 2-[ 2-( 5- chloro- 2- octahydro- 1H- azonino- phenyl)- propionyl-■ amino] ethyl] benzoic acid ethyl ester
Fremstilt analogt med eksempel 1 fra 2-(2-oktahydro-lH-azonino-5-klor-fenyl)propionsyre og 4 -(2-aminoetyl)benzoesyre-etylester . Prepared analogously to example 1 from 2-(2-octahydro-1H-azonino-5-chloro-phenyl)propionic acid and 4-(2-aminoethyl)benzoic acid ethyl ester.
Utbytte: 43 % av det teoretiske,Yield: 43% of the theoretical,
Smeltepunkt: <2 0°CMelting point: <2 0°C
Eksempel 53 Example 53
DL- 4-[ 2-[( 2- piperidino- difenyl)- acetylamino] etyl] benzoesyre-etylester DL- 4-[ 2-[( 2- piperidino-diphenyl)- acetylamino] ethyl] benzoic acid ethyl ester
Fremstilt fra (2-piperidino-difenyl)-eddiksyre og 4-(2-aminoetyl)benzoesyre-etylester analogt med eksempel 20. Utbytte: 36 % av det" teoretiske, Prepared from (2-piperidino-diphenyl)-acetic acid and 4-(2-aminoethyl)benzoic acid ethyl ester analogously to example 20. Yield: 36% of the" theoretical,
Smeltepunkt: 84-85°CMelting point: 84-85°C
Eksempel 54 Example 54
DL- 4-[( 2- piperidino- difenyl)- acetylamino- metyl] benzoesyre-etylester DL- 4-[( 2- piperidino- diphenyl)- acetylamino- methyl] benzoic acid ethyl ester
Fremstilt fra .(2-piperidino-dif enyl) eddiksyre og 4-amino-metyl-benzoesyre-etylester analogt med eksempel 20. Utbytte: 43 % av det teoretiske, Prepared from .(2-piperidino-diphenyl)acetic acid and 4-amino-methyl-benzoic acid ethyl ester analogously to example 20. Yield: 43% of the theoretical,
Smeltepunkt: 137-139°CMelting point: 137-139°C
Eksempel 55 Example 55
4-[ 2-[( 5- klor- 2- pyrrolidino- fenyl)- acetylamino] etyl] benzoesyre- etylester 4-[ 2-[( 5- chloro- 2- pyrrolidino- phenyl)- acetylamino] ethyl] benzoic acid ethyl ester
Fremstilt analogt med eksempel 1 fra (5-klor-2-pyrrolidino-fenyl)-eddiksyre og 4-(2-aminoetyl)benzoesyre-etylester. Utbytte: 75 % av det teoretiske, Prepared analogously to example 1 from (5-chloro-2-pyrrolidino-phenyl)-acetic acid and 4-(2-aminoethyl)benzoic acid ethyl ester. Yield: 75% of the theoretical,
Smeltepunkt: 126-127°CMelting point: 126-127°C
Eksempel 56 4-[ 2-[( 5- klor- 2- heksametylenimino- fenyl)- acetylamino] etyl] - benzoesyre- etylester Example 56 4-[2-[(5-chloro-2-hexamethyleneimino-phenyl)-acetylamino] ethyl]-benzoic acid ethyl ester
Fremstilt analogt med eksempel 1 fra (5-klor-2-heksametylen-iminofenyl)-eddiksyre og 4-(2-amino-etyl)benzoesyre-etylester. Utbytte: 51 % av det teoretiske, Prepared analogously to example 1 from (5-chloro-2-hexamethylene-iminophenyl)-acetic acid and 4-(2-amino-ethyl)benzoic acid ethyl ester. Yield: 51% of the theoretical,
Smeltepunkt: 102-104°CMelting point: 102-104°C
Eksempel 57 Example 57
4- [ 2-[( 5- klor- 2- heptametylenimino- fenyl) acetylamino] etyl]-benzoesyre- etylester 4- [ 2-[( 5- chloro- 2- heptamethyleneimino- phenyl) acetylamino] ethyl]-benzoic acid ethyl ester
Fremstilt analogt med eksempel 1 fra (5-klor-2-heptametylenimino-fenyl)-eddiksyre og 4-(2-amino-etyl)benzoesyre-etylester. Utbytte: 57 % av det teoretiske, Prepared analogously to example 1 from (5-chloro-2-heptamethyleneimino-phenyl)-acetic acid and 4-(2-amino-ethyl)benzoic acid ethyl ester. Yield: 57% of the theoretical,
Smeltepunkt: 95,96°CMelting point: 95.96°C
Eksempel 58 Example 58
4-[ 2-( 2- oktahydro- lH- azonino- benzoylamino) etyl] benzoesyre-etylester 4-[ 2-( 2- octahydro- 1H- azonino- benzoylamino) ethyl] benzoic acid ethyl ester
Fremstilt analogt med eksempel 1 fra 2-oktahydro-lH-azonino-benzoesyre og 4-(2-amino-etyl)benzoesyre-etylester. Utbytte: 53 % av det teoretiske, Prepared analogously to example 1 from 2-octahydro-1H-azonino-benzoic acid and 4-(2-amino-ethyl)benzoic acid ethyl ester. Yield: 53% of the theoretical,
Smeltepunkt: <20°CMelting point: <20°C
Beregnet: Moltopp: m/e =4 22Calculated: Mole top: m/e =4 22
Funnet: Moltopp: m/e =4 22Found: Mole top: m/e =4 22
Eksempel 59 Example 59
4-[ 2-( 5- klor- 2-( 2, 3, 3a, 4, 7, 7a- heksahydro- lH- isoindol- 2- yl)-benzoylamino) etyl] benzoesyre- etylester 4-[ 2-( 5- chloro- 2-( 2, 3, 3a, 4, 7, 7a- hexahydro- 1H- isoindol- 2- yl)-benzoylamino) ethyl] benzoic acid ethyl ester
Fremstilt analogt med eksempel 1 fra 5-klor-2-(2,3,3a,4,7, 7a-heksahydro-lH-isoindol-2-yl)-benzoesyre og 4-(2-amino-etyl)-benzoesyre-etylester. Prepared analogously to example 1 from 5-chloro-2-(2,3,3a,4,7,7a-hexahydro-1H-isoindol-2-yl)-benzoic acid and 4-(2-amino-ethyl)-benzoic acid- ethyl ester.
Utbytte: 57 % av det teoretiske,Yield: 57% of the theoretical,
Smeltepunkt: 17 2°C Melting point: 17 2°C
Eksempel 6 0 4- [ 2-( 5- klor- 2-( 1, 3- dihydro- isoindol- 2- yl)- benzoylamino) etyl]-benzoesyre- etylester Fremstilt analogt med eksempel 1 fra 5-klor-2-(1,3-dihydroisoindol-2-yl)-benzoesyre og 4-(2-amino-etyl)benzoesyre-etylester. Utbytte: 40 % av det teoretiske, Smeltepunkt: 158°C Example 6 0 4-[2-(5-chloro-2-(1,3-dihydro-isoindol-2-yl)-benzoylamino)ethyl]-benzoic acid ethyl ester Prepared analogously to example 1 from 5-chloro-2-( 1,3-dihydroisoindol-2-yl)-benzoic acid and 4-(2-amino-ethyl)benzoic acid ethyl ester. Yield: 40% of the theoretical, Melting point: 158°C
Eksempel 61 Example 61
4-[( 5- klor- 2- piperidino- fenyl)- acetylaminometyl] benzoesyre 4-[(5-chloro-2-piperidino-phenyl)-acetylaminomethyl]benzoic acid
Fremstilt analogt med eksempel 5 ved alkalisk hydrolyse av 4-[(5-klor-2-piperidino-fenyl)-acetylaminometyl]benzoesyre-etylester. Prepared analogously to example 5 by alkaline hydrolysis of 4-[(5-chloro-2-piperidino-phenyl)-acetylaminomethyl]benzoic acid ethyl ester.
Utbytte: 92 % av det teoretiske,Yield: 92% of the theoretical,
Smeltepunkt: 18 7-18 9°C Melting point: 18 7-18 9°C
Eksempel 62 Example 62
4- [ ( 2- piperidino- f enyl) - acetylaraino- metyl] benzoesyre4-[(2-piperidino-phenyl)-acetylaraino-methyl]benzoic acid
lg (2,6 mMol) 4-[(5-klor-2-piperidino-fenyl)-acetylaminometyl] benzoesyre oppløses i 100 ml metanol og hydrogeneres ved et hydrogentrykk på 5 bar ved romtemperatur. Som katalysator anvendes 10 %ig palladium/kull. Efter avsluttet hydrogenopptak fraskilles katalysatoren, oppløsningsmidlet avdestilleres 1 g (2.6 mmol) of 4-[(5-chloro-2-piperidino-phenyl)-acetylaminomethyl] benzoic acid is dissolved in 100 ml of methanol and hydrogenated at a hydrogen pressure of 5 bar at room temperature. 10% palladium/coal is used as a catalyst. After completion of hydrogen absorption, the catalyst is separated, the solvent is distilled off
på en rotasjonsihndamper, og den tørre rest oppløses i vann. Ekstraksjon foretas ved pH 6 med kloroform, og efter tørring behandles kloroform-inndampningsresten med petroleter/eter. Utbytte: 0,5 g (55 % av det teoretiske), on a rotary evaporator, and the dry residue is dissolved in water. Extraction is carried out at pH 6 with chloroform, and after drying, the chloroform evaporation residue is treated with petroleum ether/ether. Yield: 0.5 g (55% of theoretical),
Smeltepunkt: 18 0°C Melting point: 18 0°C
Eksempel 63 Example 63
4-[ 2-[( 5- klor- 2- piperidino- fenyl)- acetylamino] etyl] benzoesyre Fremstilt analogt med eksempel 5 ved alkalisk hydrolyse av 4-[ 2-[( 5-chloro-2-piperidino-phenyl)-acetylamino] ethyl] benzoic acid Prepared analogously to example 5 by alkaline hydrolysis of
4— [ 2— [" ( 5-klor-2-piperidino-f enyl) -acetylamino] etyl ] benzoesyre-etylester. 4— [ 2— [" ( 5-chloro-2-piperidino-phenyl)-acetylamino] ethyl ] benzoic acid ethyl ester.
Utbytte: 95 % av det teoretiske, Smeltepunkt: 16 9-17 0°C Yield: 95% of the theoretical, Melting point: 16 9-17 0°C
Eksempel 64 Example 64
4-[ 2-[( 2- piperidino- fenyl)- acetylamino] etyl] benzoesyre 4-[ 2-[( 2- piperidino-phenyl)- acetylamino] ethyl] benzoic acid
Fremstilt analogt med eksempel 62 ved katalytisk dehalogenering av 4-[2-[(5-klor-2-piperidino-fenyl)-acetylamino]-etyl]-benzoesyre. Prepared analogously to example 62 by catalytic dehalogenation of 4-[2-[(5-chloro-2-piperidino-phenyl)-acetylamino]-ethyl]-benzoic acid.
Utbytte: 55 % av det'teoretiske,Yield: 55% of the'theoretical,
Smeltepunkt: 154°C Melting point: 154°C
Eksempel 65 Example 65
4-[( 5- klor- 2- oktahydro- lH- azonino- fenyl)- acetylaminometyl]-benzoesyre 4-[(5-chloro-2-octahydro-1H-azonino-phenyl)-acetylaminomethyl]-benzoic acid
Fremstilt analogt"med eksempel 5 ved alkalisk hydrolyse av 4-[(5-klor-2-oktahydro-lH-azonino-fenyl)-acetylaminometyl]-benzoesyre-etylester. Prepared analogously to example 5 by alkaline hydrolysis of 4-[(5-chloro-2-octahydro-1H-azonino-phenyl)-acetylaminomethyl]-benzoic acid ethyl ester.
Utbytte: 91 % av det teoretiske,Yield: 91% of the theoretical,
Smeltepunkt: 191°C Melting point: 191°C
Eksempel 66 Example 66
4-[( 2- oktahydro- lH- azonino- fenyl)- acetylaminometyl] benzoesyre 4-[( 2- octahydro- 1H- azonino- phenyl)- acetylaminomethyl] benzoic acid
Fremstilt analogt med eksempel 6 2 ved katalytisk dehalogenering av 4-[(5-klor-2-oktahydro-lH-azonino-fenyl)-acetylaminometyl ]benzoesyre. Prepared analogously to example 6 2 by catalytic dehalogenation of 4-[(5-chloro-2-octahydro-1H-azonino-phenyl)-acetylaminomethyl]benzoic acid.
Utbytte: 55 % av det teoretiske,Yield: 55% of the theoretical,
Smeltepunkt: 150°C Melting point: 150°C
Eksempel 67 Example 67
4-[ 2-[( 5- klor- 2- oktahydro- lH- azonino- fenyl)- acetylamino] etyl]-benzoesyre 4-[ 2-[( 5- chloro- 2- octahydro- 1H- azonino- phenyl)- acetylamino] ethyl]-benzoic acid
Fremstilt analogt med eksempel 5 ved alkalisk hydrolyse av 4-.[2—[ ( 5-klor-2-oktahydro-lH-azonino-fenyl) -acetylamino] etyl ] - benzoesyre-etylester. Prepared analogously to example 5 by alkaline hydrolysis of 4-[2-[(5-chloro-2-octahydro-1H-azonino-phenyl)-acetylamino]ethyl]-benzoic acid ethyl ester.
Utbytte: 88 % .av det teoretiske,Yield: 88% of the theoretical,
Smeltepunkt: 179°CMelting point: 179°C
Eksempel 68 Example 68
4-[ 2-[( 2- oktahydro- lH- azonino- fenyl)- acetylamino] etyl] benzoesyre Fremstilt analogt med eksempel 62 ved katalytisl dehalogenering av 4 -[2-[(5-klor-2-oktahydro-lH-azonino-fenyl)-acetylamino]etyl]benzoesyre.. Utbytte: .55 % av det teoretiske, 4-[2-[(2-octahydro-1H-azonino-phenyl)-acetylamino]ethyl]benzoic acid Prepared analogously to example 62 by catalytic dehalogenation of 4-[2-[(5-chloro-2-octahydro-1H-azonino) -phenyl)-acetylamino]ethyl]benzoic acid.. Yield: .55% of the theoretical,
Smeltepunkt: 154°CMelting point: 154°C
Eksempel 6 9 Example 6 9
4 - [ ( 5- klor- 2- ( ok. tahydro- isoindol- 2- yl) - f enyl) - acetylaminometyl ] benzoesyre- 4 - [ ( 5- chloro- 2- ( ok. tahydro- isoindol- 2- yl) - phenyl) - acetylaminomethyl ] benzoic acid-
Fremstilt analogt" med eksempel 5 ved alkalisk hydrolyse av 4- [ (5-klor-2-(oktahydro-isoindol-2-yl)-fenyl)-acetylaminometyl] benzoesyre-etylester . Prepared analogously to example 5 by alkaline hydrolysis of 4-[(5-chloro-2-(octahydro-isoindol-2-yl)-phenyl)-acetylaminomethyl]benzoic acid ethyl ester.
Utbytte: 78 % av det teoretiske,Yield: 78% of the theoretical,
Smeltepunkt: 200°CMelting point: 200°C
Eksempel 70 Example 70
DL- 4- [ ( 2- ( 5- klor- 2- piperidino- f enyl) propionylamino)' metyl ] - benzoesyre DL- 4- [ ( 2- ( 5- chloro- 2- piperidino- phenyl) propionylamino)' methyl ] - benzoic acid
Fremstilt analogt med eksempel 5 ved alkalisk hydrolyse av 4-[(2-(5-klor-2-piperidino-fenyl)propionylamino)metyl]benzoesyre-etylester . Prepared analogously to example 5 by alkaline hydrolysis of 4-[(2-(5-chloro-2-piperidino-phenyl)propionylamino)methyl]benzoic acid ethyl ester.
Utbytte: 65 % av det teoretiske,Yield: 65% of the theoretical,
Smeltepunkt: 170°CMelting point: 170°C
Eksempel 71 Example 71
DL- 4-[ 2-( 2- piperidino- fenyl) propionylamino) metyl] benzoesyre Fremstilt analogt med eksempel 62 ved katalytisk hydro- gehering av 4-[(2-(5-klor-2-piperidino-fenyl)propionylamino)-metyl]benzoesyre. DL- 4-[ 2-( 2-piperidino-phenyl) propionylamino) methyl] benzoic acid Prepared analogously to example 62 by catalytic hydrogenation of 4-[(2-(5-chloro-2-piperidino-phenyl)propionylamino)- methyl]benzoic acid.
Utbytte: 60 % av det teoretiske,Yield: 60% of the theoretical,
Smeltepunkt: 12 5°C Melting point: 12 5°C
Eksempel 7 2 Example 7 2
DL- 4-[ 2-[ 2-( 5- klor- 2- piperidino- fenyl) propionylamino] etyl]-benzoesyre DL- 4-[ 2-[ 2-( 5- chloro- 2- piperidino- phenyl) propionylamino] ethyl] benzoic acid
Fremstilt analogt med eksempel 5 ved alkalisk hydrolyse 'av DL-4-[2-[2-(5-klor-2-piperidino)-fenyl)propionylamino]etyl]-benzoesyre-etylester. Prepared analogously to example 5 by alkaline hydrolysis of DL-4-[2-[2-(5-chloro-2-piperidino)-phenyl)propionylamino]ethyl]-benzoic acid ethyl ester.
Utbytte: 73 % av det teoretiske,Yield: 73% of the theoretical,
Smeltepunkt: 174°CMelting point: 174°C
Eksempel 73 Example 73
DL- 4-[ 2-[ 2-( 2- piperidino- fenyl) propionylamino] etyl] benzoesyre DL- 4-[ 2-[ 2-( 2-piperidino-phenyl) propionylamino] ethyl] benzoic acid
Fremstilt analogt"med eksempel 62 ved katalytisk dehalogenering av DL-4-[2-[2-(5-klor-2-piperidino-fenyl)propionylamino] etyl ] benzoesyre . Prepared analogously to Example 62 by catalytic dehalogenation of DL-4-[2-[2-(5-chloro-2-piperidino-phenyl)propionylamino]ethyl]benzoic acid.
Utbytte: 7 0 % av det teoretiske,Yield: 7 0% of the theoretical,
Smeltepunkt: 151°CMelting point: 151°C
Eksempel 7 4 DL- 4-[ 2-[ 2-( 5- klor- 2- oktahydro- lH- azonino- fenyl)- propionylamino] etyl] benzoesyre Example 7 4 DL- 4-[ 2-[ 2-( 5- chloro- 2- octahydro- 1H- azonino- phenyl)- propionylamino] ethyl] benzoic acid
Fremstilt analogt med eksempel 5 ved alkalisk hydrolyse av DL-4-[2-[2-(5-klor-2-oktahydro-lH-azonino-fenyl)propionylamino] etyl]benzoesyre-etylester. Prepared analogously to example 5 by alkaline hydrolysis of DL-4-[2-[2-(5-chloro-2-octahydro-1H-azonino-phenyl)propionylamino]ethyl]benzoic acid ethyl ester.
Utbytte: 65 % av det teoretiske,Yield: 65% of the theoretical,
Smeltepunkt: 1.68-170°CMelting point: 1.68-170°C
Eksempel 75 Example 75
DL- 4-[ 2-[ 2-( 2- oktahydro- lH- azonino- fenyl) propionylamino] ety1]-benzoesyre DL- 4-[ 2-[ 2-( 2- octahydro- 1H- azonino- phenyl) propionylamino] ethyl]-benzoic acid
Fremstilt analogt med eksempel 62 ved katalytisk de halogenering av DL-4-[2-[2-(5-klor-2-oktahydro-lH-azonino-fenyl)-propionylamino]etyl]benzoesyre. Prepared analogously to example 62 by catalytic dehalogenation of DL-4-[2-[2-(5-chloro-2-octahydro-1H-azonino-phenyl)-propionylamino]ethyl]benzoic acid.
Utbytte': 64 % av det teoretiske,Yield': 64% of the theoretical,
Smeltepunkt: 152-154°CMelting point: 152-154°C
Eksempel 7 6 DL- 4-[ 2-[( 2- piperidino- difenyl)- acetylamino] etyl] benzoesyre-Fremstilt ved alkalisk forsepning av 4-[2-[(2-piperidino-dif enyl) -acetylamino] etyl] benzoesyre-etylester analogt med eksempel 29. Example 7 6 DL- 4-[ 2-[(2-piperidino-diphenyl)-acetylamino] ethyl] benzoic acid-Prepared by alkaline saponification of 4-[2-[(2-piperidino-diphenyl)-acetylamino] ethyl] benzoic acid -ethyl ester analogously to example 29.
Utbytte: 64 % av det teoretiske,Yield: 64% of the theoretical,
Smeltepunkt: 166-168°CMelting point: 166-168°C
Eksempel 77 Example 77
DL- 4 - ( 2- piperidino- difenyl)- acetylaminometyl) benzoesyre DL- 4 - ( 2- piperidino-diphenyl)- acetylaminomethyl) benzoic acid
Fremstilt ved alkalisk forsepning av 4-(2-piperidino-difenyl)-acetylaminometyl)benzoesyre-etylester analogt med eksempel 29. Prepared by alkaline saponification of 4-(2-piperidino-diphenyl)-acetylaminomethyl)benzoic acid ethyl ester analogously to example 29.
Utbytte: 75 % av det teoretiske,Yield: 75% of the theoretical,
Smeltepunkt: 2 2 0-222°CMelting point: 2 2 0-222°C
Eksempel 78 Example 78
4- [ 2- [ ( 5- klor- 2- heksametylenimino- f enyl) - acetylamino]' etyl] - benzoesyre 4-[2-[(5-chloro-2-hexamethyleneimino-phenyl)-acetylamino]'ethyl]-benzoic acid
Fremstilt analogt med eksempel 5 ved alkalisk hydrolyse av 4 -[2-[(5-klor-2-heksametylenimino-fenyl)-acetylamino]etyl]-benzoesyre-etylester. Prepared analogously to example 5 by alkaline hydrolysis of 4-[2-[(5-chloro-2-hexamethyleneimino-phenyl)-acetylamino]ethyl]-benzoic acid ethyl ester.
Utbytte: 42 % avdet teoretiske,Yield: 42% of the theoretical,
Smeltepunkt: 168°CMelting point: 168°C
Eksempel 7 9 Example 7 9
4-[ 2-[( 2- heksametylenimino- fenyl)- acetylamino] etyl] benzoesyre 4-[ 2-[( 2- hexamethyleneimino-phenyl)- acetylamino] ethyl] benzoic acid
Fremstilt analogt med eksempel 62 ved katalytisk dehalogenering av 4-[2-[(5-klor-2-heksametylenimino-feny1)-acetyl- Prepared analogously to example 62 by catalytic dehalogenation of 4-[2-[(5-chloro-2-hexamethyleneimino-phenyl)-acetyl-
aminoj etyl]benzoesyre.aminoj ethyl]benzoic acid.
Utbytte: 70 % av det teoretiske, Yield: 70% of the theoretical,
Smeltepunkt: 14 4°CMelting point: 14 4°C
Eksempel 8 0 Example 8 0
4-[ 2- [ ( 5- klor- 2- pyrrolidino- fenyl)- acetylamino] etyl] benzoesyre 4-[ 2- [ ( 5- chloro- 2- pyrrolidino- phenyl)- acetylamino] ethyl] benzoic acid
Fremstilt analogt med eksempel 5 ved alkalisk hydrolyse av 4 -[ 2-[(5-klor-2-pyrrolidino-fenyl)-acetylamino]etyl]benzoesyre-etylester . Prepared analogously to example 5 by alkaline hydrolysis of 4-[2-[(5-chloro-2-pyrrolidino-phenyl)-acetylamino]ethyl]benzoic acid ethyl ester.
Utbytte: 86 % av det teoretiske,Yield: 86% of the theoretical,
Smeltepunkt: 174-176°CMelting point: 174-176°C
Eksempel 81 Example 81
4-[ 2-[( 2- pyrroiidino- fenyl)- acetylamino] etyl] benzoesyre 4-[ 2-[( 2- pyrroiidino- phenyl)- acetylamino] ethyl] benzoic acid
Fremstilt analogt med eksempel 62 ved katalytisk dehalogenering av 4-[2-[(5-klor-2-pyrrolidino-fenyl)-acetylamino]-etyl]benzoesyre. Prepared analogously to example 62 by catalytic dehalogenation of 4-[2-[(5-chloro-2-pyrrolidino-phenyl)-acetylamino]-ethyl]benzoic acid.
Utbytte: 3-7 % av det teoretiske,Yield: 3-7% of the theoretical,
Smeltepunkt: 150-152°CMelting point: 150-152°C
Eksempel 82 Example 82
4-[ 2-[( 5- klor- 2- heptametylenimino- fenyl)- acetylamino] etyl]-benzoesyre 4-[ 2-[( 5- chloro- 2- heptamethyleneimino- phenyl)- acetylamino] ethyl]-benzoic acid
Fremstilt analogt med eksempel 5 ved alkalisk hydrolyse av 4 -[2-[(5-klor-2-heptametylenimino-fenyl)-acetylamino]etyl]-benzoesyre-etylester. Prepared analogously to example 5 by alkaline hydrolysis of 4-[2-[(5-chloro-2-heptamethyleneimino-phenyl)-acetylamino]ethyl]-benzoic acid ethyl ester.
Utbytte: 43 % av det teoretiske,Yield: 43% of the theoretical,
Smeltepunkt: 188<Q>CMelting point: 188<Q>C
Eksempel 83 Example 83
4-[ 2-[( 2- heptametylenimino- fenyl)- acetylamino] etyl] benzoesyre 4-[ 2-[( 2- heptamethyleneimino-phenyl)- acetylamino] ethyl] benzoic acid
Fremstilt analogt med eksempel 62 ved katalytisk dehalogenering av 4-[2-[(5-klor-2-heptametylenimino-fenyl)-acetylamino] etyl ] benzoesyre . Prepared analogously to example 62 by catalytic dehalogenation of 4-[2-[(5-chloro-2-heptamethyleneimino-phenyl)-acetylamino] ethyl ] benzoic acid.
Utbytte: 73 % av det teoretiske,Yield: 73% of the theoretical,
Smeltepunkt: 152-154°C Melting point: 152-154°C
Eksempel 84 Example 84
DL- 4-[ 2-[ 2-( 2- pyrrolidino- fenyl) propionylamino] etyl] benzoesyre- etylester DL- 4-[ 2-[ 2-( 2- pyrrolidino-phenyl) propionylamino] ethyl] benzoic acid ethyl ester
Fremstilt fra DL-2-(2-pyrrolidino-fenyl)propionsyre og 4-(2-aminoetyl)benzoesyreetylester analogt med eksempel 1. Utbytte: 64 % av det teoretiske, Prepared from DL-2-(2-pyrrolidino-phenyl)propionic acid and 4-(2-aminoethyl)benzoic acid ethyl ester analogously to example 1. Yield: 64% of the theoretical,
Smeltepunkt: <20°CMelting point: <20°C
Beregnet: Moltopp: m/e =3 94Calculated: Mole top: m/e =3 94
Funnet: Moltopp: m/e =3 94Found: Mole top: m/e =3 94
Eksempel 8 5 Example 8 5
DL- 4-[[ 2-( 2- pyrrolidino- fenyl) propionylamino] metyl] benzoesyre-etylester DL- 4-[[ 2-( 2- pyrrolidino-phenyl) propionylamino] methyl] benzoic acid ethyl ester
Fremstilt fra DL-2-(2-pyrrolidino-fenyl)propionsyre og 4-amino-metyl-b.enzoesyre-etylester analogt med eksempel 1. Utbytte: 58 % av det teoretiske, Prepared from DL-2-(2-pyrrolidino-phenyl)propionic acid and 4-amino-methyl-b.enzoic acid ethyl ester analogously to example 1. Yield: 58% of the theoretical,
Smeltepunkt: <20°C Beregnet: Moltopp: m/e =38 0 Melting point: <20°C Calculated: Mole peak: m/e =38 0
Funnet: Moltopp: m/e = 380Found: Mole top: m/e = 380
Eksempel 8 6 Example 8 6
DL- 4-[ 2-[ 2-( 2- heksametylenimino- fenyl) propionylamino] etyl]-benzoesyre- etylester DL- 4-[ 2-[ 2-( 2- hexamethyleneimino-phenyl) propionylamino] ethyl]-benzoic acid ethyl ester
Fremstilt fra DL-2-(2-heksametylenimino-fenyl)propionsyre og 4-(2-amino-etyl)benzoesyre-etylester analogt med eksempel 1. Utbytte: 72 % av det teoretiske, Prepared from DL-2-(2-hexamethyleneimino-phenyl)propionic acid and 4-(2-amino-ethyl)benzoic acid ethyl ester analogously to example 1. Yield: 72% of the theoretical,
Smeltepunkt: <2 0°CMelting point: <2 0°C
Beregnet: Moltopp: m/e = 422Calculated: Mole top: m/e = 422
Funnet: Moltopp: m/e = 422Found: Mole top: m/e = 422
Eksempel 87 Example 87
DL- 4-[[ 2-( 2- heksametylenimino- fenyl) propionylaminojmetyl]-benzoesyre- etylester DL- 4-[[ 2-( 2- hexamethyleneimino-phenyl) propionylaminojmethyl]-benzoic acid ethyl ester
Fremstilt fra DL-2-(2-heksametylenimino-fenyl)propionsyre og 4-(aminometyl)benzoesyre-etylester analogt med eksempel I. Utbytte: 6 9 % av det teoretiske, Prepared from DL-2-(2-hexamethyleneimino-phenyl)propionic acid and 4-(aminomethyl)benzoic acid ethyl ester analogously to example I. Yield: 6 9% of the theoretical,
Smeltepunkt: <2 0°CMelting point: <2 0°C
Beregnet: Moltopp: m/e =4 08Calculated: Mole top: m/e =4 08
Funnet: Moltopp: m/e =4 08 Found: Mole top: m/e =4 08
Eksempel 88 DL- 4-[ 2-[( 2- pyrrolidino- difenyl)- acetylamino] etyl] benzoesyre-etylester Fremstilt fra (2-pyrrolidino-difenyl)-eddiksyre og 4-(2-aminoetyl)benzoesyre-etylester analogt med eksempel 20. Utbytte: 51 % av det teoretiske, Smeltepunkt: 89-92°C Example 88 DL- 4-[ 2-[( 2-pyrrolidino-diphenyl)-acetylamino] ethyl] benzoic acid ethyl ester Prepared from (2-pyrrolidino-diphenyl)-acetic acid and 4-(2-aminoethyl)benzoic acid ethyl ester analogously to example 20. Yield: 51% of theoretical, Melting point: 89-92°C
Eksempel 89 Example 89
DL- 4-[ 2-[( 2- heksametylenimino- difenyl)- acetylamino] etyl]-benzoesyre- etylester DL- 4-[ 2-[( 2- hexamethyleneimino- diphenyl)- acetylamino] ethyl]-benzoic acid ethyl ester
Fremstilt fra (2-heksametylenimino-difenyl)-eddiksyre og 4-(2-aminoetyl)-benzoesyre-etylester analogt med eksempel 20. Prepared from (2-hexamethyleneimino-diphenyl)-acetic acid and 4-(2-aminoethyl)-benzoic acid ethyl ester analogously to example 20.
Utbytte: 49 % av det teoretiske,Yield: 49% of the theoretical,
Smeltepunkt: 8 0-8 3°C Melting point: 8 0-8 3°C
Eksempel 90 Example 90
4- [ 2- ( 2- oktahydro- lH- az. onino- benzoylamino) etyl ] benzoesyre 4- [ 2- ( 2- octahydro- 1H- az. onino- benzoylamino) ethyl ] benzoic acid
Fremstilt analogt med eksempel 5 ved alkalisk hydrolyse av 4-[2-(2-oktahydro-lH-azonino-benzoylamino)etyl]benzoesyre-etylester. Prepared analogously to example 5 by alkaline hydrolysis of 4-[2-(2-octahydro-1H-azonino-benzoylamino)ethyl]benzoic acid ethyl ester.
Utbytte: 71 % av det teoretiske,Yield: 71% of the theoretical,
Smeltepunkt: 154-156°C Melting point: 154-156°C
Eksempel 91 Example 91
4-[ 2-( 5- klor- 2-( 2, 3, 3a, 4, 7, 7a- heksahydro- lH- isoindol- 2- yl)-benzoylamino) etyl] benzoesyre- semihydrat 4-[ 2-( 5- chloro- 2-( 2, 3, 3a, 4, 7, 7a- hexahydro- 1H- isoindol- 2- yl)-benzoylamino) ethyl] benzoic acid hemihydrate
Fremstilt analogt med eksempel .5 ved alkalisk hydrolyse av 4-[2-J5-klor-2-(2,3,3a,4,7,7a-heksahydro-lH-isoindol-2-yl)-benzoylamino)etyl]benzoesyre-etylester. Prepared analogously to example 5 by alkaline hydrolysis of 4-[2-N5-chloro-2-(2,3,3a,4,7,7a-hexahydro-1H-isoindol-2-yl)-benzoylamino)ethyl]benzoic acid -ethyl ester.
Utbytte: 86 % av det teoretiske,Yield: 86% of the theoretical,
Smeltepunkt: 90°C spaltningMelting point: 90°C decomposition
Eksempel 92 Example 92
4-[ 2-( 5- klor- 2-( 1, 3- dihydro- isoindol- 2- yl)- benzoylamino) etyl]-benzoesyre 4-[ 2-( 5- chloro- 2-( 1, 3- dihydro- isoindol- 2- yl)- benzoylamino) ethyl] benzoic acid
Fremstilt analogt med eksempel 5 ved alkalisk hydrolyse av 4-[2-(5-klor-2-(1,3-dihydro-isoindol-2-yl)-benzoylamino)etyl]-benzoesyre-etylester. Prepared analogously to example 5 by alkaline hydrolysis of 4-[2-(5-chloro-2-(1,3-dihydro-isoindol-2-yl)-benzoylamino)ethyl]-benzoic acid ethyl ester.
Utbytte: 74 % av det teoretiske,Yield: 74% of the theoretical,
Smeltepunkt: 224-226°CMelting point: 224-226°C
Eksempel 93 Example 93
5- amino- 2-( 2- azabicyklo[ 3. 3. 1] nonan- 2- yl)- benzoesyre5- amino- 2-( 2- azabicyclo[ 3. 3. 1] nonan- 2- yl)- benzoic acid
I 100 ml dimetylformamid oppløses 11 g 2-(2-azabicyklo-[3.3.1]nonan-2-yl)-5-nitro-benzoesyré, og ved et hydrogentrykk på 5 bar hydrogeneres med 10 %ig palladiumkull som katalysator ved romtemperatur. Efter avsluttet hydrogenopptak firafiltreres katalysatoren, oppløsningsmidlet a<y>destilleres i vakuum, og residuet bringes til krystallisasjon med etanol/petroleter. Utbytte: 7,5 g (76 % av det teoretiske), 11 g of 2-(2-azabicyclo-[3.3.1]nonan-2-yl)-5-nitro-benzoic acid are dissolved in 100 ml of dimethylformamide, and hydrogenated at a hydrogen pressure of 5 bar with 10% palladium charcoal as a catalyst at room temperature. After completion of hydrogen absorption, the catalyst is filtered off, the solvent is distilled in vacuum, and the residue is brought to crystallization with ethanol/petroleum ether. Yield: 7.5 g (76% of theoretical),
Smeltepunkt: 215-217°CMelting point: 215-217°C
Eksempel 94 5- amino- 2-[ 4-( 3- pentyl)- piperidino] benzoesyre Fremstilt analogt med eksempel 93 ved katalytisk hydrogenering av 5-nitro-2-[4-(3-pentyl)-piperidino]benzoesyre. Utbytte: 94,1 % av det teoretiske, Smeltepunkt: 218°C Example 94 5-amino-2-[4-(3-pentyl)-piperidino]benzoic acid Prepared analogously to example 93 by catalytic hydrogenation of 5-nitro-2-[4-(3-pentyl)-piperidino]benzoic acid. Yield: 94.1% of the theoretical, Melting point: 218°C
Eksempel 9 5 Example 9 5
5- amino- 2-[ 4-( 5- nonyl)- piperidino] benzoesyre5-amino-2-[4-(5-nonyl)-piperidino]benzoic acid
Fremstilt analogt med eksempel 93 ved katalytisk hydro genering av 5-nitro-2-[4-(5-nonyl)-piperidino]benzoesyre. Utbytte: 85 % av det teoretiske, Prepared analogously to example 93 by catalytic hydrogenation of 5-nitro-2-[4-(5-nonyl)-piperidino]benzoic acid. Yield: 85% of the theoretical,
Smeltepunkt: 130°CMelting point: 130°C
Eksempel 9 6 Example 9 6
5- amino- 2-( oktahydro- isoindol- 2- yl)- benzoesyre5-amino-2-(octahydro-isoindol-2-yl)-benzoic acid
Fremstilt analogt med eksempel 93 ved katalytisk -hydrogenering av 5-nitro-2-(oktahydro-isoindol-2-yl)-benzoesyre. Utbytte: 78,7 % av det teoretiske, Prepared analogously to example 93 by catalytic hydrogenation of 5-nitro-2-(octahydro-isoindol-2-yl)-benzoic acid. Yield: 78.7% of the theoretical,
Smeltepunkt: 244-245°C Melting point: 244-245°C
Eksempel 97 5- amino- 2-( 1, 3- dihydro- isoindol- 2- yl)- benzoesyre Fremstilt ved katalytisk hydrogenering av 2-(1,3-dihydroisoindol-2-yl)-5-nitro-benzoesyre analogt med eksempel 93. Utbytte: 54 % av det teoretiske, Smeltepunkt: 26 0°C Example 97 5-amino-2-(1,3-dihydro-isoindol-2-yl)-benzoic acid Prepared by catalytic hydrogenation of 2-(1,3-dihydroisoindol-2-yl)-5-nitro-benzoic acid analogously to example 93. Yield: 54% of theoretical, Melting point: 26 0°C
Eksempel 98 Example 98
5- amino- 2-( 2, 3, 3a, 4, 7, 7a- heksahydro- lH- isoindol- 2- yl)- benzoesyre 5- amino- 2-( 2, 3, 3a, 4, 7, 7a- hexahydro- 1H- isoindol- 2- yl)- benzoic acid
3,4 g (11,8 mMol) 2-(2,3,3a,4,7,7a-heksahydro-lH-isoindol-2-yl)-5-nitro-benzpesyre suspenderes i 32 ml av en blanding av konsentrert saltsyre og metanol 1:1 og reduseres ved 0°C por-sjonsvis med 15,6 g (69 mMol) tinn(II)klorid-dihydrat. Efter avsluttet tilsetning efter-røres i noen timer ved romtemperatur, fortynnes med 3 00 ml H20, pH-verdien innstilles på 4 med natronlut, og ekstraksjon foretas med kloroform. Kloroformekstraktene tørres, og efter avdestillering av kloroformen i vakuum bringes residuet til krystallisasjon i aceton/eter. Utbytte: 2,3 g (75 % av det teoretiske), 3.4 g (11.8 mmol) of 2-(2,3,3a,4,7,7a-hexahydro-1H-isoindol-2-yl)-5-nitro-benzoic acid are suspended in 32 ml of a mixture of concentrated hydrochloric acid and methanol 1:1 and reduced at 0°C in portions with 15.6 g (69 mmol) tin (II) chloride dihydrate. After the addition has been completed, the mixture is stirred for a few hours at room temperature, diluted with 300 ml H20, the pH value is adjusted to 4 with caustic soda, and extraction is carried out with chloroform. The chloroform extracts are dried, and after distilling off the chloroform in a vacuum, the residue is brought to crystallization in acetone/ether. Yield: 2.3 g (75% of theoretical),
Smeltepunkt: 287°CMelting point: 287°C
Beregnet: Moltopp: m/e =2 58Calculated: Mole top: m/e =2 58
Funnet: Moltopp: m/e = 258Found: Mole top: m/e = 258
Eksempel 9 9 Example 9 9
( 5- amino- 2- pyrrolidino- fenyl) eddiksyre(5-amino-2-pyrrolidino-phenyl)acetic acid
Fremstilt ved katalytisk hydrogenering av (5-nitro-2-pyrrolidino-fenyl)eddiksyre analogt med eksempel 93. Prepared by catalytic hydrogenation of (5-nitro-2-pyrrolidino-phenyl)acetic acid analogously to example 93.
Utbytte: 7 2 % av det teoretiske,Yield: 7 2% of the theoretical,
Smeltepunkt: 158°CMelting point: 158°C
Eksempel 100 Example 100
. ( 5- amino- 2- heptametylenimino- fenyl) eddiksyre. (5-amino-2-heptamethyleneimino-phenyl) acetic acid
Fremstilt ved katalytisk hydrogenering av (5-nitro-2-heptametylenimino-fenyl)eddiksyre analogt med eksempel 93. Utbytte: 42 % av det teoretiske, Prepared by catalytic hydrogenation of (5-nitro-2-heptamethyleneimino-phenyl)acetic acid analogously to example 93. Yield: 42% of the theoretical,
Smeltepunkt: 152-154°C Melting point: 152-154°C
Eksempel 101 Example 101
[ 5- amino- 2-( oktahydro- isoindol- 2- yl)- fenyl] eddiksyre[ 5- amino- 2-( octahydro- isoindol- 2- yl)- phenyl] acetic acid
Fremstilt ved katalytisk hydrogenering av [2-(oktahydro-isoindol-2-yl)-5-nitro-fenyl]-eddiksyre analogt med eksempel 93. Utbytte: 92 % av det teoretiske, Prepared by catalytic hydrogenation of [2-(octahydro-isoindol-2-yl)-5-nitro-phenyl]-acetic acid analogously to example 93. Yield: 92% of the theoretical,
Smeltepunkt: 202-203°CMelting point: 202-203°C
Eksempel 102 [ 5- amino- 2-( oktahydro- lH- azonino)- fenyl] eddiksyre Fremstilt ved katalytisk hydrogenering av [2-(oktahydro-lH-azonino) -5-nitro-f enyl] eddiksyre analogt med eksempel 93. Utbytte: 74 % av det teoretiske, Smeltepunkt: 187-189°C Example 102 [5-amino-2-(octahydro-1H-azonino)-phenyl]acetic acid Prepared by catalytic hydrogenation of [2-(octahydro-1H-azonino)-5-nitro-phenyl]acetic acid analogous to example 93. Yield : 74% of the theoretical, Melting point: 187-189°C
Ek. sempel 103 Oak. simple 103
( 5- amino- 2- heksametylenimino- fenyl)- eddiksyre(5-amino-2-hexamethyleneimino-phenyl)-acetic acid
Fremstilt ved katalytisk hydrogenering av (2-heksametylenimino-5-nitrofenyl)-eddiksyre analogt med eksempel 93. Utbytte: 48 % av det teoretiske, Prepared by catalytic hydrogenation of (2-hexamethyleneimino-5-nitrophenyl)-acetic acid analogously to example 93. Yield: 48% of the theoretical,
Smeltepunkt: 156°C Melting point: 156°C
( 5- amino- 2- piperidino- fenyl)- eddiksyre (5-amino-2-piperidino-phenyl)-acetic acid
Fremstilt ved katalytisk hydrogenering av (5-nitro-2-piperidino-fenyl)-eddiksyre analogt med eksempel 93.. Utbytte: 65 % av det teoretiske, Prepared by catalytic hydrogenation of (5-nitro-2-piperidino-phenyl)-acetic acid analogously to example 93.. Yield: 65% of the theoretical,
Smeltepunkt: 179-181°CMelting point: 179-181°C
Eksempel 105 Example 105
DL- 2-( 5- amino- 2- piperidino- fenyl)- propionsyreDL-2-(5-amino-2-piperidino-phenyl)-propionic acid
Fremstilt fra DL-2-(5-nitro-2-piperidino-fenyl)-propionsyre ved katalytisk hydrogenering analogt med eksempel 93. Utbytte: 40 % av det teoretiske, Prepared from DL-2-(5-nitro-2-piperidino-phenyl)-propionic acid by catalytic hydrogenation analogous to example 93. Yield: 40% of the theoretical,
Smeltepunkt: 2 0 7°CMelting point: 2 0 7°C
Eksempel 106 Example 106
DL- 2-( 5- amino- 2- oktahydro- lH- azonino- fenyl)- propionsyre DL- 2-( 5- amino- 2- octahydro- 1H- azonino- phenyl)- propionic acid
Fremstilt fra DL-2-(5-nitro-2-oktahydro-lH-azonino-fenyl)-propionsyre ved katalytisk hydrogenering analogt med eksempel 93. Prepared from DL-2-(5-nitro-2-octahydro-1H-azonino-phenyl)-propionic acid by catalytic hydrogenation analogously to example 93.
Utbytte: 19 % av det teoretiske, Smeltepunkt: 218°C Yield: 19% of the theoretical, Melting point: 218°C
Eksempel 107 DL- 2-[ 5- amino- 2-( oktahydro- isoindol- 2- yl)- fenyl]- propionsyre Fremstilt ved katalytisk hydrogenering av DL-2-[5-nitro-2-(oktahydro-isoindol-2-yl)-fenyl]propionsyre analogt med eksempel 93. Example 107 DL-2-[5-amino-2-(octahydro-isoindol-2-yl)-phenyl]-propionic acid Prepared by catalytic hydrogenation of DL-2-[5-nitro-2-(octahydro-isoindol-2- yl)-phenyl]propionic acid analogously to example 93.
Utbytte: 21 % av det teoretiske,Yield: 21% of the theoretical,
Smeltepunkt: 24 3°CMelting point: 24 3°C
Eksempel 108 Example 108
5- klor- 2-( 2- azabicyklo[ 3. 3. 1] nonan- 2- yl)- benzoesyre5- chloro- 2-( 2- azabicyclo[ 3. 3. 1] nonan- 2- yl)- benzoic acid
6,5 g (25 mMol) 5-amino-2-(2-azabicyklo[3.3.1]nonan-2-yl)-benzoesyre oppløses i 90 ml halvkonsentrert saltsyre og diazo- • teres ved 0°C med en oppløsning av 1,5 g (27 mMol) natriumnitritt i 18 ml vann. Diazoniumoppløsningen settes dråpevis under omrøring til en oppløsning av 3 g (30 mMol) kobber(I)-klorid i 45 ml konsentrert saltsyre. Efter avsluttet nitrogen-utvikling omrøres videre i 2 til 3 timer. Klorforbindelsen utrystes med kloroform og renses over en silikagelkolonné med 6.5 g (25 mmol) of 5-amino-2-(2-azabicyclo[3.3.1]nonan-2-yl)-benzoic acid are dissolved in 90 ml of semi-concentrated hydrochloric acid and diazotized at 0°C with a solution of 1.5 g (27 mmol) of sodium nitrite in 18 ml of water. The diazonium solution is added dropwise with stirring to a solution of 3 g (30 mmol) of copper (I) chloride in 45 ml of concentrated hydrochloric acid. After the end of nitrogen development, stirring continues for 2 to 3 hours. The chlorine compound is shaken off with chloroform and purified over a silica gel column with
eddiksyreetylester som elueringsmiddel.acetic acid ethyl ester as eluent.
Utbytte: 5,2 g (75 % av det teoretiske),Yield: 5.2 g (75% of theoretical),
Smeltepunkt: 85-87°CMelting point: 85-87°C
Eksempel 109 Example 109
5- klor- 2-[ 4-( 3- pentyl)- piperidino]- benzoesyre5-chloro-2-[4-(3-pentyl)-piperidino]-benzoic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra 5-amino-2-[4-(3-pentyl)-piperidino]benzoesyre. Utbytte: 60,6 % av det teoretiske, Prepared analogously to example 108 by Sandmeyer reaction starting from 5-amino-2-[4-(3-pentyl)-piperidino]benzoic acid. Yield: 60.6% of the theoretical,
Smeltepunkt: 150°CMelting point: 150°C
Eksempel 110 Example 110
5- klor- 2-[ 4-( 5- nonyl)- piperidino] benzoesyre5-chloro-2-[4-(5-nonyl)-piperidino]benzoic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra 5-amino-2-[4-(5-nonyl)-piperidino]benzoesyre. Utbytte: 58 % av det teoretiske, Prepared analogously to example 108 by Sandmeyer reaction starting from 5-amino-2-[4-(5-nonyl)-piperidino]benzoic acid. Yield: 58% of the theoretical,
Smeltepunkt: 148-150°CMelting point: 148-150°C
Eksempel 111 Example 111
5- brom- 2-( oktahydro- isoindol- 2- yl)- benzoesyre5-bromo-2-(octahydro-isoindol-2-yl)-benzoic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra 5-amino-2-(oktahydro-isoindol-2-yl)-benzoesyre. Utbytte: 21 % av det teoretiske, Prepared analogously to example 108 by Sandmeyer reaction starting from 5-amino-2-(octahydro-isoindol-2-yl)-benzoic acid. Yield: 21% of the theoretical,
Smeltepunkt: 176°CMelting point: 176°C
Eksempel 112 Example 112
5- jod- 2-( oktahydro- isoindol- 2- yl)- benzoesyre5-iodo-2-(octahydro-isoindol-2-yl)-benzoic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra 5-amino-2-(oktahydro-isoindol-2-yl)-benzoesyre. Utbytte: 19 % av det teoretiske, Prepared analogously to example 108 by Sandmeyer reaction starting from 5-amino-2-(octahydro-isoindol-2-yl)-benzoic acid. Yield: 19% of the theoretical,
Smeltepunkt: 174°CMelting point: 174°C
Eksempel 113 Example 113
5- cyan- 2-( oktahydro- isoindol- 2- y1)- benzoesyre5- cyano- 2-( octahydro- isoindole- 2- y1)- benzoic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra 5-amino-2-(oktahydro-isoindol-2-yl)-benzoesyre. Utbytte: . 33 % av det teoretiske, Prepared analogously to example 108 by Sandmeyer reaction starting from 5-amino-2-(octahydro-isoindol-2-yl)-benzoic acid. Dividend: . 33% of the theoretical,
Smeltepunkt: 190°CMelting point: 190°C
Eksempel 114 Example 114
5- fluor- 2-( oktahydro- isoindol- 2- y1)- benzoesyre5-fluoro-2-(octahydro-isoindole-2-y1)-benzoic acid
Fremstilt fra 5-amino-2-(oktahydro-isoindol-2-yl)-benzoesyre over [5-diazonium-2-(oktahydro-i soindol-2-yl)-benzoesyre]tetra-fluorborat [Utbytte 73 %, Smeltepunkt: 173°C (spaltning)] og påfølgende termisk spaltning. Prepared from 5-amino-2-(octahydro-isoindol-2-yl)-benzoic acid over [5-diazonium-2-(octahydro-isoindol-2-yl)-benzoic acid]tetrafluoroborate [Yield 73%, Melting point: 173°C (decomposition)] and subsequent thermal decomposition.
Utbytte: 2 % av det teoretiske,Yield: 2% of the theoretical,
Beregnet: Moltopp m/e = 263Calculated: Moltop m/e = 263
Funnet: Moltopp m/e = 263Found: Moltop m/e = 263
Eksempel 115 Example 115
5- hydroksy- 2-( oktahydro- isoindol- 2- yl)- benzoesyre5-hydroxy-2-(octahydro-isoindol-2-yl)-benzoic acid
Fremstilt fra 5-amino-2-(oktahydro-isoindol-2-yl)-benzoesyre ved diazotering og påfølgende utkokning av diazonium-saltet i 50 %ig svovelsyre ved 80-90°C. Prepared from 5-amino-2-(octahydro-isoindol-2-yl)-benzoic acid by diazotization and subsequent boiling of the diazonium salt in 50% sulfuric acid at 80-90°C.
Utbytte: 61 '% av det teoretiske,Yield: 61% of the theoretical,
Smeltepunkt: 222-223°CMelting point: 222-223°C
Eksempel 116 Example 116
5- metoksy- 2-( oktahydro- isoindol- 2- yl)- benzoesyre- metylester5- methoxy- 2-( octahydro- isoindol- 2- yl)- benzoic acid methyl ester
1 g (3,8 mMol) 5-hydroksy-2-(oktahydro-isoindol-2-yl)-benzoesyre i 10 ml absolutt dimetylformamid overføres til dinatrium- saltet med 0,19 g (8 mMol) 50 %ig natriumhydrid-dispersjon og alkyleres derefter med 1,66 g (11,7 mMol) metyljodid. Utbytte: 0,9 g (82 % av det teoretiske), 1 g (3.8 mmol) of 5-hydroxy-2-(octahydro-isoindol-2-yl)-benzoic acid in 10 ml of absolute dimethylformamide is transferred to the disodium salt with 0.19 g (8 mmol) of a 50% sodium hydride dispersion and then alkylated with 1.66 g (11.7 mmol) of methyl iodide. Yield: 0.9 g (82% of theoretical),
Smeltepunkt: 6 6-6 8°CMelting point: 6 6-6 8°C
Eksempel 117 Example 117
5- metoksy- 2-( oktahydro- isoindol- 2- yl)- benzoesyre5-Methoxy-2-(octahydro-isoindol-2-yl)-benzoic acid
Fremstilt analogt med eksempel 5 ved alkalisk hydrolyse av 5-metoksy-2-(oktahydro-isoindol-2-yl)-benzoesyre-metylester. Utbytte: 91 % av det teoretiske, Prepared analogously to example 5 by alkaline hydrolysis of 5-methoxy-2-(octahydro-isoindol-2-yl)-benzoic acid methyl ester. Yield: 91% of the theoretical,
Smeltepunkt: 132-134°CMelting point: 132-134°C
Eksempel 118 Example 118
5- metyl- 2-( oktahydro- isoindol- 2- yl)- benzoesyre5-methyl-2-(octahydro-isoindol-2-yl)-benzoic acid
Fremstilt analogt med eksempel 135 fra 3-brom^4-(oktahydro-isoindol-2-yl)-toluen (Smeltepunkt: 110-112°C) med butyllitium og påfølgende karboksylering. Prepared analogously to example 135 from 3-bromo^4-(octahydro-isoindol-2-yl)-toluene (Melting point: 110-112°C) with butyllithium and subsequent carboxylation.
Utbytte: 46 % av det teoretiske,Yield: 46% of the theoretical,
Smeltepunkt: 157-159°CMelting point: 157-159°C
Eksempel 119 Example 119
5- klor- 2-( 2, 3, 3a, 4, 7, 7a- heksahydro- lH- isoindoi- 2- y1)- benzoesyre 5- chloro- 2-( 2, 3, 3a, 4, 7, 7a- hexahydro- 1H- isoindoi- 2- y1)- benzoic acid
Fremstilt ved Sandmeyer-reaksjon analogt med eksempel 108 ved å gå ut fra 5-amino-2-(2,3,3a,4,7,7a-heksahydro-lH-isoindol-2-yl)-benzoesyre. Prepared by Sandmeyer reaction analogous to example 108 starting from 5-amino-2-(2,3,3a,4,7,7a-hexahydro-1H-isoindol-2-yl)-benzoic acid.
Utbytte: 12 % av det teoretiske,Yield: 12% of the theoretical,
Smeltepunkt: 201°CMelting point: 201°C
Eksempel 120 Example 120
2-( 2, 3, 3a, 4, 7, 7a- heksahydro- lH- isoindol- 2- yl)- benzoesyre 2-(2,3,3a,4,7,7a-hexahydro-1H-isoindol-2-yl)-benzoic acid
Fremstilt fra 5-amino-2-(2,3,3a,4,7,7a-heksahydro-lH-isoindol-2-yl)-benzoesyre ved diazotering med natriumnitritt og påfølgende reduksjon med kobber/saltsyre. Prepared from 5-amino-2-(2,3,3a,4,7,7a-hexahydro-1H-isoindol-2-yl)-benzoic acid by diazotization with sodium nitrite and subsequent reduction with copper/hydrochloric acid.
Utbytte: 5 % av det teoretiske,Yield: 5% of the theoretical,
Smeltepunkt: 156°CMelting point: 156°C
Eksempel 121 Example 121
5- acetamino- 2-( 2, 3, 3a, 4, 7, 7a- héksahydro- lH- isoindol- 2- yl)-benzoesyre 5-acetamino-2-(2,3,3a,4,7,7a-hexahydro-1H-isoindol-2-yl)-benzoic acid
Fremstilt fra 5-amino-2-(2,3,3a,4,7,7a-heksahydro-iH-isoindol-2-yl)benzoesyre ved acylering med acetylklorid i pyridin. Utbytte: 76 % av .det teoretiske, Prepared from 5-amino-2-(2,3,3a,4,7,7a-hexahydro-1H-isoindol-2-yl)benzoic acid by acylation with acetyl chloride in pyridine. Yield: 76% of the theoretical,
Smeltepunkt: 226-227°CMelting point: 226-227°C
Eksempel 122 Example 122
5- klor- 2-( 1, 3- dihydro- isoindol- 2- yl)- benzoesyre5- chloro- 2-( 1, 3- dihydro- isoindol- 2- yl)- benzoic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra 5-amino-2-(1,3-dihydro-isoindol-2-yl)-benzoesyre. Prepared analogously to example 108 by Sandmeyer reaction starting from 5-amino-2-(1,3-dihydro-isoindol-2-yl)-benzoic acid.
Utbytte: 37 % av det teoretiske,Yield: 37% of the theoretical,
Smeltepunkt: 16 2°CMelting point: 16 2°C
Eksempel 123 Example 123
5- brom- 2-( 1, 3- dihydro- isoindol- 2- yl)- benzoesyre5- bromo- 2-( 1, 3- dihydro- isoindol- 2- yl)- benzoic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra 5-amino-2-(1,3-dihydro-isoindol-2-yl)-benzoesyre. Prepared analogously to example 108 by Sandmeyer reaction starting from 5-amino-2-(1,3-dihydro-isoindol-2-yl)-benzoic acid.
Utbytte: 63 % av det teoretiske,Yield: 63% of the theoretical,
Smeltepunkt: 178°CMelting point: 178°C
Eksempel 124 Example 124
2-( l, 3- dihydro- isoindol- 2- yl)- benzoesyre2-(1,3-dihydro-isoindol-2-yl)-benzoic acid
Fremstilt analogt med eksempel 62 ved katalytisk dehalogenering. av 5-klor-2-(1,3-dihydro-isoindol-2-yl)-benzoesyre. Utbytte: 68 % av det teoretiske, Prepared analogously to example 62 by catalytic dehalogenation. of 5-chloro-2-(1,3-dihydro-isoindol-2-yl)-benzoic acid. Yield: 68% of the theoretical,
Smeltepunkt: 146-148°CMelting point: 146-148°C
Eksempel 125 Example 125
5- amino- 2-( 1, 3- dihydro- 5- klor- isoindol- 2- yl- benzoesyre 5- amino- 2-( 1, 3- dihydro- 5- chloro- isoindole- 2- yl- benzoic acid
Fremstilt analogt med eksempel 93 ved reduksjon av 2-(1,3-d ihydro-5-klor-isoindol-2-yl)-5-nitro-benzoesyre med tinn(II)-klorid. Prepared analogously to example 93 by reduction of 2-(1,3-dihydro-5-chloro-isoindol-2-yl)-5-nitro-benzoic acid with stannous chloride.
Utbytte: 23 % av det teoretiske, Smeltepunkt: 235°C Yield: 23% of the theoretical, Melting point: 235°C
Eksempel 126 5- klor- 2-( 1, 3- dihydro- 5- klor- isoindol- 2- yl)- benzoesyre Example 126 5-chloro-2-(1,3-dihydro-5-chloro-isoindol-2-yl)-benzoic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra 5-amino-2-(1, 3-dihy.dro-5-kldr-isoindol-2-yl)-benzoesyre. Prepared analogously to example 108 by Sandmeyer reaction starting from 5-amino-2-(1,3-dihydro-5-chloro-isoindol-2-yl)-benzoic acid.
Utbytte: 18 % av det teoretiske, Smeltepunkt: 157°C Yield: 18% of the theoretical, Melting point: 157°C
Eksempel 127 5- amino- 2-( 1, 3- dihydro- 5- metoksy- isoindol- 2- yl)- benzoesyre Example 127 5-amino-2-(1,3-dihydro-5-methoxy-isoindol-2-yl)-benzoic acid
Fremstilt analogt med eksempel 93 ved katalytisk hydrogenering av 2-(1,3-dihydro-5-metoksy-isoindol-2-yl)-5-nitro-benzoesyre. Prepared analogously to example 93 by catalytic hydrogenation of 2-(1,3-dihydro-5-methoxy-isoindol-2-yl)-5-nitro-benzoic acid.
Utbytte: 75 % av det teoretiske,Yield: 75% of the theoretical,
Smeltepunkt: 2 02°CMelting point: 2 02°C
Eksempel 128 5- klor- 2-( 1, 3- dihydro- 5- metoksy- isoindol- 2- yl)- benzoesyre Example 128 5-chloro-2-(1,3-dihydro-5-methoxy-isoindol-2-yl)-benzoic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra 5-amino-2-(1,3-dihydro-5-metoksy-isoindol-2-yl)-benzoesyre. Prepared analogously to example 108 by Sandmeyer reaction starting from 5-amino-2-(1,3-dihydro-5-methoxy-isoindol-2-yl)-benzoic acid.
Utbytte: 34 % av det teoretiske,Yield: 34% of the theoretical,
Smeltepunkt: 148°CMelting point: 148°C
Eksempel 12 9 2- ( 1, 3- dihydro- 5- me. toksy- isoindol- 2- yl) - benzoesyre Fremstilt analogt m,ed eksempel 62 ved katalytisk de halogenering av 5-klor-2-(1,3-dihydro-5-metoksy-isoindol-2-yl)-benzoesyre. Example 12 9 2-(1,3-dihydro-5-me.toxy-isoindol-2-yl)-benzoic acid Prepared analogously to example 62 by catalytic dehalogenation of 5-chloro-2-(1,3-dihydro -5-Methoxy-isoindol-2-yl)-benzoic acid.
Utbytte: 64 % av det teoretiske,Yield: 64% of the theoretical,
Smeltepunkt: 14 0°CMelting point: 14 0°C
Eksempel 13 0 Example 13 0
2 -[ 4-( 3- pentyl)- piperidino]- benzoesyre2-[4-(3-pentyl)-piperidino]-benzoic acid
Fremstilt analogt med- eksempel 62 ved katalytisk dehalogenering av 5-klor-2-[4-(3-pentyl)-piperidino]benzoesyre. Utbytte: 31 % av det teoretiske, Prepared analogously to example 62 by catalytic dehalogenation of 5-chloro-2-[4-(3-pentyl)-piperidino]benzoic acid. Yield: 31% of the theoretical,
Smeltepunkt: 134-136°CMelting point: 134-136°C
Eksempel 131 Example 131
5- brom-- 2-- [ 4- ( 3- pentyl) - piperidino] benzoesyre5- bromo-- 2-- [ 4- ( 3- pentyl)-piperidino] benzoic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra 5-amino-2-[4-(3-pentyl)-piperidino]benzoesyre. Utbytte: 21 % av det., teoretiske , Prepared analogously to example 108 by Sandmeyer reaction starting from 5-amino-2-[4-(3-pentyl)-piperidino]benzoic acid. Yield: 21% of it., theoretical ,
Smeltepunkt: 157-158°CMelting point: 157-158°C
Eksempel 132 Example 132
5- cyan- 2-[ 4-( 3- pentyl)- piperidino] benzoesyre5-cyano-2-[4-(3-pentyl)-piperidino]benzoic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra 5-amino-2-[4-(3-pentyl)-piperidino]benzoesyre. Utbytte: 19 % av det teoretiske, Prepared analogously to example 108 by Sandmeyer reaction starting from 5-amino-2-[4-(3-pentyl)-piperidino]benzoic acid. Yield: 19% of the theoretical,
Smeltepunkt: 171°CMelting point: 171°C
Eksempel 13 3 Example 13 3
4 -[ 4-( 3- pentyl)- piperidino]- isoftalsyre4-[4-(3-pentyl)-piperidino]-isophthalic acid
Fremstilt ved alkalisk forsepning av 5-cyan-2-[4-(3-pentyl)-piperidino]-benzoesyre analogt med eksempel 5. Prepared by alkaline saponification of 5-cyano-2-[4-(3-pentyl)-piperidino]-benzoic acid analogously to example 5.
Utbytte: 27 .% av det teoretiske,Yield: 27.% of the theoretical,
Eksempel 134 Example 134
5- acetamino- 2-[ 4-( 3- pentyl)- piperidino]- benzoesyre 5- acetamino- 2-[ 4-( 3- pentyl)-piperidino]- benzoic acid
Fremstilt fra 5-amino-2-[4-(3-pentyl)-piperidino]-benzoesyre ved acetylering med eddiksyreanhydrid. Prepared from 5-amino-2-[4-(3-pentyl)-piperidino]-benzoic acid by acetylation with acetic anhydride.
Utbytte: 23 % av det teoretiske,Yield: 23% of the theoretical,
Smeltepunkt: 26 0-2 63°CMelting point: 26 0-2 63°C
Eksempel 135- Example 135-
5 ?metyl- 2-( oktahydro- lH- azonino)- benzoesyre5?methyl-2-(octahydro-1H-azonino)-benzoic acid
3,1 g (10,5 mMol) 3-brom-4-(oktahydro-lH-azonino)-toluen oppløses i 100 ml absolutt eter. Under nitrogen tilsettes dråpevis ved -50°C 20 ml av en 15 %ig butyllitiumoppløsning i heksan. Deréfter lar man reaksjonsblandingen komme til romtemperatur. Derefter settes reaksjonsblandingen raskt dråpevis til en suspensjon av fast karbondioksyd i absolutt eter, og den omrøres natten over. Derefter tilsettes vann, og pH-verdien innstilles på 4-5 med fortynnet saltsyre. Efter ekstraksjon med kloroform foretas kolonnekromatografisk rensning over silikagel (elueringsmiddel: toluen/eddiksyreetylester = 1:1). 3.1 g (10.5 mmol) of 3-bromo-4-(octahydro-1H-azonino)-toluene are dissolved in 100 ml of absolute ether. Under nitrogen, 20 ml of a 15% butyllithium solution in hexane is added dropwise at -50°C. The reaction mixture is then allowed to come to room temperature. The reaction mixture is then quickly added dropwise to a suspension of solid carbon dioxide in absolute ether, and it is stirred overnight. Water is then added, and the pH value is adjusted to 4-5 with diluted hydrochloric acid. After extraction with chloroform, column chromatographic purification is carried out over silica gel (eluent: toluene/acetic acid ethyl ester = 1:1).
Utbytte: 1,35 g (49,3 % av det teoretiske),Yield: 1.35 g (49.3% of the theoretical),
Smeltepunkt: ' 87°CMelting point: ' 87°C
• Eksempel 136 • Example 136
DL- 2-( 5- klor- 2- piperidino- fenyl)- propionsyreDL-2-(5-chloro-2-piperidino-phenyl)-propionic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra DL-2-(5-amino-2-piperidino-fenyl)-propionsyre. Utbytte: 45 % av det teoretiske, Prepared analogously to example 108 by Sandmeyer reaction starting from DL-2-(5-amino-2-piperidino-phenyl)-propionic acid. Yield: 45% of the theoretical,
Smeltepunkt: 134-135°CMelting point: 134-135°C
Eksempel 137 Example 137
DL- 2-( 5- klor- 2- oktahydro- lH- azonino- fenyl)- propionsyre DL- 2-( 5- chloro- 2- octahydro- 1H- azonino- phenyl)- propionic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra DL-2-(5-amino-2-oktahydro-lH-azonino-fenyl)-propionsyre. Prepared analogously to example 108 by Sandmeyer reaction starting from DL-2-(5-amino-2-octahydro-1H-azonino-phenyl)-propionic acid.
Utbytte: 17 % av det teoretiske,Yield: 17% of the theoretical,
Smeltepunkt: 139-140°CMelting point: 139-140°C
Eksempel 138 Example 138
DL- 2-[ 5- klor- 2-( oktahydro- isoindol- 2- yl)- fenyl]- propionsyre DL- 2-[ 5- chloro- 2-( octahydro- isoindol- 2- yl)- phenyl]- propionic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra DL-2-[5-amino-2-(oktahydro-isoindol-2-yl)-fenyl]-propionsyre. Prepared analogously to example 108 by Sandmeyer reaction starting from DL-2-[5-amino-2-(octahydro-isoindol-2-yl)-phenyl]-propionic acid.
Utbytte: 27 % av det teoretiske,Yield: 27% of the theoretical,
Smeltepunkt: 151-152°CMelting point: 151-152°C
Eksempel 13 9 Example 13 9
( 5- klor- 2- oktahydro- lH- azonino- fenyl)- eddiksyre(5-chloro-2-octahydro-1H-azonino-phenyl)-acetic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra (5-amino-2-oktahydro-lH-azonino-fenyl)-eddiksyre . Prepared analogously to example 108 by Sandmeyer reaction starting from (5-amino-2-octahydro-1H-azonino-phenyl)-acetic acid.
Utbytte: 58 % av det teoretiske,Yield: 58% of the theoretical,
Smeltepunkt: 63-65°CMelting point: 63-65°C
Eksempel 140 Example 140
( 5- klor- 2- heptametylenimino- fenyl)- eddiksyre(5-chloro-2-heptamethyleneimino-phenyl)-acetic acid
...Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra (5-amino-2-heptametylenimino-fenyl)-eddiksyre. Utbytte: 43 % av det teoretiske, ...Prepared analogously to example 108 by Sandmeyer reaction starting from (5-amino-2-heptamethyleneimino-phenyl)-acetic acid. Yield: 43% of the theoretical,
Smeltepunkt: 78°CMelting point: 78°C
Beregnet: Moltopp m/e = 280/2Calculated: Mole top m/e = 280/2
Funnet: Moltopp m/e = 2 80/2Found: Mole top m/e = 2 80/2
Eksempel 141 Example 141
( 5- klor- 2- heksametylenimino- fenyl)- eddiksyre(5-chloro-2-hexamethyleneimino-phenyl)-acetic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra (5-amino-2-heksametylenimino-fenyl)-eddiksyre. Utbytte: 77 % av det teoretiske, Prepared analogously to example 108 by Sandmeyer reaction starting from (5-amino-2-hexamethyleneimino-phenyl)-acetic acid. Yield: 77% of the theoretical,
Smeltepunkt:' <20°CMelting point:' <20°C
Eksempel 142 Example 142
( 5- klor- 2- piper idino- fenyl)- eddiksyre (5-chloro-2-piperidino-phenyl)-acetic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjonPrepared analogously to example 108 by Sandmeyer reaction
ved å gå ut fra (5-amino-2-piperidino-fenyl)-eddiksyre.starting from (5-amino-2-piperidino-phenyl)-acetic acid.
Utbytte: 63 % av det teoretiske,Yield: 63% of the theoretical,
Smeltepunkt: 105°CMelting point: 105°C
Eksempel 14 3 Example 14 3
( 5- klor- 2- pyrrolidino- fenyl)- eddiksyre(5-chloro-2-pyrrolidino-phenyl)-acetic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra (5-amino-2-pyrrolidino-fenyl)-eddiksyre. Utbytte: 54 % av det teoretiske, Prepared analogously to example 108 by Sandmeyer reaction starting from (5-amino-2-pyrrolidino-phenyl)-acetic acid. Yield: 54% of the theoretical,
Smeltepunkt: 105-107°CMelting point: 105-107°C
Eksempel 144 Example 144
[ 5- klor- 2-( oktahydro- isoindol- 2- yl)- fenyl]- eddiksyre Fremstilt analogt.med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra f5-amino-2-(oktahydro-isoindol-2-yl)-fenyl]-eddiksyre. [5-chloro-2-(octahydro-isoindol-2-yl)-phenyl]-acetic acid Prepared analogously to example 108 by Sandmeyer reaction starting from f5-amino-2-(octahydro-isoindol-2-yl) )-phenyl]-acetic acid.
Utbytte: 40 % av det teoretiske,Yield: 40% of the theoretical,
Smeltepunkt: 156-157°CMelting point: 156-157°C
Eksempel 14 5 Example 14 5
[ 2-( oktahydro- isoindol- 2- yl)- fenyl]- eddiksyre[ 2-( octahydro-isoindol-2-yl)-phenyl]-acetic acid
Fremstilt analogt med eksempel 120 fra [5-amino-2-(oktahydro-i soindol-2-yl)-fenyl]-eddiksyre. Prepared analogously to Example 120 from [5-amino-2-(octahydro-indol-2-yl)-phenyl]-acetic acid.
Utbytte: 15 % av det teoretiske,Yield: 15% of the theoretical,
Smeltepunkt: 135-136°CMelting point: 135-136°C
Eksempel 14 6 Example 14 6
[ 5- klor- 2- (- 4- ( 3- pentyl) - piperidino) - fenyl ] - eddiksyre [ 5- chloro- 2-(- 4-( 3- pentyl)-piperidino)-phenyl]-acetic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra [5-amino-2-(4-(3-pentyl)-piperidino)-fenyl]-eddiksyre. Prepared analogously to example 108 by Sandmeyer reaction starting from [5-amino-2-(4-(3-pentyl)-piperidino)-phenyl]-acetic acid.
Utbytte: 17 % av det teoretiske, Yield: 17% of the theoretical,
Smeltepunkt: <2 0°CMelting point: <2 0°C
Eksempel 147 . Example 147 .
( 2- piperidino- difenyl) eddiksyre- hydroklorid( 2- piperidino-diphenyl) acetic acid hydrochloride
a) ( 2- piperidino- difenyl) acetonitrila) (2-piperidino-diphenyl)acetonitrile
Til 17,0 g (52,8 mMol) 2-piperidino-benzhydryl-klorid^To 17.0 g (52.8 mmol) of 2-piperidino-benzhydryl chloride^
hydroklorid (fremstilt fra 2-piperidino-benzhydrylalkohol ved behandling med tionylklorid);i 200 ml dimetylsulfoksyd setter man 8,5 g (0,17 mol) natriumcyanid og omrører videre i 2 timer ved 60-70°C. Derefter tilsetter man kald, fortynnet natronlut og ekstraherer med metylenklorid. Efter tilsetning av noe aktivt kull ekstraheres de inndampede ekstrakter i varm til-stand med petroleter (90-110°C). Efter inndampning av petroleter-ekstraktene blir det tilbake en gulig olje. hydrochloride (produced from 2-piperidino-benzhydryl alcohol by treatment with thionyl chloride); 8.5 g (0.17 mol) of sodium cyanide are added to 200 ml of dimethyl sulphoxide and the mixture is stirred for 2 hours at 60-70°C. Cold, diluted caustic soda is then added and extracted with methylene chloride. After adding some activated charcoal, the evaporated extracts are extracted in a warm state with petroleum ether (90-110°C). After evaporation of the petroleum ether extracts, a yellow oil remains.
Utbytte: 12,7 g (87 % av det teoretiske), olje.Yield: 12.7 g (87% of theory), oil.
b) ( 2- piperidino- difenyl)- eddiksyre- hydrokloridb) (2-piperidino-diphenyl)-acetic acid hydrochloride
1,5 g (5,4 mMol) '(2-piperidino-dif enyl)-acetonitril kokes 1.5 g (5.4 mmol) of '(2-piperidino-diphenyl)-acetonitrile is boiled
under tilbakeløpskjøling i 3 timer med 50 ml konsentrert saltsyre. Derefter inndamper man til tørrhet og omkrystallisérer fra 2 N saltsyre. under reflux for 3 hours with 50 ml of concentrated hydrochloric acid. It is then evaporated to dryness and recrystallized from 2 N hydrochloric acid.
Utbytte: 1,2 g (75,2 % av det teoretiske),Yield: 1.2 g (75.2% of the theoretical),
Smeltepunkt: 195-200°C (spaltning)Melting point: 195-200°C (decomposition)
Eksempel 148 Example 148
2-( oktahydro- i soindol- 2- yl)- nikotinsyre2-( octahydro- i soindol- 2- yl)- nicotinic acid
3,15 g (20 mMol)'2-klor-nikotinsyre og 2,5 g (20 mMol) oktahydro-isoindol i 50 ml etanol oppvarmes i 18 timer under til-bakeløpsk jøling sammen med 5,2 g (40 mMol) N-etyldiisopropylamin. Derefter inndampes reaks jonsblandingen,. opptas i vann og tilsettes 20 mMol iseddik. Derefter ekstraheres med kloroform. 3.15 g (20 mmol) of 2-chloronicotinic acid and 2.5 g (20 mmol) of octahydroisoindole in 50 ml of ethanol are heated for 18 hours under reflux together with 5.2 g (40 mmol) of N -ethyldiisopropylamine. The reactive ion mixture is then evaporated. taken up in water and 20 mmol of glacial acetic acid are added. Then extract with chloroform.
De tørrede kloroformekstrakter inndampes, og den oppnådde krystallinske rest omkrystalliseres fra acetonitril. The dried chloroform extracts are evaporated, and the crystalline residue obtained is recrystallized from acetonitrile.
Utbytte: 1,8. g (37 % av det teoretiske),Yield: 1.8. g (37% of the theoretical),
Smeltepunkt: 217-218°CMelting point: 217-218°C
Eksempel 14 9 5- klor- 2-( oktahydro- isoindol- 2- yl)- nikotinsyre Example 14 9 5-chloro-2-(octahydro-isoindol-2-yl)-nicotinic acid
Fremstilt fra 2,5-diklor-nikotinsyre og oktahydro-isoindol analogt med eksempel 148. Prepared from 2,5-dichloro-nicotinic acid and octahydro-isoindole analogously to example 148.
Utbytte: 36 % av det teoretiske,Yield: 36% of the theoretical,
Smeltepunkt: 23 3-23 5°CMelting point: 23 3-23 5°C
Eksempel 150 Example 150
6- metyl- 2- piperidino- nikotinsyre6- methyl- 2- piperidino- nicotinic acid
Fremstilt fra 2-klor-6-metyl-nikotinsyre og piperidin analogt med eksempel 148. Prepared from 2-chloro-6-methyl-nicotinic acid and piperidine analogously to example 148.
Utbytte: 68 % av det teoretiske, Smeltepunkt: 120-122°C Yield: 68% of the theoretical, Melting point: 120-122°C
Eksempel 151 Example 151
5- klor- 6- metyl- 2- piperidinonikotinsyre5- Chloro- 6- Methyl- 2- Piperidinenicotinic acid
Fremstilt fra 2,5--diklor-6-metyl-nikotinsyre og' piperidin analogt med eksempel 148. Prepared from 2,5-dichloro-6-methyl-nicotinic acid and piperidine analogously to example 148.
Utbytte: 56 % av det teoretiske,Yield: 56% of the theoretical,
Smeltepunkt: 130-132°CMelting point: 130-132°C
Eksempel 152 Example 152
5- klor- 2- oktahydro- lH- azonino- nikotinsyre5- chloro- 2- octahydro- 1H- azonino- nicotinic acid
Fremstilt fra 2,5-diklor-nikotinsyre og oktahydro-lH-azonin analogt med eksempel 148. Prepared from 2,5-dichloro-nicotinic acid and octahydro-1H-azonine analogously to Example 148.
Utbytte: 57 % av. det teoretiske,Yield: 57% of. the theoretical,
Smeltepunkt: 154-156°CMelting point: 154-156°C
Eksempel 153 Example 153
5- klor- 2-( cis- 3, 5- dimetyl- piperidino)- nikotinsyre 5-chloro-2-(cis-3,5-dimethyl-piperidino)-nicotinic acid
Fremstilt fra 2,5-diklornikotinsyre og cis-3,5-dimetyl-piperidin analogt med eksempel 14 8. Utbytte: 40 % av det teoretiske, Prepared from 2,5-dichloronicotinic acid and cis-3,5-dimethyl-piperidine analogously to example 14 8. Yield: 40% of the theoretical,
Smeltepunkt: 78-80°CMelting point: 78-80°C
Eksempel 154 Example 154
5- klor- 2- piperidino- nikotinsyre5-chloro-2-piperidino-nicotinic acid
Fremstilt fra 2,5-diklor-nikotinsyre og piperidin analogt med eksempel 14 8. Prepared from 2,5-dichloronicotinic acid and piperidine analogously to example 14 8.
Utbytte: 63 % av det teoretiske,Yield: 63% of the theoretical,
Smeltepunkt: 149-152°CMelting point: 149-152°C
Eksempel 155 Example 155
5- brom- 6- metyl- 2- piperidino- nikotinsyre5- bromo- 6- methyl- 2- piperidino- nicotinic acid
Fremstilt fra 5-brom-2-klor-6-metyl-nikotinsyre og piperidin Prepared from 5-bromo-2-chloro-6-methyl-nicotinic acid and piperidine
. analogt med eksempel 148.. analogous to example 148.
Utbytte: 35 % av det teoretiske,Yield: 35% of the theoretical,
Smeltepunkt: 108-111DCMelting point: 108-111DC
Eksempel 156 Example 156
5- brom- 2- piperidino- nikotinsyre5- bromo- 2- piperidino- nicotinic acid
Fremstilt fra 5-br6m-2-klor-nikotinsyre og piperidin analogt med eksempel 14 8. Prepared from 5-br6m-2-chloro-nicotinic acid and piperidine analogously to example 14 8.
Utbytte: 43 % av det teoretiske,Yield: 43% of the theoretical,
Smeltepunkt: . 172-174°CMelting point: . 172-174°C
Eksempel 157 Example 157
[ 2- piperidino- pyridyl-( 3) jeddiksyre [ 2- Piperidino- pyridyl-(3) acetic acid
Fremstilt ved alkalisk forsepning av [2-piperidino-pyridyl-(3)]eddiksyre-etylester med smeltepunkt <20°C (fremstilt fra Prepared by alkaline saponification of [2-piperidino-pyridyl-(3)]acetic acid ethyl ester with melting point <20°C (prepared from
[2-piperidino-pyridyl-(3)]-acetonitril ved kokning med etanolisk saltsyre) analogt med eksempel 5. [2-piperidino-pyridyl-(3)]-acetonitrile by boiling with ethanolic hydrochloric acid) analogously to example 5.
Utbytte:. 81 % av det teoretiske,Dividend:. 81% of the theoretical,
Smeltepunkt: 112-115°CMelting point: 112-115°C
Eksempel 158 Example 158
[ 5- klor- 2- piperidino- pyridyl-( 3)] eddiksyre[5-chloro-2-piperidino-pyridyl-(3)]acetic acid
Fremstilt ved alkalisk forsepning av [5-klor-2-piperidiho-pyridyl-(3)]eddiksyre-etylester med smeltepunkt <20°C (fremstilt fra [5-klor-2-piperidino-pyridyl-(3)]acetonitril ved kokning med etanolisk saltsyre) analogt med eksempel 5. Prepared by alkaline saponification of [5-chloro-2-piperidino-pyridyl-(3)]acetic acid ethyl ester of melting point <20°C (prepared from [5-chloro-2-piperidino-pyridyl-(3)]acetonitrile by boiling with ethanolic hydrochloric acid) analogously to example 5.
Utbytte: 89 % av det teoretiske,Yield: 89% of the theoretical,
Smeltepunkt: 12 4-12 6°CMelting point: 12 4-12 6°C
Eksempel 159 Example 159
5- klor- 6- metyl- 2-( cis- 3, 5- dimetyl- piperidino) nikotinsyre 5- chloro- 6- methyl- 2-( cis- 3, 5- dimethyl- piperidino) nicotinic acid
Fremstilt fra 2,5-diklor-6-metyl-nikotinsyre og cis-3,5-dimetyl-piperidin analogt med eksempel 14 8. Prepared from 2,5-dichloro-6-methyl-nicotinic acid and cis-3,5-dimethyl-piperidine analogously to example 14 8.
Utbytte: 18 % av det teoretiske,Yield: 18% of the theoretical,
Smeltepunkt: <2 0°CMelting point: <2 0°C
Eksempel 160 5- brom- 6- metyl- 2-( cis- 3, 5- dimetyl- piperidino) nikotinsyre Example 160 5-bromo-6-methyl-2-(cis-3,5-dimethyl-piperidino)nicotinic acid
Fremstilt fra 5-brom-2-klor-6-metyl-nikotinsyre og cis-3,5-dimetyl-piperidin analogt med eksempel 14 8. Prepared from 5-bromo-2-chloro-6-methyl-nicotinic acid and cis-3,5-dimethyl-piperidine analogously to example 14 8.
Utbytte: 28 % av det.teoretiske,Yield: 28% of the.theoretical,
Smeltepunkt: <20°CMelting point: <20°C
Eksempel 161 Example 161
1- metyl- 2- piper idino- benzoesyre1- methyl- 2- piper idino- benzoic acid
Fremstilt analogt med eksempel 135 ved omsetning av 3-brorn-2- piperidino-toluen med butyl-litium og påfølgende karboksylering med karbondioksyd. Prepared analogously to example 135 by reaction of 3-brorn-2-piperidino-toluene with butyllithium and subsequent carboxylation with carbon dioxide.
Utbytte: 64 % av det teoretiske,Yield: 64% of the theoretical,
Smeltepunkt: . 126-128°CMelting point: . 126-128°C
Beregnet: Moltopp: m/e = 219Calculated: Mole top: m/e = 219
Funnet: Moltopp: m/e = 219Found: Mole top: m/e = 219
Eksempel 162 Example 162
3- klor- 2- piperidino- benzoesyre3-chloro-2-piperidino-benzoic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra 3-amino-2-piperidino-benzoesyre. Utbytte: 54 % av det teoretiske, Prepared analogously to example 108 by Sandmeyer reaction starting from 3-amino-2-piperidino-benzoic acid. Yield: 54% of the theoretical,
Beregnet: Moltopp: m/e = 239/241 (1 Cl)Calculated: Mole peak: m/e = 239/241 (1 Cl)
Funnet: Moltopp: m/e = 23 9/2 41 (1 Cl)Found: Mole top: m/e = 23 9/2 41 (1 Cl)
Eksempel 16 3 Example 16 3
3- metyl- 2-( oktahydro- isoindol- 2- yl)- benzoesyre3-methyl-2-(octahydro-isoindol-2-yl)-benzoic acid
Fremstilt analogt med eksempel 135 ved omsetning av 3-brom-2- (oktahydro-isoindol-2-yl)-toluen med butyl-litium.og på-følgende karboksylering med karbondioksyd. Prepared analogously to example 135 by reacting 3-bromo-2-(octahydro-isoindol-2-yl)-toluene with butyllithium and subsequent carboxylation with carbon dioxide.
Utbytte: 53 % av det teoretiske,Yield: 53% of the theoretical,
Beregnet: C 74,10 H 8,16 N 5,40Calculated: C 74.10 H 8.16 N 5.40
Funnet: 74,27 8,29 5,53 Found: 74.27 8.29 5.53
Beregnet: Moltopp m/e =2 59Calculated: Moltop m/e =2 59
Funnet: Moltopp m/e = 259Found: Moltop m/e = 259
Eksempel 164Example 164
3- kior- 2-( oktahydro- isoindol- 2- yl)- benzoesyre3-chloro-2-(octahydro-isoindol-2-yl)-benzoic acid
Fremstilt analogt med eksempel 108 ved Sandmeyer-reaksjon ved å gå ut fra '3-amino-2-(oktahydro-isoindol-2-yl)-benzoesyre. Utbytte: 59 % av det teoretiske, Prepared analogously to example 108 by Sandmeyer reaction starting from '3-amino-2-(octahydro-isoindol-2-yl)-benzoic acid. Yield: 59% of the theoretical,
Beregnet: C 64,40 H 6,48 Cl 12,67 N 5,00 Calculated: C 64.40 H 6.48 Cl 12.67 N 5.00
Funnet: 64, 27 .6,40 12 , 49! 5,12 Found: 64, 27 .6,40 12 , 49! 5.12
Beregnet: Moltopp m/e = 279/281 (1 Cl)Calculated: Mole peak m/e = 279/281 (1 Cl)
Funnet: Moltopp m/e = 279/281 (1 Cl) Found: Mole peak m/e = 279/281 (1 Cl)
Claims (5)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3100535A DE3100535A1 (en) | 1981-01-10 | 1981-01-10 | "NEW CARBONIC ACID DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS" |
Publications (1)
Publication Number | Publication Date |
---|---|
NO820046L true NO820046L (en) | 1982-07-12 |
Family
ID=6122396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO820046A NO820046L (en) | 1981-01-10 | 1982-01-08 | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOXYLIC ACID DERIVATIVES |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0056144A1 (en) |
JP (1) | JPS57140766A (en) |
KR (1) | KR830009072A (en) |
AU (1) | AU7929082A (en) |
CS (1) | CS236668B2 (en) |
DD (1) | DD202021A5 (en) |
DE (1) | DE3100535A1 (en) |
DK (1) | DK536281A (en) |
ES (4) | ES508586A0 (en) |
FI (1) | FI820060L (en) |
GB (2) | GB2091729A (en) |
GR (1) | GR75135B (en) |
HU (1) | HU187561B (en) |
IL (1) | IL64732A0 (en) |
NO (1) | NO820046L (en) |
PH (1) | PH20430A (en) |
PL (2) | PL238405A1 (en) |
PT (1) | PT74262A (en) |
ZA (1) | ZA82149B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3139970A1 (en) * | 1981-10-08 | 1983-04-28 | Boehringer Mannheim Gmbh, 6800 Mannheim | NEW CARBONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
DE3211934A1 (en) * | 1982-03-31 | 1983-10-13 | Hoechst Ag, 6230 Frankfurt | SALICYL ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS BASED ON THESE COMPOUNDS AND THEIR USE |
DE3320583A1 (en) * | 1983-06-08 | 1984-12-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | NEW GALENIC PREPARATION FORMS OF ORAL ANTIDIABETICS AND METHOD FOR THE PRODUCTION THEREOF |
DE3320582A1 (en) * | 1983-06-08 | 1984-12-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | METHODS OF PREPARATION WITH GLIQUIDONE AND METHOD FOR THE PRODUCTION THEREOF |
US5312924A (en) | 1983-12-30 | 1994-05-17 | Dr. Karl Thomae Gmbh | Phenylacetic acid benzylamides |
DE3347565A1 (en) * | 1983-12-30 | 1985-07-11 | Thomae Gmbh Dr K | NEW PHENYL ACETIC DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
US5216167A (en) * | 1983-12-30 | 1993-06-01 | Dr. Karl Thomae Gmbh | Phenylacetic acid benzylamides |
JPS61165372A (en) * | 1985-01-17 | 1986-07-26 | Daicel Chem Ind Ltd | 3-halopyridine-3-carboxamide compound |
JPH0710846B2 (en) * | 1985-01-18 | 1995-02-08 | ダイセル化学工業株式会社 | 4-Substituted oxy-3-pyridinecarboxamide compound |
EP0716656A1 (en) * | 1993-09-03 | 1996-06-19 | Smithkline Beecham Plc | Amide derivatives as 5ht1d receptor antagonists |
US20050261278A1 (en) | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
CN101137758B (en) | 2004-11-03 | 2012-10-10 | 意力速分子诊断股份有限公司 | Homogeneous analyte detection |
ES2376578T3 (en) | 2004-11-03 | 2012-03-15 | Iris Molecular Diagnostics, Inc. | MICROBUBBLES FOR AFFINITY SEPARATION. |
KR20070112775A (en) * | 2005-01-10 | 2007-11-27 | 아카디아 파마슈티칼스 인코포레이티드 | Aminophenyl derivatives as selective androgen receptor modulators |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4163788A (en) * | 1968-03-27 | 1979-08-07 | Ciba-Geigy Corporation | Tertiary aminoacids |
DE2500157C2 (en) * | 1975-01-03 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | N-acyl-4- (2-aminoethyl) benzoic acids, their salts and esters, process for their preparation and their use |
DE2655144A1 (en) * | 1976-12-06 | 1978-06-08 | Basf Ag | 2,6-Di:amino-nicotinamide derivs. used in azo dyestuffs - as coupling components and prepn. from nicotinonitrile and amine cpds. |
DE3016650A1 (en) * | 1979-07-13 | 1981-11-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Amino-pyridine or benzene carboxylic acid derivs. - with metabolic, esp. hypoglycaemic and hypolipaemic, activity |
DE3016651A1 (en) * | 1980-04-30 | 1981-11-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Amino-pyridine or benzene carboxylic acid derivs. - with metabolic, esp. hypoglycaemic and hypolipaemic, activity |
EP0023569B1 (en) * | 1979-07-13 | 1983-06-22 | Dr. Karl Thomae GmbH | Derivatives of carboxylic acids, their preparation and medicaments containing them |
DE2928352A1 (en) * | 1979-07-13 | 1981-01-15 | Thomae Gmbh Dr K | Hypoglycaemic 2-amino-benzamido-ethyl-benzoic acid derivs. - prepd. e.g. by reaction of 2-amino-benzoic acid derivs. with 4-aminoethyl-benzoic acid derivs. |
DE2949259A1 (en) * | 1979-07-13 | 1981-06-11 | Dr. Karl Thomae Gmbh, 7950 Biberach | Amino-pyridine or benzene carboxylic acid derivs. - with metabolic, esp. hypoglycaemic and hypolipaemic, activity |
-
1981
- 1981-01-10 DE DE3100535A patent/DE3100535A1/en not_active Withdrawn
- 1981-12-03 DK DK536281A patent/DK536281A/en not_active Application Discontinuation
- 1981-12-23 EP EP81110731A patent/EP0056144A1/en not_active Ceased
-
1982
- 1982-01-04 GR GR66965A patent/GR75135B/el unknown
- 1982-01-07 DD DD82236614A patent/DD202021A5/en unknown
- 1982-01-08 IL IL64732A patent/IL64732A0/en unknown
- 1982-01-08 PL PL23840582A patent/PL238405A1/en unknown
- 1982-01-08 NO NO820046A patent/NO820046L/en unknown
- 1982-01-08 CS CS82178A patent/CS236668B2/en unknown
- 1982-01-08 PH PH26760A patent/PH20430A/en unknown
- 1982-01-08 HU HU8258A patent/HU187561B/en unknown
- 1982-01-08 GB GB8200489A patent/GB2091729A/en not_active Withdrawn
- 1982-01-08 AU AU79290/82A patent/AU7929082A/en not_active Abandoned
- 1982-01-08 PL PL23466282A patent/PL234662A1/en unknown
- 1982-01-08 ES ES508586A patent/ES508586A0/en active Granted
- 1982-01-08 FI FI820060A patent/FI820060L/en not_active Application Discontinuation
- 1982-01-08 PT PT74262A patent/PT74262A/en unknown
- 1982-01-09 KR KR1019820000091A patent/KR830009072A/en unknown
- 1982-01-11 ZA ZA82149A patent/ZA82149B/en unknown
- 1982-01-11 JP JP57001885A patent/JPS57140766A/en active Pending
- 1982-07-09 ES ES513844A patent/ES8306137A1/en not_active Expired
- 1982-07-09 ES ES513846A patent/ES513846A0/en active Granted
- 1982-07-09 ES ES513845A patent/ES513845A0/en active Granted
-
1984
- 1984-09-04 GB GB848422314A patent/GB8422314D0/en active Pending
Also Published As
Publication number | Publication date |
---|---|
ES8305345A1 (en) | 1983-04-01 |
FI820060L (en) | 1982-07-11 |
PH20430A (en) | 1987-01-05 |
ES8305718A1 (en) | 1983-04-16 |
ZA82149B (en) | 1983-09-28 |
CS236668B2 (en) | 1985-05-15 |
ES513846A0 (en) | 1983-04-16 |
AU7929082A (en) | 1982-07-22 |
PL234662A1 (en) | 1983-01-31 |
ES8304145A1 (en) | 1983-02-16 |
PT74262A (en) | 1982-02-01 |
KR830009072A (en) | 1983-12-17 |
ES508586A0 (en) | 1983-02-16 |
JPS57140766A (en) | 1982-08-31 |
GB2091729A (en) | 1982-08-04 |
ES513844A0 (en) | 1983-05-01 |
PL238405A1 (en) | 1983-05-23 |
ES513845A0 (en) | 1983-04-01 |
DK536281A (en) | 1982-07-11 |
GR75135B (en) | 1984-07-13 |
DE3100535A1 (en) | 1982-08-12 |
GB8422314D0 (en) | 1984-10-10 |
DD202021A5 (en) | 1983-08-24 |
ES8306137A1 (en) | 1983-05-01 |
IL64732A0 (en) | 1982-03-31 |
HU187561B (en) | 1986-01-28 |
EP0056144A1 (en) | 1982-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO820046L (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOXYLIC ACID DERIVATIVES | |
US4284629A (en) | Process for the preparation of 4-pyridone-3-carboxylic acids and/or derivatives thereof | |
CA1064933A (en) | Benzoic acids, their derivatives and process for preparing them | |
US5359068A (en) | Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one | |
KR20080049020A (en) | Novel indole compounds | |
US4727150A (en) | Pyridyl methylsulfinyl benzimidazole derivatives | |
PL164432B1 (en) | Method of obtaining novel aminophenol derivatives | |
NO152005B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOXYLIC ACID DERIVATIVES | |
NO820047L (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOXYLIC ACIDAMIDS | |
NO760054L (en) | ||
NO831170L (en) | SALICYL DERIVATIVES, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS BASED ON THESE COMPOUNDS AND THEIR USE | |
US3271394A (en) | Alpha-indolyl-3-acetic acid esters | |
NO141850B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRAZOLD DERIVATIVES | |
NO845169L (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZIMIDAZOLE DERIVATIVES | |
US4158063A (en) | Acylamino(alkyl)benzene derivatives and process for preparing them | |
US4515944A (en) | 1,5-Diphenyl-2-haloalkylpyrazolin-3-one intermediates | |
US4154734A (en) | Amides of 4-hydroxy-6H-thieno[2,3-b]thiopyran-5-carboxylic acid-7,7-dioxide | |
US5137909A (en) | Indole derivative and method of production thereof | |
DK158227B (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF SUBSTITUTED IMIDAZOOE1,5-AAAPYRIDINES OR 5,6,7,8-TETRAHYDRODE DERIVATIVES OR SALTS THEREOF | |
JPS63141969A (en) | Novel imidazole derivative | |
US4806560A (en) | Imidazo[4,5-b]pyridin-2-one derivatives | |
NO159590B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PHENYLEDIC ACID DERIVATIVES. | |
EP0084292B1 (en) | N,n-disubstituted alkenamides and phenylalkenamides, processes for their production and their use as pharmaceuticals | |
US4859663A (en) | Multiply substituted pyridine 1-oxide compounds which are useful in treating brain disorders | |
EP0287971A2 (en) | Benzimidazole derivatives and process for their preparations |